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A B S T R A C T
Background
Previous systematic reviews and meta-analyses consistently show the positive effect of exercise-based rehabilitation for heart failure (HF)
on exercise capacity; however, the direction and magnitude of effects on health-related quality of life, mortality and hospital admissions
in HF remain less certain. This is an update of a Cochrane systematic review previously published in 2010.
Objectives
To determine the effectiveness of exercise-based rehabilitation on themortality, hospitalisation admissions, morbidity and health-related
quality of life for people with HF. Review inclusion criteria were extended to consider not only HF due to reduced ejection fraction
(HFREF or ’systolic HF’) but also HF due to preserved ejection fraction (HFPEF or ’diastolic HF’).
Search methods
We updated searches from the previous Cochrane review. We searched the Cochrane Central Register of Controlled Trials (CENTRAL)
(Issue1, 2013) from January 2008 to January 2013. We also searched MEDLINE (Ovid), EMBASE (Ovid), CINAHL (EBSCO) and
PsycINFO (Ovid) (January 2008 to January 2013). We handsearched Web of Science, bibliographies of systematic reviews and trial
registers (Controlled-trials.com and Clinicaltrials.gov).
Selection criteria
Randomised controlled trials of exercise-based interventions with six months’ follow-up or longer compared with a no exercise control
that could include usual medical care. The study population comprised adults over 18 years and were broadened to include individuals
with HFPEF in addition to HFREF.
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Data collection and analysis
Two review authors independently screened all identified references and rejected those that were clearly ineligible. We obtained full-
text papers of potentially relevant trials. One review author independently extracted data from the included trials and assessed their
risk of bias; a second review author checked data.
Main results
We included 33 trials with 4740 people with HF predominantly with HFREF and New York Heart Association classes II and III.
This latest update identified a further 14 trials. The overall risk of bias of included trials was moderate. There was no difference in
pooled mortality between exercise-based rehabilitation versus no exercise control in trials with up to one-year follow-up (25 trials, 1871
participants: risk ratio (RR) 0.93; 95% confidence interval (CI) 0.69 to 1.27, fixed-effect analysis). However, there was trend towards
a reduction in mortality with exercise in trials with more than one year of follow-up (6 trials, 2845 participants: RR 0.88; 95% CI
0.75 to 1.02, fixed-effect analysis). Compared with control, exercise training reduced the rate of overall (15 trials, 1328 participants:
RR 0.75; 95% CI 0.62 to 0.92, fixed-effect analysis) and HF specific hospitalisation (12 trials, 1036 participants: RR 0.61; 95% CI
0.46 to 0.80, fixed-effect analysis). Exercise also resulted in a clinically important improvement superior in the Minnesota Living with
Heart Failure questionnaire (13 trials, 1270 participants: mean difference: -5.8 points; 95% CI -9.2 to -2.4, random-effects analysis) -
a disease specific health-related quality of life measure. However, levels of statistical heterogeneity across studies in this outcome were
substantial. Univariate meta-regression analysis showed that these benefits were independent of the participant’s age, gender, degree
of left ventricular dysfunction, type of cardiac rehabilitation (exercise only vs. comprehensive rehabilitation), mean dose of exercise
intervention, length of follow-up, overall risk of bias and trial publication date. Within these included studies, a small body of evidence
supported exercise-based rehabilitation for HFPEF (three trials, undefined participant number) and when exclusively delivered in a
home-based setting (5 trials, 521 participants). One study reported an additional mean healthcare cost in the training group compared
with control of USD3227/person. Two studies indicated exercise-based rehabilitation to be a potentially cost-effective use of resources
in terms of gain in quality-adjusted life years (QALYs) and life-years saved.
Authors’ conclusions
This updated Cochrane review supports the conclusions of the previous version of this review that, compared with no exercise control,
exercise-based rehabilitation does not increase or decrease the risk of all-cause mortality in the short term (up to 12-months’ follow-up)
but reduces the risk of hospital admissions and confers important improvements in health-related quality of life. This update provides
further evidence that exercise training may reduce mortality in the longer term and that the benefits of exercise training on appear to
be consistent across participant characteristics including age, gender and HF severity. Further randomised controlled trials are needed
to confirm the small body of evidence seen in this review for the benefit of exercise in HFPEF and when exercise rehabilitation is
exclusively delivered in a home-based setting.
P L A I N L A N G U A G E S U M M A R Y
Exercise-based rehabilitation for heart failure
Background
People with heart failure experience marked reductions in their exercise capacity, which has detrimental effects on their activities of
daily living, health-related quality of life and ultimately their hospital admission rate and mortality.
Study characteristics
We searched the scientific literature for randomised controlled trials (experiments inwhich two ormore interventions, possibly including
a control intervention or no intervention, are compared by being randomly allocated to participants) looking at the effectiveness of
exercise-based treatments compared with no exercise on heart failure in adults over 18 years of age. The inclusion criteria of this updated
review were extended to consider not only HF due to reduced ejection fraction (HFREF or ’systolic HF’) (ejection fraction is a measure
of how well your heart is pumping), but also HF due to preserved ejection fraction (HFPEF or ’diastolic HF’). The search is current
to January 2013.
Key results
We found 33 RCTs that included 4740 participants. The findings of this update are consistent with the previous (2010) version of this
Cochrane review and show important benefits of exercise-based rehabilitation that include a reduction in the risk of hospital admissions
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due to HF and improvements in health-related quality of life compared with not undertaking exercise. There was a high level of
variation across studies in health-related quality of life outcome. While the majority of evidence was for exercise-based rehabilitation in
people with HFREF, this update did identify a broader evidence base that included higher risk (New York Heart Association class IV)
and older people, people with HFPEF and more programmes conducted in a home-based setting. We found no evidence to suggest
that exercise training programmes cause harm in terms of an increase in the risk of death in either the short or longer term. A small
body of economic evidence was identified indicating exercise-based rehabilitation to be cost-effective. Further evidence is needed to
understand the effect of exercise training in people with HFPEF better and the costs and effects of exclusively home-based exercise
rehabilitation programmes.
Quality of evidence
The general lack of reporting of methods in the included trial reports made it difficult to assess their methodological quality and thereby
judge their risk of possible bias.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Trial first author (year) Follow-up Measure Outcome values (or
change from baseline) at
follow-up
Mean (standard devia-
tion)
Control vs. exercise; be-
tween-group P value
Between-group differ-
ence
Austin (2005/8) 6 months
5 years
MLWHF
Physical
Emotional
Total
EQ-5D
MLWHF
Physical
Emotional
Total
EQ-5D
20.4 (12.2) vs. 12.6 (9.7)
; P value <0.0001*
8.0 (7.1) vs. 4.4 (10.4); P
value <0.01*
36.9 (24.0) vs. 22.9 (17.
8); P value <0.001*
0.58 (0.19) vs. 0.70 (0.
16); P value <0.0001*
19.3 (23.5) vs. 18.3 (11.
2); P value = 0.66*
7.6 (7.1) vs. 7.4 (6.5); P
value = 0.88*
37.1 (24.9) vs. 35.5 (21.
7); P value = 0.72*
0.58 (0.22) vs. 0.64 (0.
19); P value = 0.12*
Exercise >Control
Exercise >Control
Exercise >Control
Exercise >Control
Exercise = Control
Exercise = Control
Exercise = Control
Exercise = Control
Belardinelli (1999) 15 months
29 months
MLWHF total 52 (20) vs. 39 (20); P
value <0.001
54 (22) vs. 44 (21); P
value <0.001
Exercise >Control
Exercise >Control
DANREHAB (2008) 12 months SF-36
PCS
MCS
37.4 (11.4) vs. 42.7 (9.1)
*; P value = 0.14
50.5 (10.0) vs. 49.7 (8.8)
*; P value = 0.81
Exercise = Control
Exercise = Control
Davidson (2010) 12 months MLWHF total 56.4 (18.3) vs. 52.9 (15.
7); P value = 0.33
Exercise = Control
Dracup (2007) 6 months MLWHF
Physical
Emotional
Total
19.4 (11.5) vs. 16.1 (10.
0); P value = 0.04*
10.5 (7.4) vs. 7.8 (6.6); P
value = 0.01*
43.2 (26.5) vs. 35.7 (23.
7); P value = 0.05
Exercise >Control
Exercise >Control
Exercise >Control
Gary (2010) Comp 6 months MLWHF total 34.3 (23.6) vs. 24.2 (16.
3); P value = 0.18*
Exercise = Control
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Gary (2010) Exer 6 months MLWHF total 28.9 (29.9) vs. 25.6 (19.
7); P value = 0.71*
Exercise = Control
Gottlieb (1999) 6 months MLWHF
Total
MOS
PF
RL
GH
NR (NR) vs. 22 (20) NR
-
NR (NR) vs. 68 (28) NR
NR (NR) vs. 50 (42) NR
NR (NR) vs. 361 (224) NR
NR
-
NR
NR
NR
HF-ACTION (2009) 3 months KCCQ+ 5.21 (95% CI 4.42 to 6.
00) vs. 3.28 (2.48 to 4.
09); P value <0.001
Exercise >control
Jolly (2009) 6 months
12 months
MLWHF total
EQ-5D
MLWHF total
EQ-5D
34.5 (24.0) vs. 36.3 (24.
1); P value = 0.30
0.62 (0.32) vs. 0.66 (0.
24); P value = 0.004
34.9 (24.8) vs. 37.6 (21.
0); P value = 0.80
0.69 (0.28) vs. 0.68 (0.
21); P value = 0.07
Exercise = Control
Exercise >Control
Exercise = Control
Exercise = Control
Jónsdóttir (2006) 6 months Icelandic Quality of Life
Questionnaire
4.10 (14.04) vs. 47.55 (8.
7); P value = 0.34
Exercise = Control
Klocek (2005) 6.5 months PGWB total 99.0 vs. 109.0 (training
group A) vs. 71.7 (training
group B); P value <0.01
Exercise >Control
Koukouvou (2004) 6 months MLWHF total
Spritzer QLI total
34.1 (13.0) vs. 45.1 (9.9)
; P value = 0.05*
7.1 (1.1) vs. 9.1 (1.1); P
value <0.0001*
Exercise >Control
Exercise >Control
McKelvie (2002) 12 months MLWHF total+ -3.3 (13.9) vs. -3.4 (18.1)
; P value = 0.98
Exercise = Control
Nilsson (2008) 12 months MLWHF total 28 (20) vs. 22 (12); P
value = 0.003
Exercise >Control
Norman (2012) 6 months KCCQ 77.9 (11.6) vs. 81.0 (18.
2); P value = 0.78
Exercise = Control
Passino (2006) 9.75 months MLWHF total 53 (32) vs. 32 (26.5); P
value <0.0001*
Exercise >Control
Willenheimer (2001) 10 months PGAQoL 0 (1) vs. 0.7 (0.9); P value
= 0.023
Exercise >Control
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Witham (2005) 6 months GCHFQ 69 (13) vs. 65 (10); P
value = 0.48
Exercise = Control
Yeh (2011) 12 months MLWHF total 18 (6) vs. 13 (4); P value
<0.0001
Exercise >Control
*P values calculated by authors of this paper; +: change in outcome from baseline.
GCHFQ: Guyatt chronic heart failure questionnaire; GH: General health; KCCQ: Kansas City Cardiomyopathy Questionnaire; MCS: mental
component score; MLWHF: Minnesota Living with Heart Failure questionnaire; MOS: Medical Outcomes Study; NR: not reported; PCS:
physical component score; PF: physical functioning; PGAQoL: Patient’s Global Assessment of Quality of life; PGWB: Psychological
General Wellbeing Index; QLI: Quality of Life Index; RL: role limitation; SF-36: 36-item Short Form.
Exercise = Control: no statistically significant difference (P value >0.05) in HRQoL between exercise and control groups at follow-up.
Exercise >Control: statistically significant (P value ≤ 0.05) higher HRQoL in exercise compared to control group at follow-up.
Exercise <Control: statistically significant (P value ≤ 0.05) lower HRQoL in exercise versus control group at follow-up.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
B A C K G R O U N D
Description of the condition
People with heart failure (HF) present with a variety of symp-
toms most of which are non-specific (Watson 2000). The most
frequently presenting symptom is exertional breathlessness. Other
important symptoms are fatigue and lethargy in addition to
swelling of the feet and ankles. There is no single diagnostic test for
HF and diagnosis relies on clinical judgement based on a combi-
nation of history, physical examination and appropriate investiga-
tions. The symptoms and functional exercise capacity are used to
classify the severity of HF, using the New York Heart Association
(NYHA) classification (NYHA 1994), and to judge responsiveness
to treatment. While diagnosis is based upon symptoms, disease
severity can be quantified using objective measures, for example
echocardiographic assessment of ejection fraction.
People with HF experience marked reductions in their exercise
capacity, which has detrimental effects on their activities of daily
living, health-related quality of life (HRQoL), and ultimately their
hospital admission rate and mortality (WGCR 2001). While sur-
vival after HF diagnosis has improved (AHA 2014), HF has a
poor prognosis as 30% to 40% of people diagnosed with HF die
within one year although thereafter the mortality is less than 10%
per year (AHA 2014). Hospital admission rates for HF in the US
appear to have fallen between 1998 and 2008 (Chen 2011). How-
ever, in the UK, despite a progressive reduction in age-adjusted
hospital admission rates since 1992 to 1993, admissions due HF
are projected to rise by 50% over the next 25 years, largely due
to the ageing of the population (NICE 2010). It is estimated that
the total annual cost of HF to the UK National Health Service
(NHS) is around GBP1 billion, or around 2% of the total UK
NHS budget; approximately 70% of this total is due to the costs
of hospitalisation (Editorial 2011; NICE 2010).
The prevalence and incidence of HF is steadily increasing, with
approximately 825,000newcases annually in theUS (AHA 2014).
While improved management of hypertension has reduced this
condition as an aetiological factor in the development of HF, the
increased survival rate from myocardial infarction has led to a
subsequent increase in the number of cases of HF (Kostis 1997), as
has increasing longevity in developed countries. Estimates of the
prevalence of HF in the US range from 0.7% to 1.5% in adults
aged 40 to 59 years; over 80 years of age the prevalence of HF is
in the region of 8.6% to 11.5% (AHA 2014).
It has been increasingly recognised that HF has two subcategories.
People with HF can be categorised as having impaired left ven-
tricular contraction, which results in a reduced ejection fraction
(less than 35% to 50%), known as HF with reduced ejection frac-
tion (HFREF) or ’left ventricular dysfunction’ or ’systolic HF’.
The other category is HF with preserved ejection fraction (HF-
PEF) with an ejection fraction of greater than 35% to 50% and
also known as ’diastolic HF’ (Lam 2011; Owen 2006). Prognosis
in HFPEF is better than HFREF. One meta-analysis reported a
mortality of 32.1% in HFPEF versus 40.6% in HFREF (risk ra-
tio (RR) 0.79) over a mean of 47 months’ follow-up (Somaratne
2009). Although individuals with HFPEF are thought to con-
tribute 54% of all people with HF, most trials to date of drug and
medical device therapies have recruited only people with HFREF.
This limited number of studies examining the effect of different
pharmacological agents with proven use in HFREF has largely
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been disappointing in the HFPEF group (Holland 2011).
National and international evidence-based guidelines have been
developed to help improve diagnosis and treatment for people
with HF. These guidelines cover aetiology, prevention, diagnos-
tic modalities and therapeutic interventions that increasingly in-
clude exercise rehabilitation (ACCF/AHA2013;McMurray 2012;
NICE 2010).
Description of the intervention
While there are many definitions of cardiac rehabilitation (CR),
the following presents their combined key elements: “The coordi-
nated sum of activities required to influence favourably the under-
lying cause of cardiovascular disease, as well as to provide the best
possible physical, mental and social conditions, so that the patients
may, by their own efforts, preserve or resume optimal function-
ing in their community and through improved health behaviour,
slow or reverse progression of disease” (BACPR 2012). A central
component of CR is exercise training (Piepoli 1998). However,
in addition to exercise, programmes are encouraged also provide
risk factor and lifestyle education on risk factor management plus
counselling and psychological support, so-called ’comprehensive
CR’ (Corra 2005).
Based on current evidence of clinical outcomes and costs, national
and international guidelines on the management of HF includ-
ing the American College of Cardiology/American Heart Associ-
ation, European Society of Cardiology and National Institute for
Health and Care Excellence (NICE) in the UK consistently rec-
ommend CR as an effective and safe intervention (ACCF/AHA
2013; McMurray 2012; NICE 2010). However, these guidelines
are not fully implemented in practice and the current uptake of
CR for HF appears to be suboptimal (Dalal 2012; Tierney 2011).
A key driver of this poor uptake has shown to be that CR pro-
grammes are not offering rehabilitation to people with HF due to
lack of resources and exclusion of HF from local commissioning
agreements (Dalal 2012).
How the intervention works
The precise mechanism(s) through which exercise training bene-
fits people with HF remains unclear. One explanation, applicable
to people with Ischaemic causes of HF, is that exercise training
improves myocardial perfusion by alleviating endothelial dysfunc-
tion, therefore dilating coronary vessels and by stimulating new
vessel formation by way of intermittent ischaemia (ExTraMatch
2004). Indeed, Belardinelli and colleagues have demonstrated that
aerobic training improves myocardial contractility and diastolic
filling (Belardinelli 1998). One meta-analysis by Haykowsky et al.
demonstrated the benefits of exercise training on cardiac remod-
elling as measured by ejection fraction, end-diastolic volume and
end-systolic volume (Haykowsky 2007). Regardless of cause, there
are important neurohormonal and musculoskeletal abnormalities
in HF. Exercise training may reduce adrenergic tone and increase
vagal tone, as suggested by an assessment of variability in heart rate.
Skeletal muscle dysfunction and wasting may also respond to exer-
cise training (ExTraMatch 2004). Hambrecht et al. have demon-
strated that regular physical activity in people with HF stimulates
vasodilation in the skeletal muscle vasculature (Hambrecht 1998).
Why it is important to do this review
This is an update of a Cochrane review published in 2010. The
first Cochrane systematic review of exercise-based interventions
for HF in 2004 concluded that exercise training clearly improved
short-term (up to one-year follow-up) exercise capacity compared
with no exercise control (Rees 2004; Smart 2004). However, only
one of the 29 included randomised controlled trials (RCTs) was
powered to report hospitalisations and mortality. Few trials as-
sessedHRQoL. Accepting the evidence for improvement in short-
term exercise capacity, the updated 2010 Cochrane review focused
on trials of follow-up of six-months or longer that reported clin-
ical events (mortality, hospitalisation) or HRQoL (Davies 2010).
The 2010 review of 19 RCTs (3647 participants) showed no dif-
ference between exercise and control in either short or long-term
all-cause mortality, a reduction in HF-related hospitalisations (RR
0.72; 95% CI 0.52 to 0.99) and improvement in patient-reported
HRQoL (standardised mean difference (SMD) 20.63; 95% CI
20.37 to 20.80) with exercise therapy. The majority of trials in-
cluded in the 2010 review were in men at low-to-medium risk
(NYHA class II to III). None of the trials included people with
HFPEF and programmes delivered in a centre-based setting.
Using additional RCT evidence, since the 2010 Cochrane review,
the aim of this update was to reassess the effectiveness of exercise-
based rehabilitation on mortality, hospital admissions, morbidity
and HRQoL of people with HF compared with no exercise train-
ing. In particular, we sought to identify additional evidence: 1. for
those individuals poorly represented in previous reviews (i.e. older
individuals, females and people with HFPEF), 2. for programmes
specifically delivered in a home- or community-based setting and
3. on costs and cost-effectiveness.
O B J E C T I V E S
To determine the effectiveness of exercise-based rehabilitation on
the mortality, hospitalisation admissions, morbidity and health-
related quality of life for people with HF. Review inclusion criteria
were extended to consider not only HF due to reduced ejection
fraction (HFREF or ’systolic HF’) but also HF due to preserved
ejection fraction (HFPEF or ’diastolic HF’).
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M E T H O D S
Criteria for considering studies for this review
Types of studies
RCTs of either a parallel group or cross-over design where the
follow-up was at least six months post-randomisation.
Types of participants
Adults aged 18 years or older with HF.
We widened the inclusion criteria to include studies with indi-
viduals with HFPEF in addition to those with HFREF who were
included in the previous versions of this review. We excluded stud-
ies that included participants who had previously received exercise
rehabilitation.
Types of interventions
Exercise-based interventions either alone or as a component of
comprehensive CR (defined as programmes including compo-
nents such as health education and psychological interventions in
addition to exercise interventions). The control group must not
have received exercise training but may have received active inter-
vention (i.e. education, psychological intervention) or usual med-
ical care alone.
Types of outcome measures
Tobe included the studymust include one ormore of the following
outcomes.
Primary outcomes
Mortality and safety: all-cause mortality, deaths due to HF and
sudden death.
Hospital admission or re-hospitalisation, andwhether this was due
to HF.
Secondary outcomes
HRQoL assessed by a validated outcome measure (e.g. 36-item
Short Form (SF-36), Minnesota Living with Heart Failure (ML-
WHF) questionnaire), costs and cost-effectiveness.
Search methods for identification of studies
Electronic searches
For the previous reviews (Davies 2010; Rees 2004), the review
authors searched the Cochrane Controlled Trials Register (Issue
1, 2001; Issue 1, 2007), MEDLINE, EMBASE and CINAHL
(1984 to January 2008) (see Appendix 1; Appendix 2). The search
strategy developed in 2008 included broader terms as this search
was part of review strategy that sought to identify evidence for CR
that included an update of this review and exercise-based rehabili-
tation for coronary heart disease (Heran 2011), and home- versus
centre-based CR (Taylor 2010).
This search was updated from the last version (2008) and included
the Cochrane Central Register of Controlled Trials (CENTRAL)
(Issue 1, 2013), MEDLINE (Ovid, January 2013, week 4 2013),
MEDLINE In-Process (Ovid, 5 February 2013), EMBASE (Ovid,
January 2013, week 5), CINAHL (EBSCOhost, 5 February 2013)
and PsycINFO (Ovid, January 2013, week 5). A small addition
to the search strategy was made to reflect the more recent use of
the terms ’HFPEF’ and ’HFREF’.
We searched conference proceedings on Web of Science (2008 to
January 2013) and trial registers (Clinicaltrials.gov; Controlled-
trials.com).
We limited searches to RCTs and applied filters to limit to humans
and year 2008 onwards. We imposed no language or other limita-
tions. We considered variations in terms used and the spelling of
terms in different countries, so that studies were not missed by the
search strategy. We designed the search strategies with reference
to those of the previous systematic review (Davies 2010), and in
accordance with theCochrane Handbook of Reviews of Interventions
(Higgins 2011) (see Appendix 3).
Searching other resources
We searched reference lists of all eligible trials and identified sys-
tematic reviews for additional studies.
Data collection and analysis
Study selection
Two review authors (VAS, RST) screened the references identified
by the search strategy by title and abstract and discarded clearly
irrelevant studies. For selection, abstracts had to clearly identify the
study design, an appropriate population and relevant components
of the intervention as described above. We obtained the full-text
reports of all potentially relevant trials and two review authors
(VAS and RST) independently assessed them for eligibility based
on the defined inclusion criteria. We resolved any disagreements
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by discussion. EJD, KR and RST undertook data study selection
in previous review versions.
Data extraction
We extracted relevant data regarding inclusion criteria (study de-
sign; participants; interventions including type of exercise, fre-
quency, duration, intensity and modality; comparisons and out-
comes), risk of bias (randomisation, blinding, attrition and con-
trol) and results. One review author (VAS) extracted data and a
second review author (RST) checked entries. We contacted study
authors to seek clarification on issues of reporting or to obtain
further outcome details. Excluded studies and reasons for their
exclusion are detailed in the Characteristics of excluded studies
table. EJD, KR and RST undertook data extraction in previous
review versions.
Assessment of risk of bias in included studies
Factors considered included the quality of the random sequence
generation and allocation concealment, incomplete outcome data,
analysis by intention-to-treat, blinding (participants, personnel
and outcome assessors) and selective outcome reporting (Higgins
2011). One review author (VAS) assessed the risk of bias in eligible
trials and a second review author (RST) verified the decision. EJD,
KR and RST undertook risk of bias in previous review versions.
Data analysis
We processed data in accordance with the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We expressed
dichotomous outcomes as RR and 95% CI for each study. For
continuous variables, we compared net changes (i.e. exercise group
minus control group to give differences) and calculated mean dif-
ference (MD) or SMD and 95% CI for each study. For each trial,
we sought the mean change (and standard deviation (SD)) in out-
come between baseline and follow-up for both exercise and control
groups and when not available, we instead used the absolute mean
(and SD) outcome at follow-up for both groups. For trials with
more than one relevant intervention arm, we divided the number
randomised in the control group by the number of intervention
arms to obtain the denominator for data analysis. Where trials
reported more than one HRQoL outcome, we included the first
outcome reported in the paper in the meta-analysis. We tabulated
all reported HRQoL outcomes at all follow-up times for each in-
cluded study. We reported outcome results at two time points: 1.
up to and including 12 months’ follow-up and 2. longer than 12
months’ follow-up. The latest follow-up was used in each of these
time point analyses.
We explored heterogeneity among included studies qualitatively
(by comparing the characteristics of included studies) and quanti-
tatively (using the Chi2 test of heterogeneity and the I2 statistic).
Where appropriate, we combined the results from included stud-
ies for each outcome to give an overall estimate of treatment effect.
We used a fixed-effect meta-analysis except where we identified
statistical heterogeneity (I2 statistic greater than 50%), where we
used a random-effects model.
We explored the potential heterogeneity in exercise-based rehabil-
itation by two approaches: 1. within-trial subgroup analyses (sup-
ported by subgroup x intervention/control interaction terms) and
2. between-trial analyses using meta-regression. Meta-regression
was used to examine the association between the effect of exercise
on all-cause mortality, all hospitalisation and HRQoL (MLWHF
or other measures) up to 12 months as these three outcomes con-
tained the most trials. Specific study covariates included in the
meta-regression included: mean per cent left ventricular ejection
fraction (LVEF); dose of aerobic exercise (calculated as the overall
number of weeks of training multiplied by the mean number of
sessions per week multiplied by the mean duration of sessions in
minutes); type of exercise (aerobic training alone or aerobic plus
resistance training);mean age; sex (per centmale); setting (hospital
only, home only, both hospital and home); type of rehabilitation
(exercise only versus comprehensive); overall risk of bias (’low’, i.e.
absence of bias in five or more of eight of risk of bias items; ’high’,
i.e. absence of bias in fewer than five of eight of risk of bias items);
single versus multicentre; and publication date. We added year
of publication as an additional study level factor (pre versus post
2000) in order to assess the potential effect of a change in the stan-
dard of usual care over time, that is to reflect when beta-blockers,
angiotensin-receptor blockers and angiotensin-converting enzyme
inhibitors became established therapies for HF (Shekelle 2003).
Given the relatively small ratio of trials to covariates, meta-regres-
sion was limited to univariate analysis (Higgins 2011). The per-
mute option in STATA was used to allow for multiple testing in
meta-regression.
We used funnels plots and Egger tests to assess potential small-
study effects and publication bias for those outcomes with an ade-
quate number of trials (i.e. all-cause mortality, hospital admissions
and HRQoL) (Egger 1997).
R E S U L T S
Description of studies
The 2004 and 2010 versions of this Cochrane review contributed
eight (Rees 2004) and 19 trials (Davies 2010) to this latest update.
Several trials from the 2004 review were excluded in the 2010
review as their follow-up was less than six months or they reported
only exercise capacity outcomes. This 2014 update identified a
further 14 trials. The study selection process is summarised in the
QUORUM flow diagram shown in Figure 1.
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Figure 1.
The included 33 trials randomised 4740 participants predomi-
nantly with HFREF and NYHA classes II and III. Four trials in-
cluded a (undefined) proportionof peoplewithHFPEF (Davidson
2010; Gary 2010 (comp); Gary 2010 (exalone); Nilsson 2008;
Wall 2010). The majority of trials were small (26 trials had fewer
than 100 participants) and single centre (30 trials), with one large
trial contributing about 50% (2331 participants) of all included
participants (HF ACTION 2009). The mean age of participants
across the included studies ranged from 51 to 81 years. Studies
recruited predominantly men (median 87%), although there was
evidence that more females were recruited in recent trials. Only
four trials reported on ethnicity and 62% to 100% of the study
population was white. Eleven trials reported follow-up in excess
of 12 months (Austin 2005; Belardinelli 1999; Belardinelli 2012;
Davidson 2010; Dracup 2007; HF ACTION 2009; McKelvie
2002;Mueller 2007;Myers 2000; Nilsson 2008;Wall 2010). Two
trials had more than one exercise intervention arm. These two
trials were treated as each contributing two separate comparative
arms for the purpose of the meta-analysis (Gary 2010 (comp);
Gary 2010 (exalone); Klocek 2005 (Const); Klocek 2005 (Prog)).
All trials evaluated an aerobic intervention and 11 also included re-
sistance training (Austin 2005;DANREHAB2008;Dracup 2007;
Jolly 2009; Jónsdóttir 2006a; Koukouvou 2004; McKelvie 2002;
Norman 2012; Pozehl 2008;Witham 2005;Witham 2012). Exer-
cise training was most commonly delivered in either an exclusively
centre-based setting or a centre-based setting in combination with
some home exercise sessions. Five studies were conducted in an
exclusively home-based setting (Dracup 2007; Gary 2010 (comp);
Gary 2010 (exalone); Jolly 2009; Passino 2006; Wall 2010). The
dose of exercise training ranged widely across studies with session
duration of 15 to 120 minutes, one to seven sessions/week, inten-
sity of 40% to 80% of maximal heart rate to 50% to 85% of max-
imal oxygen uptake (VO2 max) to Borg rating of 12 to 18, over a
period of 15 to 120 weeks. In addition to exercise training,12 trials
included other (’comprehensive rehabilitation’) elements that in-
cluded education and psychological interventions (Bocalini 2008;
DANREHAB 2008; Davidson 2010; Gary 2010 (exalone); Jolly
2009; Jónsdóttir 2006a;Mueller 2007;Myers 2000;Nilsson 2008;
Pozehl 2008; Witham 2012).
Details of the studies included in the review are shown in the
Characteristics of included studies table. Reasons for exclusion are
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presented in the Characteristics of excluded studies table. The sta-
tus of ongoing trials are detailed in the Characteristics of ongoing
studies table.
Risk of bias in included studies
The overall risk of bias was moderate. A number of trials (par-
ticularly those published prior to 2000) failed to give sufficient
detail to assess their potential risk of bias (Figure 2; Figure 3).
Details of generation and concealment of random allocation se-
quence and blinding of outcomes were particularly poorly re-
ported. Only the studies of Austin 2005; DANREHAB 2008;
HF ACTION 2009; Jolly 2009; McKelvie 2002; and Witham
2012 provided an adequate description of the randomisation pro-
cess. Nevertheless, none of the studies had objective evidence of
imbalance in baseline characteristics. Most studies performed an
intention-to-treat analysis, comparing exercise and control group
outcomes according to the initial random allocation. Given the
nature of an exercise intervention, is not possible to blind partic-
ipants and carers. However, several studies reported blinding of
outcome assessment (Davidson 2010; Gary 2010 (exalone); Gary
2010 (comp); HF ACTION 2009; McKelvie 2002, Koukouvou
2004; Nilsson 2008; Willenheimer 2001; Witham 2005; Yeh
2011). By not reporting co-intervention details for both exercise
and control groups, some studies may be prone to performance
bias (Belardinelli 1999;Giannuzzi 2003;Gielen 2003;Hambrecht
1995; Hambrecht 2000; Keteyian 1996; Klecha 2007; Klocek
2005 (Prog); Klocek 2005 (Const);McKelvie 2002;Nilsson 2008;
Pozehl 2008). There was evidence of improvement in reporting
and lower risk of bias in more recent trials.
Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Effects of interventions
See: Summary of findings for the main comparison Health-
related quality of life results; Summary of findings 2 Costs
and cost-effectiveness; Summary of findings 3 Univariate meta-
regression analysis; Summary of findings 4Within trial subgroup
analyses
Mortality
Twenty-two studies reported all-cause mortality at up to 12-
months’ follow-up. The trials of Gielen 2003 and Klecha 2007
reported no deaths in either the exercise or control arm. There
was no significant difference in pooled mortality up to 12 months’
follow-up between groups (RR 0.93; 95% CI 0.69 to 1.27; P
value = 0.59, I2 = 0%; Chi2 = 12.37, P value = 0.26, fixed-effect
analysis) (Analysis 1.1). The studies of Austin 2005; Belardinelli
1999; HF ACTION 2009; Jónsdóttir 2006a; and Mueller 2007
reported mortality at 60, 26, 30, 28, and 74 months, respectively.
Although not reported in their original publication (Belardinelli
2012), we obtained mortality data at 10 years by contacting the
study authors. There was a trend towards a reduction in all-cause
mortality when pooled across longest follow-up point of the six
trials with more 12 months’ follow-up (RR 0.88; 95% CI 0.75 to
1.02; P value = 0.07, I2 = 34%; Chi2 = 7.54, P value = 0.18, fixed-
effect analysis) (Analysis 1.2). Studies did not consistently report
deaths due to HF or sudden death.
Hospital admissions
There were reductions in the number of people experiencing hos-
pital admissions with exercise compared with control up to 12
months’ follow-up, all hospital admissions up to 12 months’ fol-
low-up (15 trials, RR 0.75; 95% CI 0.62 to 0.92; P value =
0.005, I2 = 0%; Chi2 = 11.71, P value = 0.55, fixed-effect analy-
sis) (Analysis 1.3) and HF-specific admissions (12 trials, RR 0.61;
95% CI 0.46 to 0.80; P value = 0.002, I2 = 34%; Chi2 = 16.70, P
value = 0.12) (Analysis 1.4). There was no difference in all hospital
admissions in trials with more than 12 months’ follow-up (5 trials,
RR 0.92; 95% CI 0.66 to 1.29; P value = 0.63, I2 = 63%; Chi2 =
10.90, P value = 0.03, random-effects analysis) (Analysis 1.5)
Health-related quality of life
Nineteen out of the 33 included trials (20 comparisons) reported
a validated HRQoL measure (see Summary of findings for the
main comparison). The majority of studies reported disease-spe-
cific quality of life using theMLWHF, theHF ACTION2009 trial
using the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Generic HRQoL was also assessed using the EuroQoL (EQ-5D),
SF-36, Psychological General Wellbeing index (PGWB), Patient’s
Global Assessment of Quality of Life (PGAQoL) and Spritzer’s
Quality of Life Index (QLI). The study by Gottlieb 1999 reported
HRQoL values at follow-up for the exercise group but not the
controls. Eleven of the 19 trials (58%) reported superior HRQoL
at follow-up in people who exercised compared with controls and
in no case was HRQoL score lower with exercise than control
(Summary of findings for the main comparison).
There was evidence of high levels of statistical heterogeneity in the
exercise-control difference in MLWHF scores at follow-up across
studies. When pooled across the 13 studies that reported the total
MLWHF score up to 12 months’ follow-up, there was a clinically
important improvement with exercise (MD -5.8; 95% CI -9.2 to
-2.4; P value = 0.0007, I2 = 70%; Chi2 = 40.24, P value < 0.0001,
random-effects analysis) (Analysis 1.6). Pooling across all studies,
regardless of the HRQoL measure used, there was also evidence
of a significant improvement with exercise (19 trials [21 compar-
isons], SMD -0.46; 95% CI -0.66 to -0.26; P value < 0.0001, I2
= 80%; Chi2 = 93.86, P value < 0.0001, random-effects analysis)
(Analysis 1.7). The three trials that reportedMLWHF score at fol-
low-up greater than 12 months also showed greater improvement
compared with control (MD -9.5; 95% CI -17.5 to -1.5; P value
< 0.0001, I2 = 73%; Chi2 = 7.33, P value < 0.02, random-effect
analysis) (Analysis 1.8). Where studies reported more than one
total HRQoL measure score, we selected the first cited score re-
ported in the trial publication for meta-analysis to prevent double
counting of a study; the inference of the SMD meta-analysis did
not change when selecting the alternative HRQoL measure score.
Cost and cost-effectiveness
Three studies reported economic data, two undertaking a cost-ef-
fectiveness analysis (Flynn 2009; Georgiou 2001), and one report-
ing costs (Witham 2012) (see Summary of findings 2). Based on
the Belardinelli trial (Belardinelli 1999), Georgiou and colleagues
estimated an additional mean healthcare cost in the training group
compared with controls of USD3227/person (Georgiou 2001).
This cost was calculated by subtracting the averted hospitalisa-
tion cost, USD1336/person, from the cost of exercise training and
wages lost due to exercise training, estimated at USD4563/per-
son. Using exponential survival modelling to 15.5 years, the esti-
mated increment in life expectancy with exercise was 1.82 years/
person compared with people in the control group and an incre-
mental cost-effectiveness ratio of USD1773/life-year saved. The
HF ACTION group estimated a mean gain in QALY of 0.03 at
an additional mean cost of USD1161/person at 2.5 years’ follow-
up (Flynn 2009). Although an incremental cost-effectiveness ratio
was not reported, the authors stated that there was a 89.9% prob-
ability that exercise training was more cost-effective than usual
care at a maximum willingness to pay threshold of USD50,000.
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Witham and colleagues reported the mean cost in the exercise
group were lower (-GBP477.85/person) than the control group at
six months’ follow-up (Witham 2012). This cost difference was
primarily the result of a reduction in the days of hospital admission
in the exercise group compared with the control group. None of
the between-group differences in costs or outcomes across these
three studies achieved statistical significance at P value 0.05 or less
level.
Meta-regression
Predictors of all-cause mortality, hospitalisation and HRQoL in-
tervention effects (12 months or less of follow-up) were examined
using univariate meta-regression. No significant associations were
seen on all-cause mortality, all hospitalisation and HRQoL at the
P less than 0.05 level with the exception of risk of bias and setting
for HRQoL (see Summary of findings 3). The HRQoL mean ef-
fect size for studies with a higher risk of bias was larger than for
studies with lower risk of bias (MLWHFMD: high risk: -14.4 vs.
low risk -4.2, P value = 0.04): and higher for single-centre studies
(all HRQoL SMD: single centre: -0.90 vs. multicentre -0.35, P
value = 0.04).
Within-trial subgroup analyses
Several studies reported that they had undertaken subgroup anal-
yses. However, most of these analyses were not based on a formal
subgroup interaction test with the intervention effect but instead
a cross-sectional association between particular participant char-
acteristics and outcome (e.g. association between participant age
at baseline and mortality (regardless of exercise or control group
allocation)) (Austin 2005; Belardinelli 1999; Belardinelli 2012;
Davidson 2010; Klocek 2005 (Const); Klocek 2005 (Prog)). Two
studies reported subgroup analyses where the methods were un-
clear (Pozehl 2008; Yeh 2011). Only the large HF ACTION trial
undertook a pre-defined formal interaction tests of differences in
intervention effects between subgroups. The HF ACTION au-
thors reported no evidence of difference in the intervention effects
as assessed on either the primary outcome (all-cause mortality or
hospitalisation) or HRQoL (KCCQ overall score) across a num-
ber of participant-defined subgroups (see Summary of findings
4). The HF ACTION group also undertook a large post hoc ob-
servational analysis in those people assigned to exercise training
(Keteyian 2012). This analysis showed that the volume of exercise
undertaken by participants was associated with the risk for clinical
events and moderate levels (3 to 7 MET-h per week) of exercise
was needed to observe a clinical benefit.
Small-study bias
There was no evidence of funnel plot asymmetry for all-cause
mortality (Egger test P value = 0.805) (Figure 4) or WLWHF
(Egger test P value = 0.606) (Figure 5). The funnel plots for SMD
HRQoL showed evidence of asymmetry (Egger test P value <
0.0001) (Figure 6).
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Figure 4. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.1 All-cause
mortality up to 12 months’ follow-up.
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Figure 5. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.6 Health-
related quality of life - Minnesota Living with Heart Failure (MLWHF) questionnaire up to 12 months’ follow-up.
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Figure 6. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.7 Health-
related quality of life - Minnesota Living with Heart Failure (MLWHF) questionnaire and other scales.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Author (year) Georgiou (2001) HF-ACTION
Reed (2010)
Witham (2012)
Year of costs
Country
Currency
1998
US
USD
2008
US
USD
2010
UK
GBP
Intervention cost
Mean costs/participant USD4563 USD 6482 (SD 4884) GBP474.75
Costs considered Staffing, space rental, equip-
ment, participant’s lost wages
Staffing, participant time, travel,
parking
Staffing, equipment, staff and
participant travel
Cost-effectiveness
Follow-up period 15.5 years Mean 2.5 years 6 months
Total mean healthcare cost/par-
ticipant (exercise)
USD5282* USD57,338 (SD 81,343)+ GBP1888.24 (SD 3111)
Total mean healthcare costs/
participant (control)
USD2055* USD56,177 (SD 92,749)+ GBP1943.93 (SD 4551)
Incremental healthcare costs 3227* USD1161 (95% CI -6205 to
8404)
GBP-447.85 (95% CI -1696.00
to 931.00)
Additional healthcare costs con-
sidered
Hospitalisations Medication, procedures, outpa-
tient visits, emergency visits,
hospitalisations, tests
Inpatient and outpatient admis-
sions, primary care contacts,
medication
Mean healthcare benefit (exer-
cise)
10.24 life years 2.02 QALYs (SD 1.00) -
Mean healthcare benefit (con-
trol)
7.96 life years 1.99 QALYS (SD 1.01) -
Incremental mean healthcare
benefit
1.82 life years* 0.03 (95% CI -0.06 to 0.11) -
Incremental cost-effectiveness
ratio
USD1773 per life year saved Not reported -
CI: confidence interval; GBP: GB pounds; QALY: quality adjusted life year; SD: standard deviation; USD: US dollars.
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All-cause mortality
P value
All hospitalisations
P value
MLWHF
P value
All HRQoL outcomes
P value
Mean left ventricular
ejection fraction (%)
0.39 0.26 0.42 0.82
Mean age (years) 0.29 0.93 0.09 0.88
Sex (% male) 0.54 0.16 - 0.69
Type of rehabilitation
(exercise only vs. com-
prehensive)
0.76 0.77 0.23 0.28
Type of exercise (aer-
obic training alone vs.
aerobic plus resistance
training)
0.74 0.56 0.28 0.54
Exercise dose (number
of weeks x number of
sessions/week x mean
duration of session in
hours)
0.15 0.80 0.15 0.28
Exercise setting I (hospi-
tal only, home only, both
hospital and home)
0.23 0.11 0.85 0.23
Exercise setting II (sin-
gle centre vs. multicen-
tre)
0.94 0.70 0.14 0.01
Publication date 0.54 0.54 0.46 0.60
Risk of bias* 0.40 0.57 0.04 0.08
*’low’ risk of bias trial: absence of bias in >5 out 8 of risk of bias items vs. ’high’ risk of trial: absence of bias in <5 out 8 items.
HRQoL: health-related quality of life; MLWHF: Minnesota Living with Heart Failure questionnaire.
Author (year) Outcome(s) Subgroup(s) Results (P value) Data analysis methods
HF ACTION
(O’Connor, 2009)
Composite primary end
point of all-cause mortal-
ity or hospitalisation, me-
dian follow-up 30 months
Age (≤ 70 yr vs. > 70
yr), gender (males vs. fe-
males), race (white vs.
non-white), heart failure
aetiology (ischaemic vs.
“there was no significant
interaction of
exercise training with any
of the factors defining these
subgroups” (P value > 0.
Interaction test on hazard
ratio
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non-ischaemic), baseline
LVEF (≤ 25% vs. >25%)
, baseline NYHA (Class II
vs. Class III/IV), previous
revascularisation, history
of MI, on ACE or beta-
blocker at baseline
05)
HF ACTION
(Flynn, 2009)
KCCQ overall score up to
36 months
Age, LVEF (≤ 25% or >
25%), previous revascu-
larisation (coronary artery
bypass graft surgery or
percutaneous coronary
intervention, or no pre-
vious revascularisation),
history of MI, and KCCQ
overall summary score at
baseline (0-50, 50-75 or
75-100)
No significant subgroup
interactions (P value >0.
05)
Interaction test
HF ACTION
Keteyian (2012)
All-cause mortality
or hospitalisation and
cardiovascular mortality
or HF hospitalisation at
median follow-up 28.2
months
Exercise volume defined
as metabolic equivalent
[MET]-hr per week
i.e. product of exercise
intensity (where 1 MET
is 3.5 mL VO2/ kg/min)
and the hours of exercise/
week
Exercise volume was
logarithmic predictor (P
value = 0.03) for all-
cause mortality or hospi-
talisation. For cardiovas-
cular mortality or heart
failure hospitalisation, ex-
ercise volume was a sig-
nificant (P value < 0.
001) linear and logarith-
mic predictor
Moderate exercise vol-
umes of 3-5 MET-hr and
5-7 MET-hr/week were
associated with reduc-
tions in subsequent risk
that exceeded 30%
Regression-based meth-
ods (based only on exer-
cise group data)
ACE: angiotensin-converting enzyme; hr: hour; KCCQ: Kansas City Cardiomyopathy Questionnaire; LVEF: left ventricular ejection fraction;
MET: metabolic equivalent; MI: myocardial infarction; NYHA: New York Heart Association; VO2: oxygen consumption; yr: year.
D I S C U S S I O N
Summary of main findings
This update review shows that, when compared with no exercise
control, exercise-based rehabilitation did not significantly impact
on short-term (up to 12-months’ follow-up) all-cause mortality.
There was trend towards a reduction in all-cause mortality in tri-
als with follow-up in excess of 12 months. We also found a re-
duction in hospitalisations related due to HF and higher levels of
HRQoL following exercise training programmes compared with
no exercise control. It is important to note that there was signif-
icant heterogeneity in our observations on HRQoL. Univariate
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meta-regression analysis shows that the benefits of exercise-based
rehabilitation to be independent of participant age, gender, degree
of left ventricular dysfunction, type of CR (exercise only versus
comprehensive), mean dose of exercise intervention, length of fol-
low-up, overall risk of bias and trial publication date. Whilst the
majority of included participants in this review were HFREF and
NYHA class II to III, more recent trials have recruited those who
with HFPEF and NHYA IV and a greater proportion of females
and older patients. Evidence from two trials support the cost-ef-
fectiveness of exercise-based rehabilitation.
Overall completeness and applicability of
evidence
The generalisability of the previous version of this review was
limited as most included studies recruited only low- to moderate-
risk younger men. However, with the inclusion of more women,
older age and people with HFPEF in recent trials, the findings of
this updated review have potential greater external validity.
Quality of the evidence
The general lack of reporting of methods in the included RCT
reports made it difficult to assess their methodological quality and
thereby judge their risk of bias. There was evidence of large treat-
ment effect for HRQoL outcomes in studies judged to be overall
higher risk of bias compared with lower risk of bias studies, sug-
gesting that risk of bias may be a major driver of the substantive
statistical heterogeneity seen across trials in this outcome. There
appeared to be improvement in the quality of reporting in more
recent trials.
Potential biases in the review process
We believe this is the most comprehensive systematic review to
date of RCT-based evidence for the impact of exercise-based re-
habilitation for people with HF. However, our review has some
limitations. Funnel plot asymmetry for HRQoL is indicative of
small-study bias and possible publication bias. Although a specific
goal of this updated review was to clarify the impact of exercise
training programmes on clinical events, many included trials were
relatively small and of short-term follow-up so that the number
of deaths and hospitalisations reported by most trials was small.
Indeed, in many studies, we located event data in the trial descrip-
tions of losses to follow-up and exclusions rather that as reported
outcomes per se.
Agreement and disagreements with other
studies or reviews
Based on an individual participant data pooled analysis, the ExTra-
MATCH Collaborative Group concluded that exercise training
for HF significantly reduced overall mortality (hazard ratio 0.65;
95% CI 0.46 to 0.92) at mean follow-up of approximately two
years (ExTraMatch 2004). The ExTraMATCH study was based on
a limited bibliographic literature search (MEDLINE plus hand-
searching of selected leading cardiac journals), was limited to tri-
als that reported survival data, and included unpublished data.
Therefore, it has been difficult to verify the data and the compre-
hensiveness of this meta-analysis; in addition, several of the RCTs
included in the Cochrane review were not included in the ExTra-
MATCH review. Re-analysis of the ExTraMATCH data using for-
mal meta-analytic methods (taking account of outcome clustering
at the trials level) has shown that the effect of exercise training
was not statistically significant when compared with control (RR
0.88; 95% CI 0.70 to 1.10) (Gotzsche 2005).
The impact of exercise training on mortality in people with HF
may depend on the length of follow-up and age of studies. While
we found no improvement (or worsening) in overall survival with
exercise comparedwith control in trials with short-term follow-up,
there was a trend towards an improved survival with exercise in tri-
als with follow-up beyond 12 months. More recent trials included
in this review have been conducted in the era of optimal medical
therapy. For example, at entry to the HF-ACTION trial, 94% of
participants were receiving beta-blockers and angiotensin-receptor
blockers or angiotensin-converting enzyme inhibitors (Whellan
2007). Forty-five per cent had an implantable cardioverter defib-
rillator or implanted biventricular pacemaker at the time of en-
rolment. Given the proven survival advantage of these medical
treatments (Shekelle 2003), any incremental all-cause mortality
benefit with exercise is likely to be small.
This update review found the exercise group scored on average
5.8 points higher than the control group at up 12 months’ fol-
low-up on theMLWHF questionnaire. A difference of four points
or larger on the MLWHF questionnaire has been shown to rep-
resent a clinically important, meaningful difference for patients
(McAlister 2004). The improvements in HRQoL seen with exer-
cise training are in accordance with the previous systematic review
of van Tol and colleagues (van Tol 2006), but not with that of
Chien, which focused on home-based exercise training and con-
cluded that exercise training compared with usual care or activity
did not improve the HRQoL of people with HF (Chien 2008).
Five studies included in this update review were conducted in an
exclusively home-based setting (Dracup 2007; Gary 2010 (comp);
Gary 2010 (exalone); Jolly 2009; Passino 2006; Wall 2010). Our
meta-regression analysis showed no difference in the reduction in
hospitalisations and improvement in HRQoL with exercise train-
ing between those studies based in a hospital versus home based
setting.
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Implications for practice
This review shows that exercise rehabilitation provides important
benefits by improving health-related quality of life and reducing
heart failure (HF)-related hospitalisation in people predominantly
with reduced left ventricular ejection fraction (HFREF or ’systolic
HF’) ranging from New York Heart Association (NYHA) class
I to IV. We found no evidence to support that exercise training
programmes increase (or decrease) the risk of death in the short
term but there was trend towards reduced mortality in trials with
follow-up beyond 12 months. The benefits of exercise training
programmes appears to be independent of participant character-
istics (e.g. age, gender, degree of left ventricular dysfunction) and
the characteristics and setting of the exercise programmes. Pro-
grammes are typically based on aerobic exercise training with or
without a resistance exercise element. Despite clinical guidelines
stating their support of exercise-based rehabilitation in the man-
agement of HF, the provision and uptake of rehabilitation in HF
remains poor. Future robust evidence of the economic value (costs
and cost-effectiveness) of cardiac rehabilitation is likely to be im-
portant to encourage hospital and primary care providers to ex-
tend the current provision of exercise-based programmes for HF
Implications for research
The majority of trials in this review have investigated exercise
training as a single intervention and against a no exercise con-
trol. However, in practice, exercise-based rehabilitation is often an
adjunct to other HF management interventions, such as special-
ist HF nurse support or disease management programmes. While
trials have demonstrated the benefits of such HF management
interventions alone, few trials have compared such interventions
with and without adding a structured exercise training programme
(Jolly 2009; Mudge 2011). This is an important clinical question
for the future design of HF services, because the addition of an
exercise programme adds considerably to staffing and equipment
costs. Future clinical trials of exercise rehabilitation in HF also
need to consider: the generalisability of trial populations (women,
older people and people withHFPEF remain under-represented in
trial populations); interventions to enhance the long-term main-
tenance of exercise training; and outcomes, costs and cost-effec-
tiveness of exercise-based programmes delivered exclusively in a
home-based setting.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Austin 2005
Methods Parallel group RCT
Participants N Randomised: 200 (exercise 100; control 100)
Diagnosis (% of participants):
Aetiology: ischaemic 77%; hypertension 15.5%; DCM 5.5%; other 2%
NYHA: Class II 51.5%; Class III 48.5%
LVEF: 40-35%: 16.5%; < 35-30%: 45%; < 30%: 38.5%
Case mix: 100% as above
Age (yr): exercise 71.9 (SD 6.3); control 71.8 (SD 6.8)
Male: 43%
White: not reported
Inclusion/exclusion criteria
Inclusion: age > 60 yr, NYHA Class II or III, and LVSD < 40%, confirmed by echocar-
diography
Exclusion: diastolic dysfunction, significant co-morbidity preventing entry into study
because of terminal disease or an inability to exercise (e.g. severemusculoskeletal disorder,
unstable IHD, advanced valvular disease), resident outside the catchment area or in a
long-term care establishment
Interventions Exercise: Total duration: 24 wk
Aerobic/resistance/mix: aerobic endurance training and low resistance training/high repet-
itive muscular strength work
Frequency: 2 sessions/wk (for 8 wk), 1 session/wk (16 wk) plus 3 sessions/wk at home
Duration: 2.5 hr class (8 wk) and 1 hr class (next 16 wk)
Intensity: not reported
Modality: not reported
Setting: hospital and home
Other: none
Outcomes HRQoL (MLWHFQ and EuroQol/EQ-5D); healthcare utilisation (length of stay of
hospital, admissions arising from heart disease, prescribed HF medication); mortality
Comparison Standard care group (including monitoring of clinical status, explanation of HF and its
treatment self monitoring; dietary advice and contact details of clinical nurse specialist)
Country and setting UK
Single centre
Follow-up 6 months and 5 yr (after randomisation)
Notes
Risk of bias
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Austin 2005 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A computer was used to generate a list of random numbers”
Allocation concealment (selection bias) Low risk “The numbers, placed in plain sealed envelopes by a university col-
league prior to patient recruitment, were allocated to the partici-
pants by a hospital colleague unconnected with the study. The allo-
cation schedule was not broken until the trial was completed”
Blinding (performance bias and detection
bias)
All outcomes
High risk No, for HRQoL. Data on deaths, admissions from the hospital
records department
Selective reporting (reporting bias) Low risk All outcomes described in methods are reported
Intention-to-treat analysis? Low risk Although term ITT not stated it appears from CONSORT di-
agram that ITT analysis undertaken
Incomplete outcome data? Low risk CONSORT diagram presented showing participant flow. No
imputation or sensitivity analysis to assess impact of loss or fol-
low-up
Groups balanced at baseline? Low risk “There are no significant differences in the baseline parameters of
the standard care and experimental groups”
Groups received same intervention? Low risk Yes, both groups received usual medical care and the only dif-
ference between groups was the exercise intervention
Belardinelli 1999
Methods Parallel group RCT
Participants N Randomised: 99 (exercise 50; control 49)
Diagnosis (% of participants):
Aetiology: ischaemic cardiomyopathy 85%; idiopathic DCM 15%
NYHA: Class II 49%; Class III 34%; Class IV 17%
LVEF: exercise 28.4 (SD 6); control 27.9 (SD 5)
Case mix: see above
Age (yr): exercise 56 (SD 7); control 53 (SD 9)
Male: 89%
White: not reported
Inclusion/exclusion criteria
Inclusion: HF, LVEF < 40%, and sinus rhythm, diagnosis of CHF based on clinical
symptoms and signs with or without radiological evidence of pulmonary congestion
Exclusion: unstable angina, recent acute MI, decompensated congestive HF, haemody-
namically significant valvular heart disease, significant chronic pulmonary illness, un-
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Belardinelli 1999 (Continued)
controlled hypertension, renal insufficiency (serum creatinine > 2.5 mg/dL), and or-
thopaedic or neurological limitations)
Interventions Exercise: Total duration: 14 month; 8 wk supervised then 12 months maintenance
Aerobic/resistance/mix: aerobic
Frequency: 2-3 sessions/wk
Duration: 40 min/session
Intensity: 60% max VO2
Modality: cycling
Setting: hospital-based programme
Other: all sessions were supervised by a cardiologist
Outcomes HRQoL (MLWHFQ); mortality; morbidity; cost-effectiveness
Comparison Standard medical care
Country and setting Italy
Single centre
Follow-up 14 and 26 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods, reported in results
Intention-to-treat analysis? Unclear risk Not reported
Incomplete outcome data? Low risk Losses to follow-up reported
Groups balanced at baseline? Low risk “The baseline characteristics of the study population are shown in
Table 1. The 2 groups were well balanced with respect to most
characteristics, including peak VO2, New York Heart Association
functional class, and left ventricular ejection fraction. There were
no differences in type and doses of medications, blood chemistry, and
previous cardiac events”
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Belardinelli 1999 (Continued)
Groups received same intervention? Unclear risk Not reported
Belardinelli 2012
Methods Parallel group RCT
Participants N Randomised: 123 (exercise 63; control 60)
Diagnosis (% of participants):
Aetiology: ischaemic 80%; non-ischaemic 20%
NYHA: Class II 59%; Class III 41%
LVEF: 37 (SD 8)
Case mix: see above
Age (yr): 59 (SD 14)
Male: 78%
White: not reported
Inclusion/exclusion criteria
Inclusion: clinical stability for 3 months before enrolment, LVEF < 40% and ability to
exercise
Exclusion: haemodynamically significant valvular heart disease, uncontrolled DM and
hypertension, orthopaedic or neurological problems, and renal insufficiency (creatinine
> 2.5 mg/dL)
Interventions Exercise: Total duration: 10 yr; 8 wk supervised then 12 months maintenance
Aerobic/resistance/mix: aerobic
Frequency: 2-3 sessions/wk
Duration: 40 min/session
Intensity: 60% max VO2 for first 2 months, and thereafter at 70% max VO2
Modality: cycling
Setting: Hospital and home-based
Other: trained participants were encouraged to exercise without supervision at home at
least a third time, performing aerobic activities at the same HR as the other 2 supervised
sessions
Exercises sessions held at the hospital were supervised by cardiologists. Authors emphasise
that the supervised element was maintained over the 10 yr of follow-up
Outcomes HRQoL (MLWHQ), mortality, morbidity (including hospitalisation), cost-effectiveness
Comparison Standard medical care. Participants were instructed to continue with their usual home
daily physical activities, avoiding exercise training in a supervised environment. They
were free to perform aerobic activities such as walking, cycling (home or outside), and
swimming, avoiding a duration of longer than 30 min. Authors advised control group
participants to walk and perform usual physical activities
Country and setting Italy
Single centre
Follow-up 10 yr (every 12 months) (after randomisation)
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Belardinelli 2012 (Continued)
Notes Every 6 months, participants exercised at the hospital, and then they returned to a
coronary club, where they exercised the rest of the year
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods, reported in results
Intention-to-treat analysis? Low risk “All analysis were performed with an intention-to-treat principle”
Incomplete outcome data? Low risk Losses to follow-up reported.
Drop-out rate was 3% on average in the exercise group. 2/63
did not complete the protocol, 1 because of a car accident and
the other for personal reasons. 3/60 in control group decided
to withdraw from study for reasons unrelated to their clinical
status
Groups balanced at baseline? Low risk “The baseline characteristics of the study population are shown in
Table 1. The 2 groups were well balanced with respect to most
characteristics, including peak VO2, New York Heart Association
functional class, left ventricular ejection fraction. There were no
difference in type and doses of medication, blood chemistry, and
previous cardiac events.”
Groups received same intervention? Low risk Both groups appeared to receive same interventions apart from
CR intervention
Bocalini 2008
Methods Parallel group RCT
Participants N Randomised: 42 (exercise 22; control 20)
Diagnosis (% of participants):
Aetiology: MI 45.2%; systemic hypertension 19%; dilated Chagas’ cardiomyopathy 11.
9%; DM 4.8%; other 19.1%
NYHA: Class II or III
LVEF: ≤ 45%
Case mix: 100% as above
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Bocalini 2008 (Continued)
Age (yr): exercise 61 (SD 12); control 60 (SD 11)
Male: 88%
White: not reported
Inclusion/exclusion criteria
Inclusion: EF < 45%, symptoms of NYHA functional Class II or III, optimised pharma-
cological therapy established at least 4 wk before inclusion in the study, and compensated
HF state at least 2 months prior
Exclusion: age < 50 yr, NYHA functional Class IV, clinical instability in the preceding 2
months, non-optimised therapy, uncontrolled arrhythmias,MI within the last 2months,
surgery-associated cardiomyopathy, pulmonary disease or other co-morbid conditions
that limit physical exercise, accentuated severe cardiac symptoms (hypotension, complex
ventricular arrhythmia, progressive worsening of dyspnoea and significant ischaemia at
low rates) during ergometric tests, regular participation in some exercise programme
within the last 6 months and a frequency in training protocol of < 80%
Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/wk
Duration: 90 min
Intensity: target HR (50% of work in the max HR)
Modality: walking on a treadmill
Setting: not reported
Other: relaxation and stretching exercises before and after every session
Outcomes HRQoL (shortened version ofWorldHealthOrganizationQuality of Life questionnaire)
, hospitalisation
Comparison Usual medical therapy - individual dietary guidance and pharmacological therapy
Country and setting Brazil
Single-centre
Follow-up 6 months (after randomisation)
Notes Initially randomised 53 participants, excluded data from participants who withdrew, lost
to follow-up, etc. and hence 42 participants were analysed
Although setting not reported, the exercise programme was described as “supervised”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
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Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? High risk “During the follow-up, medicine doses were not modified except
for those that presented impairment of symptoms and, consequently,
these patients were excluded from the analysis”
Incomplete outcome data? High risk “…3 patients from the untrained group experienced an impairment
of symptoms and were hospitalized”
Groups balanced at baseline? Low risk Table 1 of the publication shows groups are well balanced
Groups received same intervention? Low risk “All patients continued with pharmacological therapy and individ-
ual dietary guidance”
DANREHAB 2008
Methods Parallel group RCT
Participants N randomised: 91 (exercise 45; control 46)
Age (yr): exercise: median 66 (range 33-91); control median (range 29-94)
Male: 90%
White: not reported
Inclusion/exclusion criteria
Inclusion: present symptoms of CHF and objective findings or effect of medication
Exclusion: mental disorders and social problems (such as dementia, alcoholism or drug
addiction). Transferred to other department or hospital at discharge. Severe illness, in-
cluding NYHA Class IV. Living at nursing home. Did not speak Danish. Refused con-
sent
Interventions Exercise: Total duration: 12 wk
Aerobic/resistance/mix:mix
Frequency: 3 sessions/wk
Duration: 90 min/session
Intensity: 50% max HR
Modality: not reported
Setting: supervised centre-based plus home-based also encouraged to continue
Other: the physical exercise was conducted as a mixture of endurance and strengthening
training using various upper and lower body modalities easily implemented as activities
that the participants could perform at home. CR included participant education, exercise
training, dietary counselling, smoking cessation, psychosocial support, and risk factor
management and clinical assessment. All components included theoretical and practical
approaches followed by individual follow-up and feedback. The lifestyle intervention
strategy was based on the stages of change model and self efficacy theory. The lifestyle
interventionwas designed as group intervention, but individual counsellingwas included
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Outcomes Primary: composite outcome measure included overall mortality, MI or acute first-time
re-admission due to heart disease other than MI
Secondary: collected data using an adapted standardised interview questionnaire and a
postal questionnaire (e.g. SF-36, HADS), clinical examination and blood tests
Comparison Usual care participants were offered follow-up treatment prescribed by the discharging
physician either as outpatient control or by the general practitioner. The pharmaceutical
treatment followed routine clinical practice based on current national guidelines. The
discharging nurse or physician determinedwhether participants were referred to smoking
cessation and dietary counselling parallel to outpatient treatment
Country and setting Demark
Single centre
Follow-up 12-months
Notes HF subset of 770 participants randomised, other participants with coronary heart disease
and were high risk but no disease. Randomisation stratified by indication
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients who gave informed consent were randomized using a cen-
tralized randomization procedure administered by the Copenhagen
Trial Unit. The randomization was stratified according to risk
group (CHF, IHD, or HR) based on a random-permuted multi-
block within-stratum method”
Allocation concealment (selection bias) Low risk As above
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Because of the nature of CR, the interventions were open to the
investigators and the patients. Investigator independent outcome
data from registries were chosen to ensure blinded assessment and
outcome analysis”
Selective reporting (reporting bias) Low risk All outcomes listed in methods reported in results
Intention-to-treat analysis? Low risk ITT analysis stated
Incomplete outcome data? Low risk 81% overall follow-up at 12-months
Groups balanced at baseline? Low risk “Patients were well matched at entry”
Groups received same intervention? Low risk Both groups received control care
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Methods Parallel group RCT
Participants N Randomised: 105 (exercise 53; control 52)
Diagnosis (% of participants):
Aetiology: not reported
NYHA: Class I: exercise 2%; control 0%; Class II: exercise 38%; control 33%; Class III:
exercise 60%; control 67%; Class IV: exercise 0%; control 0%
LVEF: not reported
Case mix: as above
Age (yr): exercise 71.6 (SD not reported); control 73.9 (SD not reported)
Male: 67%
White: not reported
Inclusion/exclusion criteria
Inclusion: participants were of any age with a diagnosis of HF of any aetiology, and
NYHAClass I-IV. All participants cleared by their physician to participate in the exercise
group
Exclusion: participants with unstable angina pectoris were ineligible to participate
Interventions Exercise: Total duration: 12 wk
Aerobic/resistance/mix: aerobic
Frequency: 1 session/wk
Duration: 30-50 min
Intensity: not reported
Modality: gymnasium: treadmills, stationary cycles, recumbent cycles
Home-based: hall walks, stairs and sporting activities such as lawn bowls
Setting: supervised gymnasium, home-based programme tailored to participant’s need
Other: also attended a nurse-coordinated CR clinic with emphasis of self-management.
A group-based educational session was conducted for study participants and their fam-
ilies. Exercise group attended the nurse-co-ordinated CR clinic, where comprehensive
assessment was performed by the physiotherapist, CR co-ordinator and occupational
therapist
Outcomes HRQoL (MLWHFQ), all-cause and cardiovascular-related hospital admission,mortality
Comparison Information session and then usual medical care
Country and setting Australia
Single-centre
Follow-up 12 months (after randomisation)
Notes The trial had to be stopped prematurely at 12 months following introduction of chronic
and complex care for people with CHF by the New South Wales Health Department.
“In view of trends in favour of the intervention group and emerging evidence from other
studies, it was considered unethical and untenable to continue randomization in view of the
policy mandate. When the trial was stopped there were 53 participants in the intervention
group and 52 participants in the usual care group”
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were randomized to either the intervention or control
group by means of a computer-generated program”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “The randomization techniquewas blinded to the investigators until
the close of the study”
Selective reporting (reporting bias) Low risk All outcomes described in methods reported
Intention-to-treat analysis? Low risk Although not reported as ITT analysis, groups did appear to be
analysed according to original randomised allocation
Incomplete outcome data? Low risk “No participants were lost to follow-up”
Groups balanced at baseline? Low risk “…there were few differences between intervention and usual care
groups, indicating success of randomization. The most important
difference on clinical variable was that a significantly greater pro-
portion of people in the intervention group were taking spironolac-
tone at baseline”
Groups received same intervention? Low risk Both groups appeared to receive same interventions apart from
CR intervention
Dracup 2007
Methods Parallel group RCT
Participants N Randomised: 173 (exercise 86; control 87)
Diagnosis (% of participants):
Aetiology: ischaemic; idiopathic; valvular; DCM; other
NYHA: Class II-IV
LVEF: 26.4 (SD 6.8)
Case mix: 100% as above
Age (yr): 54 (SD 12.5)
Male: 71.7%
White: 60.1
Inclusion/exclusion criteria
Inclusion: English-speaking, age 18-80 yr, NYHA II-IV and LVSD with LVEF < 40% as
documented by echocardiogram or radionuclide ventriculography within < 6 months,
and sinus rhythm
Exclusion:MI or recurrent angina within < 3 months, orthopaedic impediments to exer-
cise, severe obstructive pulmonary disease with a forced expiratory volume < 1 L in 1 sec-
ond as measured by spirometry, stenotic valvular disease as measured by echocardiogram,
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history of uncontrolled ventricular tachyarrhythmias (documented by electrophysiology
study or 24-hr Holter monitor), or absence of an implantable cardioverter-defibrillator
despite a history of sudden cardiac death
Interventions Exercise: Total duration: unclear (6 months or 1 year)
Aerobic/resistance/mix:mix
Frequency: 4 sessions/wk
Duration: 10-45 min
Intensity: 40-60% max HR
Modality: walking
Setting: home-based
Other: “After six weeks resistive training component involved both upper and lower extremity
strengthening. Resistance training was prescribed at 80% of one repetition maximum, which
is the maximal weight lifted one time, for 2 sets of 10 repetitions using seated biceps curls to
strengthen the arms& seated lateral raises to strengthen shoulders. A second set of 10 repetitions
at 80% of one repetition maximum was also prescribed…”
Outcomes HRQoL (MLWHFQ), mortality, hospitalisation
Comparison Maintained usual level of daily activities. No exercise component
Country and setting USA
Single centre
Follow-up 6 and 12 months (after randomisation)
Notes Home-based exercise programme
Subgroup analysis reported: Evangelista 2010
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding reported for physical activity (accelerometer) outcome
but not reported for other outcomes
Selective reporting (reporting bias) Low risk All outcomes described in methods reported
Intention-to-treat analysis? Low risk Although not reported as ITT analysis, groups did appear to be
analysed according to original randomised allocation
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Incomplete outcome data? Low risk “Two patients (one from the experimental and one from the control
group) were lost to follow-up within the first three months of en-
rollment. One was incarcerated and the second left the geographic
area with no forwarding information. The remaining 173 patients
compose the final study”
Groups balanced at baseline? Low risk Current version: “There were no differences between the control and
exercise groups at baseline with respect to sociodemographic variables
(Table I) and most clinical characteristics. However, patients in
the exercise group had a significantly higher likelihood of having a
history of coronary heart disease and taking antiplatelet medication
than in the control group”
Our version: “There were no significant differences in any of baseline
characteristics between the 2 groups, except for angiotensin-convert-
ing enzyme (ACE) inhibitor; adherers were more likely to use ACE
inhibitors than nonadherers (84% vs 60%; P = 0.039)”
Groups received same intervention? Low risk “Research nurses made home visits weekly for the first two weeks
and then monthly to assess protocol adherence, correct use of the
pedometer, and tolerance to the exercise program. The home visits
also served as a form of attention control in the care- as-usual group.
All clinical questions were referred to the patient’s cardiologist”
Gary 2010 (comp)
Methods Parallel group RCT
Participants N Randomised: 28 (CBT 10; CBT and exercise 18)
Diagnosis (% of participants):
Aetiology: not reported
NYHA: Class II 43.3%; Class III 56.7% (as a whole)
LVEF: ≥ 15%
Case mix: 100% as above
Age (yr): 65.8 (SD 13.5)
Male: 41.9%
White: not reported
Inclusion/exclusion criteria
Inclusion: 1. documented medical diagnosis of HF; 2. LVEF≥ 15% documented within
the last year by echocardiogram, cardiac catheterisation ventriculography or radionu-
clide ventriculography; 3. receiving therapy for HF according to guidelines published by
the American College of Cardiology American Heart recommendations (angiotensin-
converting enzyme inhibitors, diuretics, beta-blockers, angiotensin receptor blockers,
hydralazine and nitrate combination, etc.); 4. Hamilton Rating Scale for Depression
(HAM-D) score ≥ 11; 5. positive results on the Mini International Neuropsychiatric
Interview (Mini) for minor or major depression and 6. DSM-IV diagnosis for depression
for 14 days; or 7 days if history of major depressive disorder in the last 6 months. Partici-
pants also had to be 1. English speaking, 2. living independently (non-institutionalised)
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within 100 miles of Atlanta, GA, 3. able to respond to questions appropriately, 4. able to
hear adequately to respond to verbal questions, 5. not involved in any structured exercise
programme or walking 3 times/wk for a minimum of 20 min, 6. not participating in
any psychotherapy and 7. not hospitalised within the last 60 days
Exclusion: 1. suicide ideation according to psychiatric assessment or Mini evaluation; 2.
major psychiatric co-morbidity such as schizophrenia, personality disorder or dementia;
3. planned surgery; 4. not diagnosed with HF in the past 3months; 5. renal insufficiency
(serum creatinine >2.5 mg/dL); 6. uncontrolled hypertension; 7. acute bereavement or
loss of significant other within the last month or currently involved in family crisis such
as divorce; 8. any disorder interfering with independent ambulation; and 9. terminal
illness such as cancer
Interventions Exercise: Total duration: 12 wk
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/wk
Duration: 30-45 min/session, max 1 hr
Intensity: Borg < 15 (’moderate’)
Modality: walking
Setting: home-based
Other: exercise + CBT group also received 12 wk weekly 1-hr sessions of CBT for 12
wk. No other co-interventions mentioned
Outcomes HRQoL (MLWHFQ) and mortality
Comparison Usual care
“Participants assigned to the UC [usual care] group received no information or coun-
selling from their health care provider other than that normally provided”
Country and setting USA
Single-centre
Follow-up 24 wk (after randomisation)
Notes Exercise group participants had 12 weekly face-to-face home visits by research nurse
to monitor walking progress and to tailor the exercise prescription. “At the first home
visit for EX, the research nurse (1) educated the patient on the rationale for EX in HF; (2)
instructed on self-monitoring of symptoms [dyspnea, heart rate (HR), fatigue] during walking;
(3) provided the patient with a Polar monitor and instruction on how to use it; (4) provided
patient with EX logs and instructions; (5) instructed on use of the 6- to 20-point Borg’s rate
of perceived exertion (RPE) scale; (6) provided patient with blood pressure cuff and weight
scale, if not available; and (7) observed participant response to walking out side home”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
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Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Data collectors were blinded to group assignment”
Selective reporting (reporting bias) Low risk Outcome described in methods are reported in results
Intention-to-treat analysis? Low risk Although not stated, CONSORTdiagram suggests groups anal-
ysed according to initial randomised allocation
Incomplete outcome data? Low risk QUORUM diagram and details of losses to follow-up reported.
In exercise group, 1 patient died and 3 withdrew at 24 wk. In
usual care group, 2 participants and 1 participant withdraw at
12 and 24 wk, respectively. In combined CBT/exercise group 2
withdrew at 12 wk. 1 lost to follow-up and 1 withdrew at 24
wk. In CBT group, 1 withdrew at 12 wk and 24 wk. 1 died and
1 lost to follow-up at 24 wk
Groups balanced at baseline? Low risk “There were no BL differences between groups on any demographic
or outcome variables”
Groups received same intervention? Low risk Groups appeared to receive same care other that exercise and
CBT interventions
Gary 2010 (exalone)
Methods Parallel group RCT
Participants N Randomised: 37 (exercise alone 20; control 17)
CBT only group not included to this review
Diagnosis (% of participants):
Aetiology: not reported
NYHA: Class II 43.3%; Class III 56.7%
LVEF: ≥ 15%
Case mix: 100% as above
Age (yr): 65.8 (SD 13.5)
Male: 41.9%
White: not reported
Inclusion/exclusion criteria
Inclusion: 1. documented medical diagnosis of HF; 2. LVEF of ≥ 15% documented
within the last year by echocardiogram, cardiac catheterisation ventriculography or ra-
dionuclide ventriculography; 3. receiving therapy for HF according to guidelines pub-
lished by the American College of Cardiology American Heart recommendations (an-
giotensin-converting enzyme inhibitors, diuretics, beta-blockers, angiotensin receptor
blockers, hydralazine and nitrate combination, etc.); 4. Hamilton Rating Scale for De-
pression (HAM-D) score ≥ 11; 5. positive results on the Mini International Neuropsy-
chiatric Interview (Mini) for minor or major depression; and 6. DSM-IV diagnosis for
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depression for 14 days; or 7 days if history of major depressive disorder in the last 6
months. Participants also had to be 1. English speaking, 2. living independently (non-
institutionalised) within 100 miles of Atlanta, GA, 3. able to respond to questions ap-
propriately, 4. able to hear adequately to respond to verbal questions, 5. not involved in
any structured exercise programme or walking 3 times/wk for a minimum of 20 min, 6.
not participating in any psychotherapy, and 7. not hospitalised within the last 60 days
Exclusion: 1. suicide ideation according to psychiatric assessment or Mini evaluation; 2.
major psychiatric co-morbidity such as schizophrenia, personality disorder or dementia;
3. planned surgery; 4. not diagnosed with HF in the past 3months; 5. renal insufficiency
(serum creatinine >2.5 mg/dL); 6. uncontrolled hypertension; 7. acute bereavement or
loss of significant other within the last month or currently involved in family crisis such
as divorce; 8. any disorder interfering with independent ambulation; and 9. terminal
illness such as cancer
Interventions Exercise: Total duration: 12 wk
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/wk
Duration: 30-45 min/session, max 1 hr
Intensity: Borg < 15 (’moderate’)
Modality: walking
Setting: home-based
Other: none reported
Outcomes HRQoL (MLWHFQ) and mortality
Comparison Usual care
“Participants assigned to the UC [usual care] group received no information or coun-
selling from their health care provider other than that normally provided.”
Country and setting USA
Single-centre
Follow-up 24 wk
Notes Exercise group participants had 12 weekly face-to-face home visits by research nurse
to monitor walking progress and to tailor the exercise prescription. “At the first home
visit for EX, the research nurse (1) educated the patient on the rationale for EX in HF; (2)
instructed on self-monitoring of symptoms [dyspnea, heart rate (HR), fatigue] during walking;
(3) provided the patient with a Polar monitor and instruction on how to use it; (4) provided
patient with EX logs and instructions; (5) instructed on use of the 6- to 20-point Borg’s rate
of perceived exertion (RPE) scale; (6) provided patient with blood pressure cuff and weight
scale, if not available; and (7) observed participant response to walking out side home”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
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Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Data collectors were blinded to group assignment”
Selective reporting (reporting bias) Low risk Outcome described in methods were reported in results
Intention-to-treat analysis? Low risk Although not stated, CONSORTdiagram suggests groups anal-
ysed according to initial randomised allocation
Incomplete outcome data? Low risk QUORUM diagram and details of losses to follow-up reported.
In exercise group, 1 participant died and 3 withdrew at 24 wk.
In usual care group, 2 participants and 1 participant withdrew
at 12 and 24 wk, respectively. In combined CBT/exercise group,
2 withdrew at 12 wk. 1 lost to follow-up and 1 withdrew at 24
wk. In CBT group, 1 withdrew at 12 wk and 24 wk. 1 died and
1 lost to follow-up at 24 wk
Groups balanced at baseline? Low risk “There were no BL differences between groups on any demographic
or outcome variables”
Groups received same intervention? Low risk Groups appeared to receive same care other that exercise and
CBT interventions
Giannuzzi 2003
Methods Parallel group RCT
Participants N Randomised: 90, 45 each group
Diagnosis (% of participants):
Aetiology: HF secondary to idiopathic DCM; ischaemic heart disease; valvular disease
NYHA: Class II-III
LVEF: exercise 25% (SD 4); control 25% (SD 4)
Case mix: 100%
Age (yr): exercise 60 (SD 7); control 61 (SD 7)
Male: not reported
White: not reported
Inclusion/exclusion criteria
Inclusion: 1. HF secondary to idiopathic DCM, ischaemic heart disease or valvular
disease; 2. echocardiographic ejection fraction < 35%; 3. clinical stability for at least 3
months under optimised therapy; 4. NYHA functional Class II to III; 5. peak oxygen
uptake (VO2) < 20 mL/kg/min; and 6. echocardiographic images of adequate quality
for quantitative analysis
Exclusion: any systemic disease limiting exercise, hypertrophic cardiomyopathy, valvu-
lar disease requiring surgery, angina pectoris, sustained ventricular arrhythmias, severe
hypertension, excess variability (> 10%) at baseline cardiopulmonary exercise test and
inability to participate in a prospective study for any logistic reason
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Interventions Exercise: Total duration: 24 wk
Aerobic/resistance/mix: aerobic
Frequency: 3-5 sessions/wk
Duration: 30 min
Intensity: 60% peak VO2
Modality: exercise cycle, daily brisk walk, callisthenic. In addition, requested to take brisk
daily walk of > 30 min
Setting: supervised cycling sessions at rehabilitation centre and unsupervised at home
Other: not reported
Outcomes Mortality and morbidity
Comparison Educational support but no formal exercise protocol
Country and setting Italy
Multicentre (15 CR units)
Follow-up 6 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes reported in methods are reported
Intention-to-treat analysis? Low risk Although not stated, it is clear from CONSORT diagram that
2 groups were analysed according to ITT
Incomplete outcome data? Low risk 45/45 (100%) exercise training group and44/45 (98%) available
at 6 months’ follow-up
Groups balanced at baseline? Low risk “No significant differences were observed between the 2 groups with
respect to demographic and clinical data, including age, weight,
cause of heart failure, or New York Heart Association functional
class. Furthermore, there was no difference between the 2 groups in
the medications received during the 6-month period of the study”
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Groups received same intervention? Unclear risk Not clearly stated if co-treatments (i.e. cardiovascular medica-
tion) in 2 groups were the same
Gielen 2003
Methods Parallel group RCT
Participants N Randomised: 20 (exercise 10; control 10)
Diagnosis (% of participants):
Aetiology: IHD; DCM
NYHA: Class II 90%; Class III 10%
LVEF: exercise mean 26.1% (SD 6); control mean 24.7% (SD 8)
Case mix: 100% as above
Age (yr): exercise 55 (SD 6); control 53 (SD 9)
Male: 100%
White: not reported
Inclusion/exclusion criteria
Inclusion: age < 70 yr with CHF (NYHA II to III) as result of DCM or IHD as assessed
by cardiac catheterisation. All had clinical, radiological and echocardiographic signs of
CHF and an LVEF 40% as assessed by ventriculography and clinically stable condition
for > 3 months before enrolment
Exclusion: significant valvular heart disease, uncontrolled hypertension, peripheral vas-
cular disease, pulmonary disease or musculoskeletal abnormalities precluding exercise
training
Interventions Exercise: Total duration: 2 wk inpatient followed by 6 months as outpatient
Aerobic/resistance/mix: aerobic
Frequency: 7 sessions/wk
Duration: 20 min/session
Intensity: 70% symptom limited VO2 max
Modality: cycle ergometers
Setting: supervised sessions at hospital and home-based unsupervised sessions
Other: expected to participate in 1 group training session (walking, callisthenics and
non-competitive ball games) of 60 min each wk. Participants were asked to exercise for
20 min/day at home
Outcomes Mortality
Comparison Continued their sedentary lifestyle and remained on their individually tailored cardiac
medication supervised by their private physicians
Country and setting Switzerland
Single centre
Follow-up 26 wk (after randomisation)
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods are reported in results
Intention-to-treat analysis? Low risk Although ITT analysis not reported, groups do appear to be
analysed according to original randomised allocation
Incomplete outcome data? Low risk No loss to follow-up
Groups balanced at baseline? Low risk “Patients in the training group and in the control group showed
a significantly reduced left ventricular ejection fraction (training
group: 26.1 ±3.1%, control group: 24.7± 2.4%; NS [not signif-
icant]) and exercise capacity as determined by peak oxygen uptake
(training group: 20.3 ±1.0 ml/kg min, control group: 17.9 ±1.6
ml/kg min; P NS)”
Groups received same intervention? Unclear risk Details of co-interventions not reported
Gottlieb 1999
Methods Parallel group RCT
Participants N Randomised: 33
Diagnosis (% of participants):
Aetiology: ischaemic or primary
NYHA: Class II or III
LVEF: exercise 22% (SD 8); control 25% (SD 10)
Case mix: 100% as above
Age (yr): exercise 67 (SD 7); control 64 (SD 10)
Male: exercise 15/16 (94%); control 11/14 (79%); total 87%
White: not reported
Inclusion/exclusion criteria
Inclusion: NYHA Class II-III for at least 3 months and were on stable medications for
the past 1 month. All participants were on maximal medical therapy with angiotensin-
converting enzyme inhibitors, diuretic and digoxin. All participants had EF < 40% by
nuclear ventriculography. No participants had obstructive valvular disease, MI within 3
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months, or limitation of exercise secondary to angina or new arrhythmias
Exclusion: not reported
Interventions Exercise: Total duration: 3 months
Aerobic/resistance/mix: aerobic
Frequency: 3 session/wk
Duration: 30 min
Intensity: Borg 12-13
Modality: bike and treadmill
Setting: supervised sessions at medical centre by a nurse or exercise physiologist
Other: Care provided by specialist HF physician
Outcomes HRQoL (MLWHFQ and MOS SF-36 questionnaire), mortality, morbidity
Comparison Usual medical care
Other: care provided by specialist HF physicians
Country and setting USA
Single centre
Follow-up 6 months (after randomisation)
Notes MLWHF, MOS SF-36 results not reported for the control group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods are reported
Intention-to-treat analysis? Unclear risk Not reported
Incomplete outcome data? Low risk Yes, QUORUM flow diagram reported
Unclear how loss to follow-up, drop-out and cross-over dealt
with
Groups balanced at baseline? Low risk “There were no differences at baseline between patients randomised
to the control group and those randomised to the exercise program”
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Groups received same intervention? Low risk “Medical follow-up of both the control and intervention patients
groups was provided by specialized heart failure physicians”
Hambrecht 1995
Methods Parallel group RCT
Participants N Randomised: 22 (exercise 12; control 10)
Diagnosis (% of participants):
Aetiology: DCM 86%, ischaemic heart disease 14%
NYHA: Class II (55%); Class III (45%)
LVEF: exercise 26% (SD 9); control 27% (SD 10)
Case mix: 100% as above
Age (yr): exercise 50 (SD 12); control 52 (SD 8)
Male: 100%
White: not reported
Inclusion/exclusion criteria
Inclusion: EF < 40% as assessed by radionucleotide scintigraphy, and a reduced fractional
shortening < 30% assessed by echocardiography; willingness to participate in the study
for the next 6 months; and a permanent residence within 25 km of the training facility.
Physical work capacity at baseline > 25 watts without signs of myocardial ischaemia (i.
e. angina or ST segment depression). Clinically stable > 3 months
Exclusion: exercise-inducedmyocardial ischaemia or ventricular tachyarrhythmias (higher
then Lown Class IVa), valvular heart disease, uncontrolled hypertension, peripheral vas-
cular disease, COPD, and orthopaedic or other conditions precluding regular participa-
tion in exercise sessions
Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 4-6 sessions/wk
Duration: 10-60 min/session, 1 hr at home
Intensity: 70% VO2max
Modality: cycling, walking, ball games and callisthenics
Setting: first 3 wk supervised hospital-based training; thereafter home-based
Other: none
Outcomes Morbidity and mortality
Comparison After discharge medical therapy continued and participants supervised by private physi-
cian
Country and setting Germany
Single centre
Follow-up 6 months (after randomisation)
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods, reported in results
Intention-to-treat analysis? Unclear risk Not reported
Incomplete outcome data? Low risk Drop-outs and clinical events are fully reported for both groups.
No imputation undertaken
Groups balanced at baseline? Low risk “There were no significant differences in baseline variables between
the training and control groups”
Groups received same intervention? Unclear risk The exercise group had 3 wk of hospital stay, the control only
3 days. The control group follow-up with private physician. No
comment on follow-up of intervention group
Hambrecht 1998
Methods Parallel group RCT
Participants N Randomised: 20 (exercise 10, control 10)
Diagnosis (% of participants):
Aetiology: IHD 35%; DCM 65%
NYHA: Class II 65%; Class III 35%
LVEF: exercise mean 24% (SD 13); control mean 23% (SD 10%)
Case mix: as above
Age (yr): exercise 54 (SD 9); control 56 (8)
Male: 100%
White: not reported
Inclusion/exclusion criteria
Inclusion: age < 70 yr, with CHF as a result of DCM or IHD, LVEF < 40%
Exclusion: DM, hypertension, overt atherosclerotic PVD, hypercholesterolaemia, ven-
tricular tachycardia, COPD and primary valvular disease
Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix: aerobic
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Frequency: 2-6 sessions/day
Duration: 10-20 min/session
Intensity: 70% VO2 max
Modality: bike ergometer
Setting: supervised hospital-based sessions and unsupervised home-based sessions
Other: not reported
Outcomes Mortality
Comparison Description: stayed on previous medication, continued sedentary lifestyle, and super-
vised by their private physicians
Country and setting Germany
Single centre
Follow-up 6 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk It appears that groups are analysed according to original ran-
domised allocation
Incomplete outcome data? Low risk Detailed description of losses to follow-up and drop-outs re-
ported
Groups balanced at baseline? Low risk “At baseline, patients in the control group did not differ significantly
from those in the training group with respect to age, aetiology of heart
failure, NYHA functional class, duration of heart failure, LVEF
[lett ventricular ejection fraction] or LVEDD [Left Ventricular End
Diastolic Diameter]”
Groups received same intervention? Low risk “Patients were on angiotensin-converting enzyme inhibitors (100%
in both groups), diuretics (training group 82%, control 70%), and
digoxin (training 73%, control 70%, P5NS). Drug treatment did
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not change between 4 weeks before enrolment and study termina-
tion”
Hambrecht 2000
Methods Parallel group RCT
Participants N Randomised: 73 (exercise 36; control 37)
Diagnosis (% of participants):
Aetiology: IHD 16%; DCM 84%
NYHA: Class I and II 74%; Class III 26%
LVEF: 29% (SD 9)
Case mix: 100% as above
Age (yr): exercise 54 (SD 9); control 54 (SD 8)
Male: 100%
White: not reported
Inclusion/exclusion criteria
Inclusion: documented HF by signs, symptoms and angiographic evidence of reduced left
ventricular function (LVEF < 40%) as a result of DCM or IHD; physical work capacity
at baseline > 25 watts, clinical stability >=3 months before study start
Exclusion: significant valvular heart disease, uncontrolled hypertension, DM, hyperc-
holesterolaemia, PVD, pulmonary disease, musculoskeletal abnormalities precluding ex-
ercise training
Interventions Exercise: Total duration: 6-months
Aerobic/resistance/mix: aerobic
Frequency: 6 or 7 sessions/wk
Duration: 10-20/session
Intensity: 70% of peak VO2
Modality: cycle ergometer
Setting: first 2 wk in hospital, remainder home based
Other: plus group sessions 1 hr twice weekly, walking, ball games and callisthenics
Outcomes Mortality
Comparison Continued individually tailored cardiac medications, supervised by their physicians
Country and setting Germany
Single centre
Follow-up 6 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
54Exercise-based rehabilitation for heart failure (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hambrecht 2000 (Continued)
Random sequence generation (selection
bias)
Low risk “Patients were randomly assigned to either a training group or an
inactive group sing a list of random numbers”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk Not reported
Incomplete outcome data? Low risk QUORUM diagram and details of losses to follow-up reported
Groups balanced at baseline? Low risk “No significant differences were observed between the two groups
with regard to demographic or clinical data, including age, weight,
LVEF, LVEDD [Left Ventricular End Diastolic Diameter], NYHA
or maximum oxygen uptake”
Groups received same intervention? Unclear risk The co-interventions in the control group not reported
HF ACTION 2009
Methods Parallel group RCT
Participants N Randomised: 2331 (exercise 1159; control 1172)
Diagnosis (% of participants):
Aetiology: IHD 51%
NYHA: Class II 63%; Class III 35%; Class IV 1%
LVEF: 25% (SD not reported)
Case mix: 100% as above
Age (yr): exercise 59 (SD not reported); control 59 (SD not reported)
Male: 72%
White: 62%
Inclusion/exclusion criteria
Inclusion: LVEF < 35%, NYHA Class II-IV HF for the previous 3 months despite a 6-
wk period of treatment, optimal HF therapy at stable doses for 6 wk before enrolment
or documented rationale for variation, including intolerance, contraindication, partici-
pant preference and personal physicians judgement, sufficient stability, by investigator
judgement, to begin an exercise programme
Exclusion: (selected) age <18 yr, co-morbid disease or behavioural or other limitations that
interfere with performing exercise training or prevent the completion of 1 yr of exercise
training, major cardiovascular event or cardiovascular procedure, including implantable
cardioverter defibrillator use and cardiac resynchronisation, within the previous 6 wk
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Interventions Exercise: Total duration: 30 months
Aerobic/resistance/mix: aerobic
Frequency: 3-5 sessions/wk
Duration: 15-35 min/session
Intensity: 60-70% of HR reserve
Modality: cycling or walking
Setting: First 36 sessions were supervised then advised to follow 5 day/wk home-based
exercise programme
Other: none reported
Outcomes Mortality, hospitalisation, HRQoL (KCCQ), cost-effectiveness
Comparison Usual care: all participants, regardless of group allocation, received self management
educational materials consistent with guidelines of American College of Cardiology and
American Heart Association
Country and setting USA
Multicentre
Follow-up Median 30.1 months (after randomisation)
Notes Authors contacted for further details of outcome findings but no information provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The trial uses a permuted block randomization scheme stratified
by center and by the etiology of the patient’s heart failure (ischemic
vs nonischemic)”
Allocation concealment (selection bias) Low risk “Patients are randomized at the enrolling centers using an interactive
voice response”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Event outcomes were blinded
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk
Incomplete outcome data? Low risk QUORUM diagram and details of losses to follow-up reported
Groups balanced at baseline? Low risk Table 1 of the publication shows 2 groups are well balanced
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Groups received same intervention? Low risk “All patients, regardless of group allocation, received self-manage-
ment educational materials...consistent with guidelines of American
College of Cardiology and American Heart Association”
Jolly 2009
Methods Parallel group RCT
Participants N Randomised: 169 (exercise 84; control 85)
Diagnosis (% of participants):
Aetiology: data not available
NYHA: Class I 6%; Class II 74%; Class III 20%
LVEF: ≤ 40%
Age (yr): exercise 65.9 (SD 12.5); control 70 (SD 12.5)
Male: 75%
White: 85.1%
Inclusion/exclusion criteria
Inclusion: LVEF ≤ 40% on echocardiogram and had a severity of at least NYHA group
II in the previous 24 months. They had to have been clinically stable for 4 wk and in
receipt of optimal medical treatment and in care of a specialist HF nurse team from 2
acute hospital trusts and 1 primary care trusts and not considered high-risk for a home-
based exercise programme
Exclusion: NYHA Class IV, MI or revascularisation within the past 4 months, hypoten-
sion, unstable angina, ventricular or symptomatic arrhythmias, obstructive abortive
valvular disease, COPD, hypertrophic obstructive cardiomyopathy, severe musculoskele-
tal problems preventing exercise, and case-note reported dementia or current severe psy-
chiatric disorder
Interventions Exercise: Total duration: 6 months programme progressive with aim that participants
achieved the following:
Aerobic/resistance/mix:mix
Frequency: 5 times/wk
Duration: 20-30 min
Intensity: 70% of peak VO2 or Borg 12-13
Modality: aerobic and resistance elements (upper and lower limb exercises)
Setting: first 3 sessions supervised centre-based followed by home-based programme with
home-visits by nurse at 4, 10 and 20 wk and telephone support at 6, 15 and 24 wk.
Intervention manual provided
Other: specialist HF nurse care
Outcomes HRQoL (MLWHFQ), composite of death, hospital admissions, generic quality of life
(EQ-5D)
Comparison Specialist HF nurse care
Country and setting UK
West-midlands, community
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Follow-up 6- and 12-month follow-up (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “An independent clinical trials unit using a computerized pro-
gramme undertook randomization after each patient had consented
and undergone the baseline tests and questionnaire”
Allocation concealment (selection bias) Low risk “An independent clinical trials unit using a computerized pro-
gramme undertook randomization after each patient had consented
and undergone the baseline tests and questionnaire”
Blinding (performance bias and detection
bias)
All outcomes
High risk “…, the nurse undertaking the assessment was blinded to the treat-
ment allocation of the patient, but owing to staffing issues, this oc-
curred in only 62% of participants followed up at 6 months”
Selective reporting (reporting bias) Low risk All of primary and majority of secondary outcomes described in
methods reported
Stated in methods that blood pressure and incremental shuttle
walking test were not collected at 12 months
Intention-to-treat analysis? Low risk “...between- and within-group analyses for primary and secondary
outcomes at 6 and 12months were performed according to intention
to treat”
Incomplete outcome data? Low risk Drop-outs and clinical events are fully reported
Outcome available for 161 (95%) participants at 6 months and
157 (92%) participants at 12 months. Non-imputed data re-
ported and sensitivity analysis undertaken to examine impact of
missing data
Groups balanced at baseline? Unclear risk “Baseline characteristics were broadly comparable, the exception be-
ing that the exercise group was somewhat younger and had higher
HADS depression scores and a lower systolic blood pressure”
Groups received same intervention? Low risk “Both groups received specialist heart failure nurse input in primary
and secondary care through clinic and home visits that included
the provision of information about heart failure, advice about self-
management and monitoring of their condition, and titration of
beta-blocker therapy”
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Jónsdóttir 2006a
Methods Parallel group RCT
Participants N Randomised: 43 (exercise 21; control 22)
Diagnosis (% of participants):
Aetiology: ischaemic 79%; AF 12%; valvular 7%; hypertension 2%
NYHA: Class II and III
LVEF: exercise 41.5 (SD 13.6); control 40.6% (SD 13.7)
Case mix: as above
Age (yr): exercise 68 (SD 7); control 69 (SD 5)
Male: 79%
White: not reported
Inclusion/exclusion criteria
Inclusion: CHF diagnosis, on CHF medication, clinical symptoms of CHF, clinically
stable > 3 months before study entrance, fulfil 1 of the following criteria: previous MI,
hospitalised because of CHF, lung oedema and cardiac enlargement on X-ray
Exclusion: chronic obstructive lung disease, orthopaedic disabilities, psychiatric disabili-
ties, cancer, senility and age > 80 yr
Interventions Exercise: Total duration: 5 months
Aerobic/resistance/mix: mix
Frequency: 2 sessions/wk
Duration: 45 min
Intensity: not reported
Modality: cycling, free weights and elastic rubber-bands (Thera-bands)
Setting: hospital outpatients, supervised by physiotherapists
Other: training group had 3 educational lectures, about nutrition, physical activity and
relaxation in addition to the exercise programme
Outcomes Rehospitalisation and mortality
Comparison Usual medical care (continued their previous level of physical activity, which varied from
performing little physical activity up to taking a daily walk outdoors)
Country and setting Iceland
Single centre
Follow-up 12 and 28 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
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Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk Although not reported as ITT analysis, groups did appear to be
analysed according to original randomised allocation
Incomplete outcome data? Low risk No losses to follow-up
Groups balanced at baseline? Low risk Table 2 of the publication suggests 2 groups are well balanced
Groups received same intervention? Low risk Yes, both groups appeared to receive same interventions apart
from CR intervention
Keteyian 1996
Methods Parallel group RCT
Participants N Randomised: 40 (exercise 21; control 19)
Diagnosis (% of participants):
Aetiology: DCM 40%; IHD 60%
NYHA: Class II 67.5%; Class III 32.5%
LVEF: 21% (SD 7)
Case mix: 100% as above
Age (yr): 56 (SD 11)
Male: 100%
White: 62.5% (remainder black)
Inclusion/exclusion criteria
Inclusion: NYHA Class II or III, resting EF < 35% measured by echocardiography or
gated equilibrium radionuclide angiography and no change in medical therapy >=30
days before randomisation
Exclusion: AF, acute MI ?3 months, angina pectoris at rest or induced by exercise, cur-
rent enrolment in another clinical trial, and current participation in a regular exercise
programme (at least twice weekly)
Interventions Exercise: Total duration: 24 wk
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/wk (rate of perceived exertion 12-14)
Duration: 33 min
Intensity: 60-80% peak HR
Modality: treadmills, stationary cycles, rowing machines and arm ergometers
Setting:outpatient clinic
Other: none reported
Outcomes Morality and hospital admissions
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Comparison Usual medical care
Participants were instructed to maintain their normal daily activity habits and not to
begin an exercise regimen
Country and setting North America
Single centre
Follow-up 6 months (after randomisation)
Notes Authors contacted for further details of outcome findings but no information provided.
Each participant’s physician was asked not to change drug regimen during the study, if
possible
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were randomly assigned to the exercise group or the control
group”
Allocation concealment (selection bias) Unclear risk “Each patient’s assignment was sealed in an envelope until comple-
tion of the second exercise test”
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk “Of the 40 patients entered into the study, only those who also
completed the exercise tests at weeks 12 and 24 were considered in
the data analysis”
Incomplete outcome data? Low risk “Fifteen patients in the exercise group completed the study. Two pa-
tients dropped out because of noncardiac medical conditions (pro-
gressive, limiting arthritis in one patient and newly diagnosed can-
cer in the other) that developed within 1 month of the start of the
exercise program. One patient developed atrial fibrillation between
week 12 and week 24; 3 other patients stopped exercising for per-
sonal reasons before week 12 and refused follow-up testing. Fourteen
of the 19 patients in the control group completed the study. Two
dropped out for personal reasons and refused follow-up testing, one
developed atrial fibrillation between week 12 and week 24, one was
hospitalized at week 22 for an acute myocardial infarction, and one
died suddenly”
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Groups balanced at baseline? Low risk “Among patients who completed the study, no differences in demo-
graphic characteristics were seen between the two study groups after
randomization”
Groups received same intervention? Unclear risk The co-interventions in the control group not reported
Klecha 2007
Methods Parallel group RCT
Participants N Randomised: 50 (exercise 25; control 25)
Diagnosis (% of participants):
Aetiology: IHD 100%
NYHA: Class II: exercise 56%; control 60%; Class III: exercise 44%; control 40%
LVEF: exercise mean 27.4% (SD 5.7); control: 28.5% (SD 5.2)
Case mix: 100% as above
Age (yr): exercise 59.6 (SD 10.2); control 61.2 (SD 9.5)
Male: exercise 80%; control 72%
White: not reported
Inclusion/exclusion criteria
Inclusion: ischaemic HF in NYHA Classes II and III of > 6 months, clinically stable > 6
wk and LVEF < 35%
Exclusion: uncontrolled arterial hypertension; history of major ventricular arrhythmias,
acute coronary syndrome, percutaneous coronary intervention or brain event 3 months
prior to the study; AFor other arrhythmiamaking it impossible to performMRI; previous
coronary artery bypass grafting; implantable cardiodefibrillator; permanent pacemaker
or the presence of metal parts in the body; signs of osteoarticular dysfunction excluding
participation in physical training; DM; COPD and anaemia
Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/wk
Duration: 25 min/session
Intensity: 80% predicted HR at VO2 max
Modality: cycling
Setting: centre-based
Other: none reported
Outcomes Mortality
Comparison Standard medical care only
Country and setting Poland
Single centre
Follow-up 26 wk (after randomisation)
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk Not implicit but numbers used suggest that groups analysed
according to randomised allocation
Incomplete outcome data? Low risk No participants lost to follow-up
Groups balanced at baseline? Low risk “At baseline the groups did not differ significantly in clinical char-
acteristics. The only exception was smoking, the training group con-
sisted of significantly more ex-smokers”
Groups received same intervention? Unclear risk Not reported
Klocek 2005 (Const)
Methods Parallel group RCT
Participants N Randomised: 42 (exercise group A 14; control 14)
Diagnosis (% of participants):
Aetiology: ischaemic 100%
NYHA: Class II/III exercise group A 55%; control 100%
LVEF: exercise group A: mean 33.6% (SD 3.6); control 33.2% (SD 3.8)
Case mix: 100% as above
Age (yr): exercise group A 54 (SD 7); control 55 (SD 9)
Male: 100%
White: not reported
Inclusion/exclusion criteria
Inclusion: stable CHF, LVEF < 40% on echocardiography =<1 month before inclusion,
age < 65 yr
Exclusion: moderate or severe pulmonary disease, orthostatic blood pressure fall (> 20
mmHg), or with MI, unstable angina, heart surgery or coronary angioplasty within 3
months prior to inclusion as well as inability to perform bicycle training
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Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/wk
Duration: group A - 20 min/session (4-min constant workload with 1 min rest repeated
5 times)
Intensity: group A - 60% max HR
Modality: cycle ergometer
Setting: CR, outpatient unit under supervision of the physician and rehabilitation spe-
cialist
Other: none reported
Outcomes HRQoL (Psychological General Wellbeing Index)
Comparison Description: controls were asked not to change their degree of physical activity during
the study
Country and setting Poland
Single centre
Follow-up 26 wk (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk “Results of baseline QoL examinations were not known to the pa-
tients and their physicians or to the persons performing the randomi-
sation”
Selective reporting (reporting bias) Low risk All outcomes described in methods are reported in results
Intention-to-treat analysis? Low risk It appears that groups were analysed according to initial random
allocation
Incomplete outcome data? Unclear risk No information presented on loss on loss to follow-up or drop-
outs
Groups balanced at baseline? Low risk “At baseline there were no significant differences in between groups
in left ventricular ejection fraction and other basic parameters of
left ventricular function.” “At the start of the study, mean PGWB
[Psychological General Wellbeing Index] total index was similar in
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groups A and B. Controls had lower total index than patients in
group B”
Groups received same intervention? Unclear risk Details of co-interventions not reported although degree of fol-
low-up was stated to be equivalent
Klocek 2005 (Prog)
Methods Parallel group RCT
Participants N Randomised: 42 (exercise group B 14; control 14)
Diagnosis (% of participants):
Aetiology: ischaemic 100%
NYHA: Class II/III exercise group B 75%; control 100%
LVEF: exercise group B: mean 34.2% (SD 4.2); control 33.2% (SD 3.8)
Case mix: 100% as above
Age (yr): exercise group B: 57 (SD 8); control 55 (SD 9)
Male: 100%
White: not reported
Inclusion/exclusion criteria
Inclusion: stable CHF, LVEF < 40% on echocardiography =< 1 month before inclusion,
age < 65 yr
Exclusion: moderate or severe pulmonary disease, orthostatic blood pressure fall (> 20
mmHg), or with MI, unstable angina, heart surgery or coronary angioplasty within 3
months prior to inclusion as well as inability to perform bicycle training
Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/wk
Duration: group B: 25 min/session (exercise workload gradually increased after each 5-
min training period to a total of 25 min)
Intensity: group B: up to 75% max HR
Modality: cycle ergometer
Setting: CR, outpatient unit under supervision of the physician and rehabilitation spe-
cialist
Other: none reported
Outcomes HRQoL (Psychological General Wellbeing Index)
Comparison Controls were asked not to change their degree of physical activity during the study
Country and setting Poland
Single centre
Follow-up 26 wk (after randomisation)
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk “Results of baseline QoL examinations were not known to the pa-
tients and their physicians or to the persons performing the randomi-
sation”
Selective reporting (reporting bias) Low risk All outcomes described in methods are reported in results
Intention-to-treat analysis? Low risk It appears that groups were analysed according to initial random
allocation
Incomplete outcome data? Unclear risk No information presented on loss on loss to follow-up or drop-
outs
Groups balanced at baseline? Low risk “At baseline there were no significant differences in between groups
in left ventricular ejection fraction and other basic parameters of
left ventricular function.” “At the start of the study, mean PGWB
[Psychological General Wellbeing Index] total index was similar in
groups A and B. Controls had lower total index than patients in
group B”
Groups received same intervention? Unclear risk Details of co-interventions not reported although degree of fol-
low-up was stated to equivalent
Koukouvou 2004
Methods Parallel group RCT
Participants N Randomised: 26 (exercise 16; control 10)
Diagnosis (% of participants):
Aetiology: DCM 7%; ischaemic 100%
NYHA: Class II 58%; Class III 42%
LVEF: < 40%
Case mix: 100% as above
Age (yr): exercise 52 (SD 9); control 53 (SD 11)
Male: 100%
White: not reported
Inclusion/exclusion criteria
Inclusion:aetiology of CHF was either ischaemic heart disease or DCM. Diagnosis of
CHF was mainly based on clinical signs (NYHA Class II and III), radiological findings,
and echocardiographically determined EF < 40% and shortening fraction < 30%
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Exclusion: recentMI or unstable angina; aortic stenosis; DM; uncontrolled hypertension;
musculoskeletal limitations or other contraindications for participating in an exercise
training programme; documented exercise-induced severe ischaemia or serious arrhyth-
mias or both
Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix:mix
Frequency: 3 or 4 sessions/wk
Duration: 60 min/session
Intensity: 50-75% peak VO2
Modality: cycle ergometer, walking or jogging, stair climber and step-aerobics
Plus ’light’ resistance exercise (not defined)
Setting: supervised exercise training programme at institution
Other: none reported
Outcomes HRQoL (MLWHFQ and Spritzer Quality of Life Index)
Comparison Not reported
Country and setting Greece
Single centre
Follow-up 6 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “The psychological tests were assessed from all patients in the first
week of admission, before randomization to study groups and the
end of the study by the same physician, who was not familiar with
the patients”
Selective reporting (reporting bias) Low risk All outcomes outlined in methods are reported
Intention-to-treat analysis? Low risk Not stated explicitly but appear to analysed according to initial
group allocation
Incomplete outcome data? Unclear risk Losses to follow-up, drop-outs not reported
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Groups balanced at baseline? Low risk “The two groups of patients participating in the study were similar
as regards their clinical data”
Groups received same intervention? Unclear risk Not reported
McKelvie 2002
Methods Parallel group RCT
Participants N Randomised: 181 (exercise 90; control 91)
Diagnosis (% of participants):
Aetiology: ischaemic 76%; hypertensive 7%; valvular 5%; other 12%
NYHA: Class I-III
LVEF: < 40%
Case mix: 100% as above
Age (yr): exercise 64.8±1.1 (SD 10.5); control 66.1 (SD 9.4)
Male: control 80; exercise 82
White: not reported
Inclusion/exclusion criteria
Inclusion: documented clinical signs and symptoms of HF; LVEF < 40%; NYHA Func-
tional Class I-III; 6-min walk test distance < 500 m
Exclusion: inability to attend regular exercise training sessions; exercise testing limited by
angina or leg claudication; abnormal blood pressure response to exercise testing (systolic
blood pressure during exercise > 250 mm Hg or diastolic blood pressure response > 15
mmHg, systolic blood pressure response decrease of > 20 mmHg after a normal increase
or decrease below the resting level); cerebrovascular or musculoskeletal disease preventing
exercise testing or training; respiratory limitation (forced expired volume in 1 second, or
vital capacity < 60% of predicted, or both); poorly controlled cardiac arrhythmias and
any non-cardiac condition affecting regular exercise training or decreasing survival
Interventions Exercise: Total duration: 9 months (3 supervised, 6 home based)
Aerobic/resistance/mix: mix
Frequency: 2 sessions/wk
Duration: aerobic; 30 min/session
Intensity: aerobic: 60-70% max HR. Resistance: 40% of 1-repetition maximum, with 10
repetitions for the arm exercises and 15 repetitions for the leg exercises, with an increase
over 5 wk to an intensity of 60% of 1-repetition maximum and a total of 3 sets of each
exercise per session
Modality: aerobic: cycle, treadmill and arm ergometry exercise. Resistance: arm curl, knee
extension and leg press performed individually with each limb
After 3 months of supervised training, participants in the exercise group were provided
an exercise cycle and set of free weights with instructions to continue training at home
3 times/wk for the remainder of the study
Setting:Supervised for 3 months at rehabilitation centre and unsupervised for 9 months
at home
Other: none reported
Outcomes HRQoL (MLWHFQ), mortality, composite of mortality and hospital admission for HF
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Comparison Usual medical care. Control participants were not provided with a formal exercise pre-
scription but were encouraged to continue their usual level of physical activity and were
not discouraged from regular physical activity
Country and setting Canada
Multicentre
Follow-up 12 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The predetermined allocation sequence was based on a stream of
computer-generated pseudorandom numbers from a uniform distri-
bution stratified by center and with a blocking factor of 4”
Allocation concealment (selection bias) Low risk “Eligible patients were registered in a log and treatment group de-
termined by opening the next sequential study allocation envelope”
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Outcome measures were performed in a blinded fashion. Individ-
uals responsible for supervising and recording the results of the out-
come measurements were unaware of the patients group assignment”
Selective reporting (reporting bias) Unclear risk All outcomes described in methods are reported in results
Intention-to-treat analysis? Low risk Although ITT analysis not reported, groups do appear to anal-
ysed according to original randomised allocation
Incomplete outcome data? Low risk “In the control group, 83 patients completed 3 months of follow-
up (reasons for incompletion: death 3; other problems 4; worsening
heart failure 1) and 75 patients completed 12months of follow-up
(reasons for incompletion: death 8; withdrawal 2; other problems
3; worsening heart failure 2; refused testing 1)
For the exercise group, 80 patients completed 3 months of follow-up
(reasons for incompletion: death 1; withdrawal 5; other problems 1;
worsening failure 2; refused testing 1) and 64 patients completed 12
months of follow-up (reasons for incompletion: death 9; withdrawal
6; other problems 7; worsening heart failure 3; refused testing 1)”
No imputationor sensitivity analysis undertaken to assess impact
of loss to follow-up
Groups balanced at baseline? Low risk “There were no differences between the control and exercise training
groups with respect to age, resting ejection fraction, New York Heart
Association class, cause of heart failure, or duration of heart failure”
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McKelvie 2002 (Continued)
Groups received same intervention? Unclear risk “All patients were reviewed monthly throughout the study”
Mueller 2007
Methods Parallel group RCT
Participants N Randomised: 50 (exercise 25; control 25)
Diagnosis (% of participants):
Aetiology: ischaemic; DCM (% not reported)
NYHA: not reported
LVEF: < 40% (% not reported)
Case mix: 100% as above
Age (yr): 55 (SD 10)
Male: 100%
White: not reported
Inclusion/exclusion criteria
Inclusion:CHF documented by clinical, angiographic or echocardiographic criteria; and
resting EF < 40%
Exclusion: not reported
Interventions Exercise: Total duration: 1 month
Aerobic/resistance/mix: aerobic
Frequency: 5 sessions/wk
Duration: 30 min/session cycling, 90 min walking each day
Intensity: Borg 12-14 (60-80% max HR)
Modality: cycling and walking
Setting: indoor cycling sessionswere supervised directly by amedical resident and outdoor
walking sessions were supervised by exercise physiologists
Other: resided at the rehabilitation centre for 1 month. Programme component also
included education and low-fat meals prepared daily by the centre’s cook
Outcomes Morbidity and mortality
Comparison Usual medical care
Country and setting Switzerland
Single centre
Follow-up 6.2 yr (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Mueller 2007 (Continued)
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk Outcomes described in the methods are reported in the results
Intention-to-treat analysis? Low risk ITT not stated explicitly. However, groups appear to analysed
according to original allocation
Incomplete outcome data? Low risk “Data from one patient in the control group was not available
at the two-month evaluation due to refusal to complete testing.
” “Among subjects in the exercise group, 9 died, and one refused
repeat testing. Among patients in the control group, 12 died and
two refused repeat testing. Therefore, 14 and 13 patients performed
six-year evaluations in the exercise and control groups, respectively.”
QUORUM diagram reported and detailed text. No imputation
undertaken
Groups balanced at baseline? Low risk “Nodifferences were observed between the exercise and control groups
initially in clinical or demographic data, including age, height,
weight, pulmonary function or medication status”
Groups received same intervention? Unclear risk “Patients in the exercise group resided at the rehabilitation centre for
one month. Control subjects received usual clinical care, including
verbal encouragement to remain physically active”
Myers 2000
Methods Parallel group RCT
Participants N Randomised: 25 (exercise 12; control 13)
Diagnosis (% of participants):
Aetiology: ischaemic 100%
NYHA: not reported
LVEF: exercise 31.5% (SD 7); control 33.3% (SD 6)
Case mix: 100% as above
Age (yr): exercise 56 (SD 5); control 55 (SD 7)
Male: 100%
White: not reported
Inclusion/exclusion criteria
Inclusion:MI, diagnosis of HF and stable symptoms, LVEF < 40%
Exclusion: pulmonary disease
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Interventions Exercise: Total duration: 2 months
Aerobic/resistance/mix: aerobic
Frequency: walking: 2 sessions/daily; cycling: 4 sessions/wk
Duration: walking: 1 hr; cycling: 45 min
Intensity: walking: not reported; cycling: 60-70% peak VO2
Modality: walking and cycling
Setting: centre based with supervised by physicians
Other: exercise groups received education sessions and low-fat meals prepared 3 times
daily
Outcomes Hospitalisation and mortality
Comparison Usual clinical follow-up
Country and setting Switzerland
Single-centre
Follow-up 2 and 12 months (after randomisation)
Notes “After the initial 2-months exercise training or control period, both groups were encouraged
to remain physically active over the subsequent 10 months, although no formal program was
implemented”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk Although not explicit, participants appeared to be analysed ac-
cording to initial random allocation
Incomplete outcome data? Low risk Lost to follow-up reported
Groups balanced at baseline? Low risk “No differences were observed between the 2 groups initially in
clinical or demographic data, including age, height, weight, resting
blood pressure, pulmonary function, ejection fraction, or maximal
oxygen uptake”
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Groups received same intervention? Low risk Yes, both groups appeared to receive same interventions apart
from CR intervention
Nilsson 2008
Methods Parallel group RCT
Participants N Randomised: 80 (exercise 40; control 40)
Diagnosis (% of participants):
Aetiology: ischaemic cardiomyopathy 69%; idiopathicDCM18%; hypertensiveHF13%
NYHA: Class II 47%; Class III 35%
LVEF: exercise 31% (SD 8); control 31% (SD 9)
Case mix: 100% as above
Age (yr): 70.1 (SD 7.9)
Male: 79%
White: not reported
Inclusion/exclusion criteria
Inclusion: stable CHF and a LVEF < 40% or ≥ 40% with clinical symptoms of diastolic
HF
Exclusion: acute MI within 4 wk; unstable angina pectoris; serious rhythm disturbance;
symptomatic PVD; severe CPOD, with a forced expiratory vital capacity < 50% of
expectedmeasured by spirometry; 6-minwalking distance > 550m; andwork load on the
cycle ergometer test > 110 watts, significant co-morbidities that would prevent entry into
the study due to terminal disease or an inability to exercise (e.g. severe musculoskeletal
disorder, advanced valvular disease) or were in long-term care establishments
Interventions Exercise: Total duration: 4 months
Aerobic/resistance/mix: aerobic
Frequency: 2 sessions/wk
Duration: 50 min
Intensity: 15-18 on Borg scale
Modality: fast walking, side stepping and leg lifts in combination with overhead arm
reaches
Setting: hospital outpatient department
Other: 15-30 min counselling for participants in exercise group with CHF nurse (4 hr
in total)
Outcomes HRQoL (MLWHFQ) and mortality
Comparison The control group was not provided with exercise prescriptions and encouraged to con-
tinue their usual levels of physical activity
Country and setting Norway
Single centre
Follow-up 12 months (after randomisation)
Notes All training sessionswere supervised by physiotherapist, a specialist in heart rehabilitation
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Nilsson 2008 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “computer-generated table of random numbers”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Three physicians and 3 nurses who were blinded to the clinical data
and group assignments of the patients carried out all the follow-up
tests. Patients were told not to reveal to which groups they belonged”
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk “Intention-to-treat analyses were performed”
Incomplete outcome data? Low risk 35/40 (88%) exercise training group and 37/40 (93%) control
group available at 12 months
Groups balanced at baseline? Low risk Table 1 of the publication suggests no difference between the 2
groups
Groups received same intervention? Low risk Yes
Norman 2012
Methods Parallel group RCT
Participants N Randomised: 42 (exercise 22; control 20)
Diagnosis (% of participants):
Aetiology: ischaemic 50%; non-ischaemic 50%
NYHA: Class II: exercise 64%; control 45%; Class III: exercise 36%; control 55%
LVEF: exercise: mean 33% (SD 7); control: mean 32% (SD)
Age (yr): exercise 57 (SD 12); control 63 (SD 15)
Male: 57.5%
White: not reported
Inclusion/exclusion criteria
Inclusion: age ≥ 21 yr, with HF; orientated to person, place and time; able to speak and
read English; resting LVEF ≤ 40% and stable on optimal medical therapy for at least 30
days
Exclusion: clinical evidence of decompensated HF, unstable angina pectoris, MI, coro-
nary artery bypass surgery, biventricular pacemaker < 3 months ago, orthopaedic or neu-
romuscular limitations preventing participation in aerobic or resistance exercise training,
and participation in an aerobic exercise programme during the past 12 months
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Interventions Exercise: Total duration: 24 wk
Aerobic/resistance/mix:mix
Frequency: aerobic 3 days/wk, resistance 2 days/wk
Duration: aerobic: 30 min/session (30 min warm-up); resistance: 8-10 exercises (upper
and lower extremity) performed for 1 set of 10-15 repetitions
Intensity: aerobic: 40-70% HR reserve, or Borg 11-14; resistance: not reported
Modality: aerobic: not reported; resistance: weight machines, free weights or elastic bands
based on their exercise performance
Setting: 3 wk: supervised; 21 wk: hospital’s wellness centre or home
Other: group meetings that addressed the same education topics as the control group
but in addition included information on problem-solving barriers to exercise, relapse
management and symptoms experienced during exercise
Outcomes HRQoL (KCCQ), SF-36 and mortality
Comparison “Attention control”
Instructions to continue with their normal level of activity. No instructions were given
to withhold or stop activity
Country and setting USA
Single centre
Follow-up 24 wk (after randomisation)
Notes Study conducted in 2 sequential 12-wk phases
Phase 1: separate weekly group meetings of both groups during wk 1-3, then separate
biweekly meetings during wk 4-12
Phase 2: following the groups for an additional 12 wk without group sessions
Other trial report:
Pozehl B, Duncan K, Hertzog M, Norman JF. Heart failure exercise and training camp:
effects of a multicomponent exercise training intervention in patients with heart failure.
Heart Lung 2010;39(6 Suppl):S1-13
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
High risk “Research assistants whowere blinded to group assignment assisted in
some of the data collection. However, because of budget constraints,
the investigators who were not blinded to group assignment were
also involved in data collection”
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
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Intention-to-treat analysis? Low risk Not stated but groups analysed according to randomised alloca-
tion
Incomplete outcome data? Low risk Due to mortality and drop out KCCQ scores available in 37
patients (88%) at 24 wk
Groups balanced at baseline? Low risk “…no significant difference noted between groups”
Groups received same intervention? Low risk Both groups received group sessions (attention control) so only
difference between groups was exercise based intervention
Passino 2006
Methods Parallel group RCT
Participants N Randomised: 85 (training 44; control 41)
Diagnosis (% of participants): *
Aetiology: ischaemic 59%; DCM 41%
NYHA: Class I 16%; Class II 69%; Class III 34%
LVEF: training: 35% (SD 9.3); control 32.3 (SD 14.1)
Case mix: 100% as above
Age (yr): exercise 60 (SD 13); control 61 (SD 13)
Male: 87%
White: not reported
Inclusion/exclusion criteria
Inclusion: impaired left ventricular systolic function (EF < 45%) and exercise capacity
(peak VO2 < 25 mL/min/kg)
Exclusion: NYHA Class IV, MI or unstable angina < 6 months before the examination,
exercise-limiting diseases, and severe pulmonary or renal disease
* baseline data only available for 85 participants
Interventions Exercise: Total duration: 9 months
Aerobic/resistance/mix: aerobic
Frequency: > 3 sessions/wk
Duration: 30 min/session
Intensity: 65% max VO2
Modality: cycle
Setting: home-based
Other: not reported
Outcomes HRQoL (MLWHFQ)
Morbidity
Comparison Not reported
Country and setting Italy
Not reported
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Passino 2006 (Continued)
Follow-up 9 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Exercise test assessor blinded
Selective reporting (reporting bias) Unclear risk Not reported
Intention-to-treat analysis? Low risk Although ITT not stated, groups appeared to be analysed ac-
cording to original randomisation
Incomplete outcome data? Low risk Outcomes described in methods reported in results
Groups balanced at baseline? Low risk “The two groups did not differ as to age, gender, NYHA functional
class, EF, pharmacologic treatment, or HF etiology (Table 1)”
Groups received same intervention? Low risk “Patients in [control] group underwent follow-up visits at the third
and ninth month to exclude changes in their usual lifestyle and
physical activity”
Pozehl 2008
Methods Parallel group RCT
Participants N Randomised: 21 (exercise 15; control 6)
Diagnosis (% of participants):
Aetiology: ischaemic 71%; non-ischaemic 29%
NYHA: Class II 39%; Class III 52%; Class IV 9%
LVEF: exercise 27.9% (SD 7.0); control 29.7% (SD 8.7)
Case mix: 100% as above
Age (yr): exercise 66.3 (SD 9.6); control 66 (SD 12.6)
Male: 90%
White: 100%
Inclusion/exclusion criteria
Inclusion: able to speak and read English; stable NYHA Class II-IV no change in med-
ical therapy for 30 days; resting LVEF < 40% measured by echocardiography or gated
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Pozehl 2008 (Continued)
equilibrium radionuclide angiography; medical diagnosis of HF either ischaemic or non-
ischaemic; and standard pharmacological therapy for HF (diuretics, angiotensin-con-
verting enzyme inhibitors and beta-blockers)
Exclusion: participation in a formal exercise programme < 30 days prior to this study;
clinical evidence decompensated HF; and any of the following medical conditions: AF,
acute MI < 3 months, unstable angina pectoris, end-stage renal disease or orthopaedic
impediments to exercise
Interventions Exercise: Total duration: 24 wk
Aerobic/resistance/mix:mix
Frequency: 3 sessions/wk
Duration: 30 min aerobic, 20 min resistance
Intensity: 60-85% max VO2, 12-14 Borg scale
Modality: aerobic: treadmill, stationary bike, rower, arm ergometer; resistance: light up-
per-body exercises (military press, biceps curl and lateral deltoid raises) and lower-body
exercises (knee extension, side hip raise and hip extension) with 1-10 lb hand and ankle
weights. Wall push-ups, abdominal curl-ups, pelvic tilts, or a combination
Setting: first 12 wk at the hospital and remaining sessions were unsupervised at rehabili-
tation centre
Other: strategies from social learning theory (goal-setting, feedback and problem-solving
guidance) utilised to facilitate, improve adherence to the training programme
Outcomes Mortality
Comparison Usual medical care
Country and setting USA
Single centre
Follow-up 6 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk Outcomes described in methods are reported in results
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Pozehl 2008 (Continued)
Intention-to-treat analysis? Low risk Although not stated, groups appear to analysed according to
initial randomised allocation
Incomplete outcome data? Low risk “One subject in the control group died of myocardial infarction
and one subject in the exercise training group was diagnosed with
cancer and unable to continue the exercise training.”No imputation
undertaken
Groups balanced at baseline? Low risk “Subjects did not differ in fatigue or dyspnea by type of HF (ischemic
vs. nonischemic) or years since diagnosis of HF (length of time since
diagnosis)”
Groups received same intervention? Unclear risk Not reported
Wall 2010
Methods Parallel group RCT
Participants N Randomised: 19 (exercise 9; control 10)
Diagnosis (% of participants):
Aetiology: not reported
NYHA: mean: exercise 2 (SE 0); control 2.13 (SE 0.13)
LVEF: ≤ 60%
Case mix: as above
Age (yr): exercise 69 (SD 4.44); control 70 (SD 4.05)
Male: 58%
White: 100%
Inclusion/exclusion criteria
Inclusion: 1. a diagnosis of NYHA Class I-III congestive HF, 2. an EF≤ 60%, 3. systolic
dysfunction, 4. physician approval and 5. the ability to complete a minimum of 3 min
of a modified Bruce-protocol stress test
Exclusion: failure tomeet any of the inclusion criteria, inability to speak English or having
noticeable cognitive impairment
Interventions Exercise: Total duration: 12 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/wk
Duration: > 15 min
Intensity: not reported
Modality: treadmill
Lifestyler® treadmill provided for 1 year of in-home use, 3 supervised exercise sessions
at hospital with CR specialist. Weekly in-home exercise visits with CR specialist, Month
1. Monthly in-home exercise visits with CR specialist, Months 2-12. Also received com-
prehensive disease management programme
Setting: 3 hospital based and the remainder at home
Other: not reported
Outcomes Disease-specific HRQoL (Chronic Heart Failure Questionnaire), mortality
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Comparison Comprehensive disease management - by dedicated case manager (participant education
on nutrition, medications, and disease management; an oximetry assessment; and con-
stant monitoring of symptomatic changes and disease status
Country and setting USA
Single-centre
Follow-up 12 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods reported
Intention-to-treat analysis? Low risk Although not stated, it is clear from CONSORT diagram that
2 groups were analysed according to ITT
Incomplete outcome data? Low risk QUORUM flow diagram report suggests 19 were included in
the analysis
15 participants (79%) completed final follow-up measures at
month 12
Groups balanced at baseline? Low risk Table 3 of the publication suggests there is no difference between
the 2 groups (except dyspnoea score)
Groups received same intervention? Low risk Both groups received comprehensive disease management
Willenheimer 2001
Methods Parallel group RCT
Participants N Randomised: 54 (exercise 27; control 27)
Diagnosis (% of participants):
Aetiology: ischaemic 80%; non-ischaemic 20%
NYHA: exercise 2.1 (SD 0.7); control 2.4 (0.7)
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LVEF: exercise 35% (SD 12); control 38% (SD 10)
Case mix: 100% as above
Age (yr): exercise 64 (SD 5); control 64 (SD 9)
Male: exercise 73%; control 70%
White: not reported
Inclusion/exclusion criteria
Inclusion: 1. 8 points on Boston heart failure criteria; 2. LVEF 0.45 at the most recent
radionuclide or echocardiographic examination (not older than 1 year at inclusion) and
3. age 75 yr
Exclusion: 1. change of clinical status or medication (or both) within 4 wk prior to in-
clusion; 2. MI, heart surgery or coronary angioplasty within 3 months prior to inclu-
sion; 3. inability to perform a bicycle test; 4. exercise-terminating angina pectoris, ST-
depressions (> 2 mm in > 1 lead), blood pressure fall (>.10 mmHg), or arrhythmia (e.g.
ventricular tachycardia/fibrillation, ventricular extrasystoles, supraventricular tachycar-
dia > 170 bpm) at the most recent maximal exercise test (including the baseline test);
5. pulmonary disease judged to be the main exercise-limiting factor or peak expiratory
flow rate < 50% of the age- and sex-adjusted reference value, or both; 6. NYHA Class
IV and 7. clinically significant aortic stenosis
Interventions Exercise: Total duration: 4 months
Aerobic/resistance/mix: aerobic/interval
Frequency: 2-3 sessions/wk
Duration: 15 min/session increasing to 45 min/session
Intensity: 80% peak VO2, or 15 on Borg score
Modality: cycle ergometry
Setting: group sessions supervised by physiotherapist
Other: none
Outcomes HRQoL (Patient’s Global Assessment of Quality of Life), mortality
Comparison Control participants were asked not to change their degree of physical activity during the
active study period. Neither training participants nor controls were instructed regarding
physical activity during the 6-month extended follow-up
Country and setting Sweden
Single centre
Follow-up 10 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
81Exercise-based rehabilitation for heart failure (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Willenheimer 2001 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Low risk Outcome assessors blinded. Participants, clinical carers not
blinded
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk Although ITT not implicit, it appears that groups are analysed
according to original randomised allocation
Incomplete outcome data? High risk Outcome available in only 43/54 (80%) participants ran-
domised at 10 months’ follow-up. No imputation or sensitivity
analysis undertaken to assess effect of loss to follow-up. Authors
state that participants available at 10 months’ follow-up are rep-
resentative
Groups balanced at baseline? Low risk “There was no difference between training (n =22) and control (n
=27) patients as regards baseline variables”
Groups received same intervention? Low risk “No change in medication allowed during study”
Witham 2005
Methods Parallel group RCT
Participants N Randomised: 82 (exercise 41; control 41)
Diagnosis (% of participants):
Aetiology: IHD 66%
NYHA: Class II 56%; Class III 44%
LVEF: not reported
Case mix: as above
Age (yr): exercise 80 (SD 6); control 81 (SD 4)
Male: 55%
White: not reported
Inclusion/exclusion criteria
Inclusion: age ≥ 70 yr with clinical diagnosis of CHF according to European Society
of Cardiology guidelines, NYHA Class II or III symptoms and evidence of LVSD on
echocardiography, contrast ventriculography or radionuclide ventriculography. Evidence
of LVSD
Exclusion: uncontrolled AF, significant aortic stenosis, sustained ventricular tachycardia,
recent MI, inability to walk without human assistance, abbreviated mental score < 6 of
10, or people currently undergoing physiotherapy or rehabilitation
Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix:mix
Frequency: 2-3 sessions/wk
Duration: 20 min
Intensity: Borg 11-13
Modality: walking and wrist/ankle weights
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Setting: 3 months; hospital based by senior physiotherapist, 3 months; home-based
After 3 months of supervised training, participants in the exercise group were asked to
continue performing exercises at home 2 or 3 times/wk with the aid of video or audio
cassette with demonstrations, instructions and music. No face-to-face contact with the
physiotherapist during this period
Other: not reported
Outcomes A disease specific health-related quality-of-life (Guyatt chronic heart failure question-
naire), mortality, hospitalisation
Comparison Usual medical care
Country and setting UK
Single centre
Follow-up 6 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A researcher not otherwise connected with the operation of the
study prepared cards contained in numbered, sealed envelopes from
computer-generated random number tables”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “An experienced research nurse who was blinded to treatment allo-
cation performed all assessments”
Selective reporting (reporting bias) Low risk All outcomes described in methods are reported in results
Intention-to-treat analysis? Low risk It appeared that groups were analysed according to initial ran-
dom allocation from QUORUM diagram
Incomplete outcome data? Low risk 75/82 (91%) and 68/82 (83%) available at 3 and 6 months’
follow-up, respectively
Groups balanced at baseline? Low risk Table 1 of the publication shows groups are well balanced
Groups received same intervention? Low risk Yes, both group appeared to receive usual medical care and the
only difference between groups was the exercise intervention
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Witham 2012
Methods Parallel group RCT
Participants N Randomised: 107 (exercise 53; control 54)
Diagnosis (% of participants):
Aetiology: ischaemic 62.6%
NYHA: Class II 79%; Class III 21%
LVEF: not reported
Case mix: as above
Age (yr): exercise 80.4 (SD 5.8); control 79.5 (SD 4.9)
Male: exercise 35%; control 37%
White: 100%
Inclusion/exclusion criteria
Inclusion: age ≥ 70 yr with a confirmed diagnosis of HF due to LVSD (NYHA Class II
and III) and a history of symptoms and signs of congestive HF
Exclusion: wheelchair bound, unwilling or unable to give informed, had aortic stenosis
with peak gradient > 30 mmHg, experienced sustained ventricular tachycardia or ven-
tricular fibrillation outside the context of an acute MI, and currently (within the past
month) had unstable angina or AF with a ventricular rate of > 100/min
Interventions Exercise: Total duration: 24 wk
Aerobic/resistance/mix:mix
Frequency: 2 sessions/wk
Duration: ≤ 60 min
Intensity: not reported
Modality: home; walking
Setting: hospital and home*
Other: cognitive and behavioural techniques were incorporated into first 8-wk hospital-
based rehabilitation. Resistance training with elasticised bands
Outcomes Disease-specific HRQoL (MLWHFQ), HRQoL (EuroQoL-5D), mortality, hospital ad-
mission, cost
Comparison Usual medical care (given a booklet with general advice on diet, exercise and lifestyle).
Not discouraged from exercising if they were already in the habit of doing so
Country and setting UK
Single-centre
Follow-up 24 wk (after randomisation)
Notes *8 wk in hospital delivered by experienced physiotherapist, 16-wk home-based (tele-
phoned every 2 wk for 8 wk by the physiotherapists, then monthly for the final 8 wk)
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk “Using off-site telephone randomization service, randomization was
performedwithout stratification and with block sizes between 8 and
16, depending on the size of each planned exercise class”
Allocation concealment (selection bias) Low risk “…the project coordinator passed the participants’details to the re-
search physiotherapist who obtained group allocation, ensuring that
the project coordinator remained blind to group assignments”
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
Intention-to-treat analysis? Low risk Analyses were by ITT
Incomplete outcome data? Low risk 89/104 (86%) and 87/104 (83%) available for follow-up at 8
and 24 wk, respectively
Groups balanced at baseline? Low risk Table 1 of the publication suggests no difference between the 2
groups
Groups received same intervention? Low risk It appeared that both groups received same care expect exercise
intervention
Yeh 2011
Methods Parallel group RCT
Participants N Randomised: 100 (Tai Chi (exercise) 50; education (control) 50)
Diagnosis (% of participants):
Aetiology: ischaemic 54%; non-ischaemic 46%
NYHA: Class I 20%; Class II 63%; Class III 17%
LVEF: mean 29% (SD 8%)
Case mix: 100% as above
Age (yr): exercise 68.1 (SD 11.9); control 66.6 (SD 12.1)
Male: 64%
White: 86%
Inclusion/exclusion criteria
Inclusion: EF < 40% or lower in past 2 yr, stable medical regimen, NYHA Class I-III HF
Exclusion: unstable angina, MI or major surgery in past 3 months; history of cardiac
arrest in the past 6 months, history of cardiac resynchronisation therapy in the past 3
months; unstable serious ventricular arrhythmias; unstable structural valve disease; cur-
rent participation in conventional CR programme; diagnosis of peripartum cardiomy-
opathy within the preceding 6 months; inability to perform a bicycle stress test; lower
extremity amputation or other inability to ambulance owing to condition other than
HF; severe cognitive dysfunction (Mini-Mental State Examination score≤ 24); inability
to speak English and regular practice of Tai Chi
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Interventions Exercise: Total duration: 12 wk
Aerobic/resistance/mix: aerobic
Frequency: 2 sessions/wk (for 12 wk) and encouraged to practice at home at least 3 times/
wk
Duration: 1 hr class (30 min warm-up)
Intensity: not reported
Modality: Tai Chi movements
1. Wk 2-5: warm-up + raising the power, withdraw and push
2. Wk 6-9: 1 + grasp sparrow’s tail, brush knee twist step
3. Wk 10-12: 2 + wave hands like clouds
Participants were given 45-min instructional videotape that outlined the exercises pre-
sented in class as an aid to practice
Participants also received same educational pamphlets used in education (control) group
with a brief (< 5 min) explanation towards end of 1 Tai Chi session weekly
Setting: centre-based and home-based
Other: none reported
Outcomes HRQoL (MLWHFQ), mortality, hospital admission
Comparison Education group (’attention control’): nurse practitioner lead education session (same
duration and frequency as the Tai Chi group classes)
Participants were asked not to start Tai Chi classes during the study
Country and setting USA
Multisite
Follow-up 12 wk and 6 months (after randomisation)
Notes Single blind
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The trial uses a permuted block randomization with variable block
size to generate treatment assignment”
Allocation concealment (selection bias) Unclear risk “Patients who chose to were randomly assigned to receive a 12-
week tai chi exercise program or a heart health education program
(attention control)”
Blinding (performance bias and detection
bias)
All outcomes
Low risk “We masked all the study staff performing all tests to each partici-
pant’s group allocation”
Selective reporting (reporting bias) Low risk All outcomes described in methods reported in results
86Exercise-based rehabilitation for heart failure (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
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Intention-to-treat analysis? Low risk All participants were included in the analysis regardless of their
attendance
Incomplete outcome data? Low risk Figure 1 of the publication shows 91% to 96% complete data
across HRQoL and exercise outcomes
Groups balanced at baseline? Low risk “The 2 groups were generally similar in demographics, clinical clas-
sification of heart disease severity, and rates of comorbidities”
Groups received same intervention? Low risk Yes, both groups received comprehensive disease management
AF: atrial fibrillation; bpm: beats/minute; CBT: cognitive behavioural therapy; CHF: chronic heart failure; CONSORT: CONsol-
idated Standards of Reporting Trials; COPD: chronic obstructive pulmonary disease; CR: cardiac rehabilitation; DCM: dilated
cardiomyopathy; DM: diabetes mellitus; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; EF: ejection
fraction; HADS: Hospital Anxiety and Depression Scale; HF: heart failure; hr: hour; HR: heart rate; HRQoL: health-related quality
of life; ITT: intention to treat; KCCQ: Kansas City Cardiomyopathy Questionnaire; LVEF: left ventricular ejection fraction; LVSD:
left ventricular systolic dysfunction; max: maximum; MI: myocardial infarction; min: minute; MOS: Medical Outcomes Survey;
MLWHFQ: Minnesota Living with Heart Failure Questionnaire; MRI: magnetic resonance imaging; NYHA: New York Heart
Association; PVD: peripheral vascular disease; RCT: randomised controlled trial; SD: standard deviation; SE: standard error; SF-
36: 36-item Short Form; VO2: oxygen consumption; wk: week; yr: year.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adamopoulos 2001 Relevant outcomes not reported
Alves 2012 Relevant outcomes not reported
Barrow 2008 < 6 months’ follow-up
Belardinelli 2005 < 6 months’ follow-up
Briffa 2005 Not heart failure
Brotons 2009 Not exercise-based cardiac rehabilitation intervention
Chang 2005 Relevant outcomes not reported
Coats 1992 < 6 months’ follow-up
Collins 2004 < 6 months’ follow-up
Corvera-Tindel 2004 < 6 months’ follow-up
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Cowie 2011 < 6 months’ follow-up
Deng 2006 Relevant outcomes not reported
Dingli 2002 Relevant outcomes not reported
Edelmann 2011 < 6 months’ follow-up
Erbs 2003 Relevant outcomes not reported
Erbs 2010 Relevant outcomes not reported
ExTraMATCH 2004 Meta-analysis
Franco 2006 < 6 months’ follow-up
Gary 2004 Relevant outcomes not reported
Gary 2007 < 6 months’ follow-up
Haykowsky 2007 Meta-analysis
Inglis 2006 Exercise advice only
Jolly 2007 Protocol only
Jónsdóttir 2006b < 6 months’ follow-up
Kiilavuori 1999 Relevant outcomes not reported
Kitzman 2010 < 6 months’ follow-up
Kobayashi 2003 Relevant outcomes not reported
Korzeniowska-Kubacka 2010 Not a randomised controlled trial
Lloyd-Williams 2002 Meta-analysis
Meyer 2005 Relevant outcomes not reported
Molloy 2006 Relevant outcomes not reported
Mudge 2011 Protocol
Myers 2001 Relevant outcomes not reported
Myers 2002 Relevant outcomes not reported
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Myers 2007 Relevant outcomes not reported
Niebauer 2005a Relevant outcomes not reported
Niebauer 2005b Relevant outcomes not reported
Oka 2000 Relevant outcomes not reported
Owen 2000 < 6 months’ follow-up
Parnell 2002 < 6 months’ follow-up
Passino 2008 Relevant outcomes not reported
Ponikowski 1997 < 6 months’ follow-up
Pozehl 2003 < 6 months’ follow-up
Pu 2001 Relevant outcomes not reported
Sabelis 2004 Relevant outcomes not reported
Sarullo 2006 < 6 months’ follow-up
Selig 2004 < 6 months’ follow-up
Senden 2005 Relevant outcomes not reported
Smart 2004 Meta-analysis
Smart 2007 < 6 months’ follow-up
Stewart 1998 Exercise advice only
Taylor-Piliae 2004 Meta-analysis
Tyni-Lenne 2001 < 6 months’ follow-up
van den Berg-Emons 2004 < 6 months’ follow-up
van Tol 2006 Meta-analysis
Vasiliauskas 2007 Relevant outcomes not reported
Wielenga 1998 < 6 months’ follow-up
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Williams 2007 Relevant outcomes not reported
Wisløff 2007 < 6 months’ follow-up
Yeh 2004 < 6 months’ follow-up
Zhang 2003 < 6 months’ follow-up
Zhao 2005 Relevant outcomes not reported
Characteristics of ongoing studies [ordered by study ID]
ISRCTN86879094
Trial name or title Exercise Training in Diastolic Heart Failure: a Prospective, Randomized, Controlled Study to Determine the
Effects of Exercise Training in Patients with Heart Failure and Preserved Ejection Fraction (Ex-DHF)
Methods RCT
Participants Stable symptomatic HF with preserved ejection fraction (diagnosis according to criteria of the European
Society of Cardiology (Paulus 2007))
Interventions Experimental intervention: individually prescribed, supervised, combined endurance/strength training for 12
months (≥ 3 times/week)
Control intervention: usual care
Outcomes Primary
1. Combined outcome score (modified ’Packer score’, Packer 2001). This combined score classifies
participants as: 1 (worsened), 0 (unchanged) or +1 (improved)
Secondary
1. Components of the primary endpoint (all-cause mortality, cardiovascular hospitalisations, change in
NYHA class, change in global self assessment, change in peak VO2, change in E/e’)
2. Change in echocardiographic parameters of diastolic function (left atrial volume index, Grad of
diastolic function, E/e’, e’, ratio between early (E) and late (atrial - A) ventricular filling velocity (E/A),
deceleration time, isovolumic relaxation time), systolic function (LVEF), left ventricular dimensions (left
ventricular end diastolic diameter) and structure (left ventricular mass index) after 6 and 12 months
3. Change in quality of life (SF-36, Minnesota Living with Heart Failure Questionnaire, Hospital
Anxiety and Depression Scale) after 6 and 12 months
4. Change in ventilatory efficacy (VE/VCO2) and submaximal exercise capacity (anaerobic threshold, 6-
min walk distance) after 6 and 12 months
5. Change in neurohumoral activation (N-terminal pro brain natriuretic peptide) after 6 and 12 months
6. Safety and tolerability of training intervention
7. Gender aspects of all primary and secondary endpoints
Starting date 1 September 2011
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Contact information Dr Frank Edelmann: fedelmann@med.uni-goettingen.de
Notes Trial still recruiting. Recruitment completion expected in 2014 (author email reply 21 July 2013)
Mudge ongoing
Trial name or title The Exercise Joins Education: Combined Therapy to Improve Outcomes in Newly-discharged Heart Failure
(EJECTION-HF)
Methods RCT
Participants 350 recently hospitalised people with HF with impaired and preserved left ventricular systolic function
Interventions Supervised exercise training programme and disease management programme vs. disease management pro-
gramme alone
Outcomes Primary outcome
1. proportion of participants who have died or been re-admitted for any cause within 12 months of
enrolment
Secondary outcomes at 6 and 12 months
1. Depressive symptoms measured using the Geriatric Depression Scale and the Hare-Davis Cardiac
Depression Scale
2. Functional status measured using a standardised 6-min walk test, hand-held dynamometry as a
measure of grip strength and activities of daily living using standardised questions
3. Cognitive status using Folstein’s Mini-Mental Status Examination
4. Quality of life using the Assessment of Quality of Life instrument
5. Sleep quality using the Pittsburgh Sleep Quality Index (in a subset of participants)
6. Healthcare use including hospital admissions and outpatient and emergency department attendances
obtained from the hospital information systems
Starting date Not reported (150 recruited at time of publication)
“Enrolment will be completed in 2013”
Contact information Corresponding author: telephone: +61 7 36360854, fax: +61 7 36360272, Email: Alison Mudge@health.
qld.gov.au
InternalMedicine andAgedCare, Royal Brisbane andWomen’sHospital, Butterfield St,Herston,Queensland
4029 Australia
Notes Trial completed recruiting. Publication of primary outcomes expected in late 2014 (author email reply 29
July 2013)
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NCT00012883
Trial name or title Home Walking Exercise (HWE) Training in Advanced Heart Failure
Methods RCT
Participants 79 participants with stable HF in the past 3 months
Interventions 12-week nurse-managed progressive home walking exercise protocol versus usual activity
Outcomes Pre- and post-study assessment of:
Functional status (peak VO2 and ventilatory threshold via complete physical examination, 6-min walk test
and a Heart Failure Functional Status Inventory), quality of life (Cardiac Quality of Life Index, SF-36, and
Dyspnea-Fatigue Index with global rating of symptoms) and autonomic tone (norepinephrine (noradrenaline)
and heart rate variability)
Starting date December 2001
Contact information Teresita E Corvera-Tindel, PhD RN MN, VA Greater Los Angeles Health Care System, USA
Notes Contact email sent - no reply
NCT00013221
Trial name or title Exercise Effect on Aerobic Capacity and QOL in Heart Failure
Methods RCT
Participants About 84 participants with left LVEF ≤ 40%. Stable HF
Interventions Exercise group: 36 weeks of exercise training
Control group: weekly visits with a nurse for 12 weeks
Outcomes At 12 weeks, exercise capacity (peak VO2) and HRQoL (SF-36)
Starting date Not reported
Contact information Eileen G Collins, PhD RN, Edward Hines Jr. VA Hospital, USA
Notes Contact email sent - no reply (as of 20 September 2013)
NCT01033591
Trial name or title Exercise for Patients with Heart Failure in Primary Care: the EFICAR
Methods RCT
Participants Inclusion criteria:
• Age ≥ 18 years
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• Diagnosis of HF on the basis of signs and symptoms (Framingham criteria) and evidence of structural
heart alterations detected by echocardiography. Echocardiography scanning guarantees that we are dealing
with participants with HF avoiding confounding clinical factors
• LVEF < 45%
• NYHA functional Class II-IV, or Stages B and C of the American Heart Association, in a stable
situation for at least the previous 4 weeks, with no changes in baseline functional status, no signs of
congestion or changes in weight faster than 2 kg in 3 days
• Receiving optimal treatment with angiotensin-converting enzyme inhibitors, angiotensin II receptor
antagonists, beta-blockers, diuretics and aldosterone antagonists at stable doses for the previous 4 weeks, as
long as there are no justified contraindications for their use, and meeting the clinical practice guidelines of
the European Society of Cardiology
600 participant target
Interventions Experimental: exercise supervised exercise + optimised treatment according to the European Society of Car-
diology guidelines
No intervention: control optimised treatment according to the European Society of Cardiology guidelines
Outcomes Primary outcomes:
1. Change in HRQoL (SF-36 and Minnesota Living with Heart Failure Questionnaire)
Secondary outcomes:
1. Change in functional capacity (6-min walking test)
2. Cardiac structural changes (B-type natriuretic peptide)
3. Muscle strength (dynamometer)
4. Body composition (fat and muscular weight)
All at 12 months
Starting date January 2011
Contact information Contact: Dr Gonzalo Grandes
Notes Zuazagoitia A, Grandes G, Torcal J, Lekuona I, Echevarria P, Gómez MA, Domingo M, de la Torre MM,
Ramírez JI,Montoya I,Oyanguren J, PinillaRO;EFICARGroup (Ejercicio Físico en la InsuficienciaCardiaca)
. Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise program to
improve the quality of life of patients with HF in primary care: The EFICAR study protocol. BMC Public
Health. 2010;10:33
Trial still recruiting. Recruitment completion expected June 2014 (author email reply 20 July 2013)
HF: heart failure; HRQoL: health-related quality of life; LVEF: left ventricular ejection fraction; NYHA: New York Heart Association;
min: minute; RCT: randomised controlled trial; SF-36: 36-item Short Form; VCO2: carbon dioxide consumption; VE: ventilatory
efficiency; VO2: oxygen consumption.
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D A T A A N D A N A L Y S E S
Comparison 1. All exercise interventions versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All-cause mortality up to12
months’ follow-up
25 1871 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.69, 1.27]
2 All-cause mortality more than
12 months’ follow-up
6 2845 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.75, 1.02]
3 Hospital admission up to 12
months’ follow-up
15 1328 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.62, 0.92]
4 Hospital admission heart failure
only
12 1036 Risk Ratio (M-H, Fixed, 95% CI) 0.61 [0.46, 0.80]
5 Hospital admission more than
12 months’ follow-up
5 2722 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.66, 1.29]
6 Health-related quality of life -
MLWHF up to 12 months’
follow-up
13 1270 Mean Difference (IV, Random, 95% CI) -5.83 [-9.21, -2.44]
7 Health-related quality of life -
MLWHF and other scales
21 3240 Std. Mean Difference (IV, Random, 95% CI) -0.46 [-0.66, -0.26]
8 Health-related quality of life -
MLWHF 12 months’ follow-up
3 329 Mean Difference (IV, Random, 95% CI) -9.49 [-17.48, -1.50]
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Analysis 1.1. Comparison 1 All exercise interventions versus usual care, Outcome 1 All-cause mortality up
to12 months’ follow-up.
Review: Exercise-based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 1 All-cause mortality up to12 months’ follow-up
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 5/100 4/100 5.3 % 1.25 [ 0.35, 4.52 ]
DANREHAB 2008 4/45 3/46 3.9 % 1.36 [ 0.32, 5.75 ]
Davidson 2010 4/53 11/52 14.8 % 0.36 [ 0.12, 1.05 ]
Dracup 2007 9/87 8/86 10.7 % 1.11 [ 0.45, 2.75 ]
Gary 2010 (comp) 0/18 1/19 1.9 % 0.35 [ 0.02, 8.09 ]
Gary 2010 (exalone) 1/20 0/17 0.7 % 2.57 [ 0.11, 59.30 ]
Giannuzzi 2003 0/45 1/45 2.0 % 0.33 [ 0.01, 7.97 ]
Gielen 2003 0/10 0/10 Not estimable
Gottlieb 1999 1/17 1/16 1.4 % 0.94 [ 0.06, 13.82 ]
Hambrecht 1995 1/12 0/10 0.7 % 2.54 [ 0.11, 56.25 ]
Hambrecht 1998 1/10 1/10 1.3 % 1.00 [ 0.07, 13.87 ]
Hambrecht 2000 3/36 2/37 2.6 % 1.54 [ 0.27, 8.69 ]
Jolly 2009 7/84 5/85 6.6 % 1.42 [ 0.47, 4.29 ]
Keteyian 1996 0/21 1/19 2.1 % 0.30 [ 0.01, 7.02 ]
Klecha 2007 0/25 0/25 Not estimable
McKelvie 2002 19/90 20/91 26.5 % 0.96 [ 0.55, 1.68 ]
Myers 2000 1/12 0/13 0.6 % 3.23 [ 0.14, 72.46 ]
Nilsson 2008 2/40 1/40 1.3 % 2.00 [ 0.19, 21.18 ]
Norman 2012 1/22 0/20 0.7 % 2.74 [ 0.12, 63.63 ]
Pozehl 2008 0/15 1/6 2.8 % 0.15 [ 0.01, 3.16 ]
Wall 2010 1/9 1/10 1.3 % 1.11 [ 0.08, 15.28 ]
Willenheimer 2001 3/27 2/27 2.7 % 1.50 [ 0.27, 8.28 ]
Witham 2005 1/41 3/41 4.0 % 0.33 [ 0.04, 3.07 ]
Witham 2012 2/53 1/54 1.3 % 2.04 [ 0.19, 21.81 ]
Yeh 2011 0/50 3/50 4.7 % 0.14 [ 0.01, 2.70 ]
0.001 0.01 0.1 1 10 100 1000
Favours exercise Favours control
(Continued . . . )
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Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total (95% CI) 942 929 100.0 % 0.93 [ 0.69, 1.27 ]
Total events: 66 (Exercise), 70 (Control)
Heterogeneity: Chi2 = 12.60, df = 22 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.43 (P = 0.67)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours exercise Favours control
Analysis 1.2. Comparison 1 All exercise interventions versus usual care, Outcome 2 All-cause mortality
more than 12 months’ follow-up.
Review: Exercise-based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 2 All-cause mortality more than 12 months’ follow-up
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 31/100 38/100 13.6 % 0.82 [ 0.56, 1.20 ]
Belardinelli 1999 9/50 20/49 7.2 % 0.44 [ 0.22, 0.87 ]
Belardinelli 2012 4/63 10/60 3.7 % 0.38 [ 0.13, 1.15 ]
HF ACTION 2009 189/1159 198/1171 70.5 % 0.96 [ 0.80, 1.16 ]
J nsd ttir 2006a 2/21 2/22 0.7 % 1.05 [ 0.16, 6.77 ]
Mueller 2007 9/25 12/25 4.3 % 0.75 [ 0.39, 1.46 ]
Total (95% CI) 1418 1427 100.0 % 0.88 [ 0.75, 1.02 ]
Total events: 244 (Exercise), 280 (Control)
Heterogeneity: Chi2 = 7.54, df = 5 (P = 0.18); I2 =34%
Test for overall effect: Z = 1.69 (P = 0.092)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 1.3. Comparison 1 All exercise interventions versus usual care, Outcome 3 Hospital admission up
to 12 months’ follow-up.
Review: Exercise-based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 3 Hospital admission up to 12 months’ follow-up
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 9/100 19/100 12.4 % 0.47 [ 0.23, 1.00 ]
Bocalini 2008 0/22 3/20 2.4 % 0.13 [ 0.01, 2.38 ]
Davidson 2010 23/53 36/52 23.7 % 0.63 [ 0.44, 0.90 ]
Dracup 2007 35/87 37/86 24.3 % 0.94 [ 0.66, 1.33 ]
Giannuzzi 2003 2/45 1/45 0.7 % 2.00 [ 0.19, 21.28 ]
Gielen 2003 1/10 0/10 0.3 % 3.00 [ 0.14, 65.90 ]
Hambrecht 1995 0/12 1/10 1.1 % 0.28 [ 0.01, 6.25 ]
Jolly 2009 16/84 20/85 13.0 % 0.81 [ 0.45, 1.45 ]
J nsd ttir 2006a 2/21 5/22 3.2 % 0.42 [ 0.09, 1.93 ]
Keteyian 1996 0/21 1/19 1.0 % 0.30 [ 0.01, 7.02 ]
Klecha 2007 0/25 0/25 Not estimable
Passino 2006 0/44 2/41 1.7 % 0.19 [ 0.01, 3.78 ]
Witham 2005 10/41 11/41 7.2 % 0.91 [ 0.43, 1.90 ]
Witham 2012 13/53 10/54 6.5 % 1.32 [ 0.64, 2.75 ]
Yeh 2011 2/50 4/50 2.6 % 0.50 [ 0.10, 2.61 ]
Total (95% CI) 668 660 100.0 % 0.75 [ 0.62, 0.92 ]
Total events: 113 (Exercise), 150 (Control)
Heterogeneity: Chi2 = 11.71, df = 13 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 2.79 (P = 0.0052)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours exercise Favours control
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Analysis 1.4. Comparison 1 All exercise interventions versus usual care, Outcome 4 Hospital admission
heart failure only.
Review: Exercise-based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 4 Hospital admission heart failure only
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Belardinelli 1999 5/50 14/49 14.5 % 0.35 [ 0.14, 0.90 ]
Belardinelli 2012 8/63 25/60 26.3 % 0.30 [ 0.15, 0.62 ]
Dracup 2007 35/87 37/86 38.3 % 0.94 [ 0.66, 1.33 ]
Giannuzzi 2003 2/45 1/45 1.0 % 2.00 [ 0.19, 21.28 ]
Hambrecht 1995 0/12 1/10 1.7 % 0.28 [ 0.01, 6.25 ]
Jolly 2009 4/84 2/85 2.0 % 2.02 [ 0.38, 10.75 ]
J nsd ttir 2006a 0/21 3/22 3.5 % 0.15 [ 0.01, 2.73 ]
Mueller 2007 2/25 3/25 3.1 % 0.67 [ 0.12, 3.65 ]
Myers 2000 0/12 2/13 2.5 % 0.22 [ 0.01, 4.08 ]
Passino 2006 0/44 2/41 2.7 % 0.19 [ 0.01, 3.78 ]
Willenheimer 2001 0/23 3/27 3.3 % 0.17 [ 0.01, 3.07 ]
Witham 2012 1/53 1/54 1.0 % 1.02 [ 0.07, 15.87 ]
Total (95% CI) 519 517 100.0 % 0.61 [ 0.46, 0.80 ]
Total events: 57 (Exercise), 94 (Control)
Heterogeneity: Chi2 = 16.70, df = 11 (P = 0.12); I2 =34%
Test for overall effect: Z = 3.52 (P = 0.00044)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Favours expercise Favours control
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Analysis 1.5. Comparison 1 All exercise interventions versus usual care, Outcome 5 Hospital admission
more than 12 months’ follow-up.
Review: Exercise-based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 5 Hospital admission more than 12 months’ follow-up
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Austin 2005 53/100 38/100 31.0 % 1.39 [ 1.02, 1.90 ]
Belardinelli 1999 5/50 14/49 9.7 % 0.35 [ 0.14, 0.90 ]
HF ACTION 2009 729/1159 760/1171 41.9 % 0.97 [ 0.91, 1.03 ]
J nsd ttir 2006a 7/21 11/22 13.9 % 0.67 [ 0.32, 1.39 ]
Mueller 2007 2/25 3/25 3.5 % 0.67 [ 0.12, 3.65 ]
Total (95% CI) 1355 1367 100.0 % 0.92 [ 0.66, 1.29 ]
Total events: 796 (Exercise), 826 (Control)
Heterogeneity: Tau2 = 0.07; Chi2 = 10.90, df = 4 (P = 0.03); I2 =63%
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
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Analysis 1.6. Comparison 1 All exercise interventions versus usual care, Outcome 6 Health-related quality
of life - MLWHF up to 12 months’ follow-up.
Review: Exercise-based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 6 Health-related quality of life - MLWHF up to 12 months’ follow-up
Study or subgroup Exercise Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Austin 2005 95 22.9 (14.7) 94 36.9 (21.3) 10.0 % -14.00 [ -19.22, -8.78 ]
Belardinelli 1999 48 40 (19) 46 51 (22) 7.3 % -11.00 [ -19.33, -2.67 ]
Davidson 2010 50 52.9 (15.7) 42 56.4 (18.3) 8.3 % -3.50 [ -10.54, 3.54 ]
Dracup 2007 86 35.7 (23.7) 87 43.2 (27.3) 7.9 % -7.50 [ -15.12, 0.12 ]
Gary 2010 (comp) 15 24.2 (16.3) 16 34.3 (23.6) 4.0 % -10.10 [ -24.30, 4.10 ]
Gary 2010 (exalone) 17 25.6 (19.7) 14 28.9 (29.9) 2.7 % -3.30 [ -21.55, 14.95 ]
Jolly 2009 80 37.6 (21) 77 34.9 (24.8) 8.2 % 2.70 [ -4.50, 9.90 ]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 7.9 % -11.10 [ -18.65, -3.55 ]
McKelvie 2002 57 -3.4 (18.1) 67 -3.3 (13.9) 9.5 % -0.10 [ -5.86, 5.66 ]
Nilsson 2008 35 23 (14) 37 28 (20) 7.6 % -5.00 [ -12.94, 2.94 ]
Passino 2006 44 32 (26.5) 41 53 (32) 4.7 % -21.00 [ -33.54, -8.46 ]
Witham 2012 43 15.4 (14.8) 44 11.3 (12.1) 9.5 % 4.10 [ -1.59, 9.79 ]
Yeh 2011 50 13 (4) 50 18 (6) 12.5 % -5.00 [ -7.00, -3.00 ]
Total (95% CI) 636 634 100.0 % -5.83 [ -9.21, -2.44 ]
Heterogeneity: Tau2 = 22.85; Chi2 = 40.24, df = 12 (P = 0.00007); I2 =70%
Test for overall effect: Z = 3.37 (P = 0.00074)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 All exercise interventions versus usual care, Outcome 7 Health-related quality
of life - MLWHF and other scales.
Review: Exercise-based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 7 Health-related quality of life - MLWHF and other scales
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Austin 2005 95 22.9 (14.7) 94 36.9 (21.3) 6.2 % -0.76 [ -1.06, -0.47 ]
Belardinelli 1999 48 40 (19) 46 51 (22) 5.5 % -0.53 [ -0.94, -0.12 ]
Bocalini 2008 22 -87 (4) 20 -81 (6) 4.0 % -1.17 [ -1.83, -0.51 ]
DANREHAB 2008 19 -42.7 (9.1) 15 -37.4 (11.4) 3.8 % -0.51 [ -1.20, 0.18 ]
Davidson 2010 50 52.9 (15.7) 42 56.4 (18.3) 5.5 % -0.20 [ -0.62, 0.21 ]
Dracup 2007 86 35.7 (23.7) 87 43.2 (27.3) 6.2 % -0.29 [ -0.59, 0.01 ]
Gary 2010 (comp) 15 24.2 (16.3) 16 34.3 (23.6) 3.7 % -0.48 [ -1.20, 0.23 ]
Gary 2010 (exalone) 17 25.6 (19.7) 14 28.9 (29.9) 3.7 % -0.13 [ -0.84, 0.58 ]
HF ACTION 2009 906 72.39 (20.46) 850 71.24 (21.48) 7.1 % 0.05 [ -0.04, 0.15 ]
Jolly 2009 80 37.6 (21) 77 34.9 (24.8) 6.1 % 0.12 [ -0.20, 0.43 ]
J nsd ttir 2006a 21 -47.55 (8.7) 20 -44.1 (14.04) 4.2 % -0.29 [ -0.91, 0.32 ]
Klocek 2005 (Const) 14 -109 (23.5) 7 -71.7 (23.5) 2.4 % -1.52 [ -2.57, -0.48 ]
Klocek 2005 (Prog) 14 -99 (23.5) 7 -71.7 (23.5) 2.6 % -1.12 [ -2.10, -0.13 ]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 3.7 % -0.99 [ -1.69, -0.28 ]
McKelvie 2002 57 -3.4 (18.1) 67 -3.3 (13.9) 5.9 % -0.01 [ -0.36, 0.35 ]
Nilsson 2008 35 23 (14) 37 28 (20) 5.2 % -0.29 [ -0.75, 0.18 ]
Norman 2012 19 -81 (18.2) 18 -77.9 (11.6) 4.1 % -0.20 [ -0.84, 0.45 ]
Passino 2006 44 32 (26.5) 41 53 (32) 5.3 % -0.71 [ -1.15, -0.27 ]
Willenheimer 2001 20 -0.7 (0.8) 17 0 (1) 3.9 % -0.76 [ -1.44, -0.09 ]
Witham 2005 36 -69 (13) 32 -65 (10) 5.1 % -0.34 [ -0.82, 0.14 ]
Yeh 2011 50 13 (4) 50 18 (6) 5.5 % -0.97 [ -1.39, -0.56 ]
Total (95% CI) 1664 1576 100.0 % -0.46 [ -0.66, -0.26 ]
Heterogeneity: Tau2 = 0.14; Chi2 = 94.85, df = 20 (P<0.00001); I2 =79%
Test for overall effect: Z = 4.58 (P < 0.00001)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours exercise Favours control
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Analysis 1.8. Comparison 1 All exercise interventions versus usual care, Outcome 8 Health-related quality
of life - MLWHF 12 months’ follow-up.
Review: Exercise-based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 8 Health-related quality of life - MLWHF 12 months’ follow-up
Study or subgroup Exercise Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Austin 2005 57 35.5 (21.7) 55 37.1 (24.9) 30.0 % -1.60 [ -10.26, 7.06 ]
Belardinelli 1999 48 44 (21) 46 54 (22) 29.9 % -10.00 [ -18.70, -1.30 ]
Belardinelli 2012 63 43 (12) 60 58 (14) 40.1 % -15.00 [ -19.62, -10.38 ]
Total (95% CI) 168 161 100.0 % -9.49 [ -17.48, -1.50 ]
Heterogeneity: Tau2 = 35.87; Chi2 = 7.33, df = 2 (P = 0.03); I2 =73%
Test for overall effect: Z = 2.33 (P = 0.020)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours exercise Favours control
A P P E N D I C E S
Appendix 1. Search strategy 2001
Cochrane Controlled Trials Register (2001, Issue 2)
1. HEART-FAILURE-CONGESTIVE*:ME
2. (HEART and FAILURE)
3. (CARDIAC and FAILURE)
4. ((#1 or #2) or #3)
5. REHABILITATION*:ME
6. EXERCISE*:ME
7. EXERCISE-THERAPY*:ME
8. SPORTS*:ME
9. PHYSICAL-EDUCATION-AND-TRAINING*:ME
10. EXERTION*:ME
11. REHABILITAT*
12. (PHYSICAL* near FIT)
13. (PHYSICAL* near FITNESS)
14. (PHYSICAL near TRAIN*)
15. (PHYSICAL* near ACTIVIT*)
16. (TRAIN* near STRENGTH*)
17. (TRAIN* near AEROBIC*)
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18. (AEROBIC* near EXERCISE*)
19. KINESIOTHERAP*
20. (EXERCISE* near TRAIN*)
21. (((((((((((((((#5 or #6) or #7) or #8) or #9) or #10) or #11) or #12) or #13) or #14) or #15) or #16) or #17) or #18) or #19) or #20)
22. (#4 and #21)
Appendix 2. Search strategies 2008
CENTRAL on The Cochrane Library 2007, Issue 4
#1MeSH descriptor Myocardial Ischemia explode all trees
#2(myocard* NEAR isch*mi*)
#3isch*mi* NEAR heart
#4MeSH descriptor Coronary Artery Bypass explode all trees
#5coronary
#6MeSH descriptor Coronary Disease explode all trees
#7MeSH descriptor Myocardial Revascularization explode all trees
#8MeSH descriptor Myocardial Infarction explode all trees
#9myocard* NEAR infarct*
#10heart NEAR infarct*
#11MeSH descriptor Angina Pectoris explode all trees
#12angina
#13MeSH descriptor Heart Failure, Congestive explode all trees
#14heart and (failure or attack)
#15MeSH descriptor Heart Diseases explode all trees
#16heart and disease*
#17myocard*
#18cardiac*
#19CABG
#20PTCA
#21stent* AND (heart or cardiac*)
#22MeSH descriptor Heart Bypass, Left explode all trees
#23MeSH descriptor Heart Bypass, Right explode all trees
#24(#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR
#16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23)
#25MeSH descriptor Rehabilitation Centers, this term only
#26MeSH descriptor Exercise Therapy explode all trees
#27MeSH descriptor Sports, this term only
#28MeSH descriptor Exertion explode all trees
#29rehabilitat*
#30(physical* NEAR (fit* or train* or therap* or activit*))
#31MeSH descriptor Exercise explode all trees
#32(train*) near (strength* or aerobic or exercise*)
#33((exercise* or fitness) NEAR/3 (treatment or intervent* or program*))
#34MeSH descriptor Rehabilitation explode all trees
#35MeSH descriptor Patient Education explode all trees
#36(patient* NEAR/3 educat*)
#37((lifestyle or life-style) NEAR/3 (intervent* or program* or treatment*))
#38MeSH descriptor Self Care explode all trees
#39MeSH descriptor Ambulatory Care explode all trees
#40MeSH descriptor Psychotherapy explode all trees
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#41psychotherap*
#42psycholog* NEAR intervent*
#43relax*
#44MeSH descriptor Mind-Body and Relaxation Techniques explode all trees
#45MeSH descriptor Counseling explode all trees
#46counsel*ing
#47MeSH descriptor Cognitive Therapy explode all trees
#48MeSH descriptor Behavior Therapy explode all trees
#49(behavio*r*) NEAR/4 (modif* or therap* or rehab* or change)
#50MeSH descriptor Stress, Psychological explode all trees
#51stress NEAR manage*
#52cognitive* NEAR therap*
#53MeSH descriptor Meditation explode all trees
#54meditat*
#55MeSH descriptor Anxiety, this term only
#56(manage*) NEAR (anxiety or depres*)
#57CBT
#58hypnotherap*
#59goal NEAR/3 setting
#60(psycho-educat*) or (psychoeducat*)
#61motivat* NEAR interv*
#62MeSH descriptor Psychopathology explode all trees
#63psychopathol*
#64MeSH descriptor Autogenic Training explode all trees
#65autogenic*
#66self near (manage* or care or motivat*)
#67distress*
#68psychosocial* or psycho-social
#69MeSH descriptor Health Education explode all trees
#70(nutrition or diet or health) NEAR education
#71heart manual
#72(#25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37)
#73(#38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR
#51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR #64 OR
#65 OR #66 OR #67 OR #68 OR #69 OR #70 OR #71)
#74(#72 OR #73)
#75(#74 AND #24)
MEDLINE DIALOG to WEEK 1 2008
1. SEARCH: MYOCARDIAL-ISCHEMIA#.DE.
2. SEARCH: MYOCARD$4 NEAR (ISCHAEMI$2 OR ISCHEMI$2)
3. SEARCH: (ISCHAEMI$2 OR ISCHEMI$2) NEAR HEART
4. SEARCH: CORONARY-ARTERY-BYPASS#.DE.
5. SEARCH: CORONARY.TI,AB.
6. SEARCH: CORONARY-DISEASE#.DE.
7. SEARCH: MYOCARDIAL-REVASCULARIZATION#.DE.
8. SEARCH: MYOCARDIAL-INFARCTION#.DE.
9. SEARCH: MYOCARD$5 NEAR INFARCT$5
10. SEARCH: HEART NEAR INFARCT$5
11. SEARCH: ANGINA-PECTORIS#.DE.
12. SEARCH: ANGINA.TI,AB.
13. SEARCH: HEART-FAILURE-CONGESTIVE#.DE.
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14. SEARCH: HEART NEAR FAILURE
15. SEARCH: 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14
16. SEARCH: HEART-DISEASES#.DE.
17. SEARCH: (HEART NEAR DISEASE$2).TI,AB.
18. SEARCH: MYOCARD$5.TI,AB.
19. SEARCH: CARDIAC$2.TI,AB.
20. SEARCH: CABG
21. SEARCH: PTCA
22. SEARCH: STENT$4 AND (HEART OR CARDIAC$4)
23. SEARCH: HEART-BYPASS-LEFT#.DE. OR HEART-BYPASS-RIGHT#.DE.
24. SEARCH: 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23
25. SEARCH: REHABILITATION-CENTERS.DE.
26. SEARCH: EXERCISE-THERAPY#.DE.
27. SEARCH: REHABILITATION.W..DE.
28. SEARCH: SPORTS#.W..DE.
29. SEARCH: EXERTION#.W..DE.
30. SEARCH: EXERCISE#.W..DE.
31. SEARCH: REHABILITAT$5.TI,AB.
32. SEARCH: PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$5 OR THERAP$5 OR ACTIVIT$5)
33. SEARCH: TRAIN$5 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)
34. SEARCH: (EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)
35. SEARCH: PATIENT-EDUCATION#.DE.
36. SEARCH: PATIENT$2 NEAR EDUCAT$4
37. SEARCH: (LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)
38. SEARCH: SELF-CARE.DE.
39. SEARCH: SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)
40. SEARCH: AMBULATORY-CARE.DE.
41. SEARCH: PSYCHOTHERAPY#.W..DE.
42. SEARCH: PSYCHOTHERAP$2.TI,AB.
43. SEARCH: PSYCHOLOG$5 NEAR INTERVENT$5
44. SEARCH: RELAX$6.TI,AB.
45. SEARCH: RELAXATION-TECHNIQUES#.DE. OR MIND-BODY-AND-RELAXATION-TECHNIQUES#.DE.
46. SEARCH: COUNSELING#.W..DE.
47. SEARCH: (COUNSELLING OR COUNSELING).TI,AB.
48. SEARCH: COGNITIVE-THERAPY#.DE.
49. SEARCH: BEHAVIOR-THERAPY#.DE.
50. SEARCH: (BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAP$2 OR CHANGE)
51. SEARCH: STRESS-PSYCHOLOGICAL#.DE.
52. SEARCH: STRESS NEAR MANAGEMENT
53. SEARCH: COGNITIVE NEAR THERAP$2
54. SEARCH: MEDITAT$4
55. SEARCH: MEDITATION#.W..DE.
56. SEARCH: ANXIETY#.W..DE.
57. SEARCH: MANAGE$5 NEAR (ANXIETY OR DEPRES$5)
58. SEARCH: CBT.TI,AB.
59. SEARCH: HYPNOTHERAP$5
60. SEARCH: GOAL NEAR SETTING
61. SEARCH: GOAL$2 NEAR SETTING
62. SEARCH: PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
63. SEARCH: MOTIVAT$5 NEAR (INTERVENTION OR INTERV$3)
64. SEARCH: PSYCHOPATHOLOGY#.W..DE.
65. SEARCH: PSYCHOPATHOL$4.TI,AB.
66. SEARCH: PSYCHOSOCIAL$4.TI,AB.
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67. SEARCH: DISTRESS$4.TI,AB.
68. SEARCH: HEALTH-EDUCATION#.DE.
69. SEARCH: HEALTH NEAR EDUCATION
70. SEARCH: HEART ADJ MANUAL
71. SEARCH: AUTOGENIC-TRAINING#.DE.
72. SEARCH: AUTOGENIC$5.TI.AB.
73. SEARCH: 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38
74. SEARCH: 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53
OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR 66 OR 67 OR 68 OR 69 OR
70 OR 71 OR 72
75. SEARCH: 15 OR 24
76. SEARCH: 73 or 74
77. SEARCH: 75 AND 76
78. SEARCH: RANDOMIZED-CONTROLLED-TRIALS#.DE.
79. SEARCH: PT=RANDOMIZED-CONTROLLED-TRIAL
80. SEARCH: PT=CONTROLLED-CLINICAL-TRIAL
81. SEARCH: CONTROLLED-CLINICAL-TRIALS#.DE.
82. SEARCH: RANDOM-ALLOCATION#.DE.
83. SEARCH: DOUBLE-BLIND-METHOD#.DE.
84. SEARCH: SINGLE-BLIND-METHOD#.DE.
85. SEARCH: (RANDOM$ OR PLACEBO$).TI,AB.
86. SEARCH: ((SINGL$3 OR DOUBL$3 OR TRIPL$3 OR TREBL$3) NEAR (BLIND$3 OR MASK$3)).TI,AB.
87. SEARCH: RESEARCH-DESIGN#.DE.
88. SEARCH: PT=CLINICAL-TRIAL#
89. SEARCH: CLINICAL-TRIALS#.DE.
90. SEARCH: (CLINIC$3 ADJ TRIAL$2).TI,AB.
91. SEARCH: 77 AND 90
92. SEARCH: (ANIMALS NOT HUMANS).SH.
93. SEARCH: 91 NOT 92
94. SEARCH: LIMIT 93 TO 2001-DATE
EMBASE DIALOG to WEEK 1 2008
1. HEART-DISEASE#.DE.
2. (MYOCARD$4 NEAR (ISCHAEMI$2 OR ISCHEMI$2)).TI,AB.
3. ((ISCHAEMI$2 OR ISCHEMI$2) NEAR HEART).TI,AB.
4. CORONARY-ARTERY-DISEASE#.DE.
5. TRANSLUMINAL-CORONARY-ANGIOPLASTY#.DE.
6. (CORONARY NEAR (DISEASE$2 OR BYPASS$2 OR THROMBO$5 OR ANGIOPLAST$2)).TI,AB.
7. HEART-INFARCTION#.DE.
8. (MYOCARD$4 NEAR INFARCT$5).TI,AB.
9. (HEART NEAR INFARC$5).TI,AB.
10. HEART-MUSCLE-REVASCULARIZATION#.DE.
11. ANGINA-PECTORIS#.DE.
12. ANGINA.TI,AB.
13. CONGESTIVE-HEART-FAILURE#.DE.
14. (HEART NEAR FAILURE).TI,AB.
15. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14
16. (HEART NEAR DISEASE$2).TI,AB.
17. CARDIAC$2.TI,AB.
18. CABG.TI,AB.
19. PTCA.TI,AB.
20. STENT$4.TI,AB. AND HEART.TI,AB.
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21. EXTRACORPOREAL-CIRCULATION#.DE.
22. 16 OR 17 OR 18 OR 19 OR 20 OR 21
23. 15 OR 22
24. PSYCHOTHERAPY#.W..DE.
25. PSYCHOTHERAP$2.TI,AB.
26. PSYCHOLOG$5 NEAR INTERVENT$5
27. RELAX$6.TI,AB.
28. RELAXATION-TRAINING#.DE.
29. COUNSELING#.W..DE.
30. (COUNSELLING OR COUNSELING).TI,AB.
31. (BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAPY$2 OR CHANGE)
32. STRESS-MANAGEMENT#.DE.
33. STRESS NEAR MANAGEMENT
34. MEDITATION#.W..DE.
35. MEDITAT$5.TI,AB.
36. MANAGE$5 NEAR (ANXIETY OR DEPRES$5)
37. CBT.TI,AB.
38. HYPNOTHERAP$2.TI,AB.
39. GOAL$2 NEAR SETTING
40. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
41. MOTIVAT$5 NEAR INTERVENT$6
42. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
43. PSYCHOSOCIAL.TI,AB.
44. HEALTH-EDUCATION#.DE.
45. HEALTH NEAR EDUCATION
46. HEART ADJ MANUAL
47. AUTOGENIC-TRAINING#.DE.
48. AUTOGENIC.TI,AB.
49. REHABILITATION#.W..DE.
50. REHABILITATION-CENTER#.DE.
51. REHABIL$.TI,AB.
52. SPORT#.W..DE.
53. KINESIOTHERAPY#.W..DE.
54. EXERCISE#.W..DE.
55. PHYSIOTHERAPY#.W..DE.
56. PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$5 OR THERAP$5 OR ACTIVIT$5)
57. TRAIN$5 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)
58. (EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)
59. AEROBIC$4 NEAR EXERCISE$4
60. (KINESIOTHERAPY OR PHYSIOTHERAPY).TI,AB.
61. PATIENT-EDUCATION#.DE.
62. PATIENT$2 NEAR EDUCAT$4
63. (LIFESTYLE OR LIFE ADJ STYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)
64. SELF-CARE#.DE.
65. SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)
66. AMBULATORY-CARE#.DE.
67. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
68. MOTIVAT$5 NEAR INTERVENT$6
69. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
70. PSYCHOSOCIAL.TI,AB.
71. HEALTH-EDUCATION#.DE.
72. HEALTH NEAR EDUCATION
73. HEART ADJ MANUAL
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74. AUTOGENIC-TRAINING#.DE.
75. AUTOGENIC.TI,AB.
76. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
77. MOTIVAT$5 NEAR INTERVENT$6
78. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
79. PSYCHOSOCIAL.TI,AB.
80. HEALTH-EDUCATION#.DE.
81. HEALTH NEAR EDUCATION
82. HEART ADJ MANUAL
83. 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or
42 or 43 or 44 or 45 or 46 or 47 or 48 or 49
84 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR
66 OR 67 OR 68 OR 69 OR 70 OR 71 OR 72 OR 73 OR 74 OR 75 OR 76 OR 77 OR 78 OR 79 OR 80 OR 81 OR 82
85. 83 OR 84
86. (RANDOM$ OR PLACEBO$).TI,AB.
87. (SINGL$4 OR DOUBLE$4 OR TRIPLE$4 OR TREBLE$4).TI,AB. AND (BLIND$4 OR MASK$4).TI,AB.
88. (CONTROLLED ADJ CLINICAL ADJ TRIAL).TI,AB.
89. RANDOMIZED-CONTROLLED-TRIAL#.DE.
90. 1 OR 2 OR 3 OR 4
91. 23 AND 85
92. 91 AND 92
93. LIMIT 92 TO 2001-2008
CINAHL DIALOG to WEEK 1 2008
1. ((MYOCARD$4 OR HEART) NEAR (ISCHAEMI$2 OR ISCHEMI$2)).TI,AB.
2. CORONARY.TI,AB.
3. ((MYOCARD$4 OR HEART) NEAR INFARC$5).TI,AB.
4. ANGINA.TI,AB.
5. (HEART NEAR FAILURE).TI,AB.
6. (HEART NEAR DISEAS$2).TI,AB.
7. CARDIAC$2.TI,AB.
8. CABG
9. PTCA
10. STENT$4.TI,AB. AND (HEART OR CARDIAC$4).TI,AB.
11. MYOCARDIAL-ISCHEMIA#.DE.
12. MYOCARDIAL-INFARCTION#.DE.
13. CORONARY-ARTERY-BYPASS#.DE.
14. CORONARY-DISEASE#.DE.
15. CARDIAC-PATIENTS#.DE.
16. MYOCARDIAL-DISEASES#.DE.
17. MYOCARDIAL-REVASCULARIZATION#.DE.
18. HEART-DISEASES#.DE.
19. CARDIOVASCULAR-DISEASES#.DE.
20. HEART-FAILURE-CONGESTIVE#.DE.
21. ANGINA-PECTORIS#.DE.
22. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18
OR 19 OR 20 OR 21
23. REHABILITATION#.W..DE.
24. SPORTS#.W..DE.
25. EXERCISE#.W..DE.
26. PHYSICAL-ACTIVITY#.DE.
27. MUSCLE-STRENGTHENING#.DE.
108Exercise-based rehabilitation for heart failure (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
28. AEROBIC-EXERCISES#.DE.
29. PHYSICAL-FITNESS#.DE.
30. PATIENT-EDUCATION#.DE.
31. THERAPEUTIC-EXERCISE#.DE.
32. REHABILITAT$5.TI,AB.
33. (PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$4 OR THERAP$5 OR ACTIVIT$4)).TI,AB.
34. (TRAIN$4 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)).TI,AB.
35. ((EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)).TI,AB.
36. (PATIENT$2 NEAR EDUCAT$4).TI,AB.
37. ((LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)).TI,AB.
38. SELF-CARE#.DE.
39. (SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)).TI,AB.
40. AMBULATORY-CARE#.DE.
41 AEROBIC.TI,AB.
42. RESISTANCE ADJ TRAIN$4
43. MUSCLE ADJ STRENGTH$5
44. AEROBIC.TI,AB.
45. RESISTANCE ADJ TRAIN$4
46. MUSCLE ADJ STRENGTH$5
47. PSYCHOTHERAPY#.W..DE.
48. PSYCHOTHERAP$2.TI,AB.
49. (PSYCHOLOG$5 NEAR INTERVENT$5).TI,AB.
50. RELAX.TI,AB.
51. RELAXATION-TECHNIQUES#.DE.
52. (COUNSELLING OR COUNSELING).TI,AB.
53. COUNSELING#.W..DE.
54. ((BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAP$2 OR CHANGE)).TI,AB.
55. STRESS-MANAGEMENT#.DE.
56. (STRESS NEAR MANAG$5).TI,AB.
57. (COGNITIVE NEAR THERAP$2).TI,AB.
58. MEDITATION#.W..DE.
59. MEDITAT$5.TI,AB.
60. ANXIETY#.W..DE.
61. (MANAGE$5 NEAR (ANXIETY OR DEPRESS$5)).TI,AB.
62. CBT.TI,AB.
63. HYPNOTHERAP$5.TI,AB.
64. (GOAL$2 NEAR SETTING).TI,AB.
65. (PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5).TI,AB.
66. (MOTIVAT$5 NEAR (INTERV$3 OR INTERVENT$5)).TI,AB.
67. PSYCHOSOCIAL$4.TI,AB.
68. HEALTH-EDUCATION#.DE.
69. (HEALTH NEAR EDUCAT$5).TI,AB.
70. HEART ADJ MANUAL
71. AUTOGENIC$3.TI,AB.
72. 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR
39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46
73. 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR
63 OR 64 OR 65 OR 66 OR 67 OR 68 OR 69 OR 70 OR 71
74. 72 OR 73
75. 22 AND 74
76. PT=CLINICAL-TRIAL
77. CLINICAL-TRIALS#.DE.
78. (RANDOM$5 OR PLACEBO$2).TI,AB.
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79. (SINGL$ OR DOUBLE$ OR TRIPLE$ OR TREBLE$).TI,AB. AND (BLIND$ OR MASK$).TI,AB.
80. CONTROLLED ADJ CLINICAL ADJ TRIALS
81. 76 OR 77 OR 78 OR 79 OR 80
82. 75 AND 81
83. LIMIT 82 TO 2001-2008
PsycINFO DIALOG TO JANWEEK 1
1. SEARCH: HEART-DISORDERS#.DE.
2. SEARCH: MYOCARDIAL-INFARCTIONS.DE.
3. SEARCH: ISCHEMIA#.W..DE.
4. SEARCH: HEART-SURGERY.DE.
5. SEARCH: ANGIOPLASTY
6. SEARCH: HEART ADJ BYPASS
7. SEARCH: CORONARY.TI,AB.
8. SEARCH: (ISCHEMI$3 OR ISCHAEMI$3).TI,AB.
9. SEARCH: (MYOCARD$5 NEAR INFARCT$5).TI,AB.
10. SEARCH: (HEART NEAR (INFARC$5 OR FAILURE OR ATTACK)).TI,AB.
11. SEARCH: ANGINA.TI,AB.
12. SEARCH: (HEART NEAR DISEASE$2).TI,AB.
13. SEARCH: MYOCARD$5.TI,AB.
14. SEARCH: CARDIAC$4.TI,AB.
15. SEARCH: CABG.TI,AB.
16. SEARCH: PTCA.TI,AB.
17. SEARCH: 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16
18. SEARCH: PHYSICAL-ACTIVITY#.DE.
19. SEARCH: SPORTS#.W..DE.
20. SEARCH: PHYSICAL-EDUCATION.DE.
21. SEARCH: HEALTH-BEHAVIOR#.DE.
22. SEARCH: PHYSICAL-FITNESS.DE.
23. SEARCH: (PHYSICAL ADJ EDUCATION).TI,AB.
24 SEARCH: EXERTION.TI,AB.
25. SEARCH: REHABILITAT$6.TI,AB.
26. SEARCH: (PHYSICAL NEAR (FIT$5 OR TRAIN$5 OR THERAP$5 OR ACTIVIT$4)).TI,AB.
27. SEARCH: (TRAIN$4 NEAR (STRENGTH$4 OR AEROBIC OR EXERCISE$2)).TI,AB.
28. SEARCH: ((EXERCISE$3 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$4 OR
THERAP$2)).TI,AB.
29. SEARCH: (PATIENT WITH EDUCATION).TI,AB.
30. SEARCH: CLIENT-EDUCATION#.DE.
31. SEARCH: HEALTH-PROMOTION#.DE.
32. SEARCH: ((LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)).TI,AB.
33. SEARCH: OUTPATIENT-TREATMENT#.DE.
34. SEARCH: 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32
OR 33
35. SEARCH: PSYCHOTHERAPY#.W..DE.
36 SEARCH: PSYCHOTHERAP$2.TI,AB.
37 SEARCH: TREATMENT#.W..DE.
38 SEARCH: (PSYCHOLOG$4 NEAR INTERVENT$5).TI,AB.
39 SEARCH: COUNSELING#.W..DE.
40 SEARCH: COPING-BEHAVIOR#.DE.
41 SEARCH: MEDITATION.W..DE.
42 SEARCH: AUTOGENIC-TRAINING.DE.
43 SEARCH: HEALTH-EDUCATION#.DE.
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44. SEARCH: RELAX$6.TI,AB.
45. SEARCH: (COUNSELLING OR COUNSELING).TI,AB.
46. SEARCH: ((BEHAVIOUROR BEHAVIOR) NEAR (MODIF$5 ORTHERAP$5 OR REHABILIT$5 ORCHANGE)).TI,AB.
47. SEARCH: (STRESS NEAR MANAGE$5).TI,AB.
48. SEARCH: MEDITAT$5.TI,AB.
49. SEARCH: (MANAGE$5 NEAR (ANXIETY OR DEPRES$5)).TI,AB.
50. SEARCH: (CBT OR COGNITIV$2 NEAR THERAP$3).TI,AB.
51. SEARCH: HYPNOTHERAP$3.TI,AB.
52. SEARCH: (PSYCHO-EDUCAT$6 OR PSYCHOEDUCAT$6).TI,AB.
53. SEARCH: (MOTIVAT$5 NEAR INTERVENT$5).TI,AB.
54. SEARCH: (SELF NEAR MANAG$6).TI,AB.
55. SEARCH: AUTOGENIC$3.TI,AB.
56. SEARCH: (GOAL NEAR SETTING).TI,AB.
57. SEARCH: (HEALTH NEAR EDUCATION).TI,AB.
58. SEARCH: (HEART ADJ MANUAL).TI,AB.
59. SEARCH: 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49
OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58
60. SEARCH: 17 AND (34 OR 59)
61. SEARCH: (RANDOM$5 OR PLACEBO$5).TI,AB.
62. SEARCH: (DOUBLE$4 OR SINGLE$4 OR TRIPLE$4).TI,AB. AND (BLIND$4 OR MASK OR SHAM$4 OR
DUMMY).TI,AB.
63. SEARCH: RCT.TI,AB.
64. SEARCH: AT=TREATMENT$
65. SEARCH: 61 OR 62 OR 63 OR 64
66. SEARCH: 60 AND 66
67. SEARCH: LIMIT 66 TO YRS=2001-2008
ISI Proceedings, search date 1 April 2008
# 7 807 #5 and #6
Databases=STP Timespan=2001-2008
# 6 29,517 TS=(rehab* or educat*)
Databases=STP Timespan=2001-2008
# 5 52,687 #4 OR #3 OR #2 OR #1
Databases=STP Timespan=2001-2008
# 4 27,506 TS=(angina or cardiac* or PTCA or CABG)
Databases=STP Timespan=2001-2008
# 3 11,226 TS=((heart) SAME (infarct* or isch?emia or failure or attack))
Databases=STP Timespan=2001-2008
# 2 12,618 TS=((coronary* or heart*) SAME (by?pass or disease*))
Databases=STP Timespan=2001-2008
# 1 11,809 TS=((myocard*) SAME (isch?emia or infarct* or revasculari?*))
Databases=STP Timespan=2001-2008
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Appendix 3. Search strategies 2013
CENTRAL on The Cochrane Library 2013, Issue 1
1. MeSH descriptor: [Myocardial Ischemia] explode all trees
2. (myocard* near isch*mi*):ti or (myocard* near isch*mi*):ab
3. (isch*mi* near heart):ti or (isch*mi* near heart):ab
4. MeSH descriptor: [Coronary Artery Bypass] explode all trees
5. (coronary):ti or (coronary):ab
6. MeSH descriptor: [Coronary Disease] explode all trees
7. MeSH descriptor: [Myocardial Revascularization] explode all trees
8. MeSH descriptor: [Myocardial Infarction] explode all trees
9. (myocard* near infarct*):ti or (myocard* near infarct*):ab
10. (heart near infarct*):ti or (heart near infarct*):ab
11. MeSH descriptor: [Angina Pectoris] explode all trees
12. (angina):ti or (angina):ab
13. MeSH descriptor: [Heart Failure] explode all trees
14. (heart and (failure or attack)):ti or (heart and (failure or attack)):ab
15. (Heart diseases):ti or (Heart diseases):ab
16. MeSH descriptor: [Heart Diseases] explode all trees
17. (heart and (disease*)):ti or (heart and (disease*)):ab
18. (myocard*):ti or (myocard*):ab
19. (cardiac*):ti or (cardiac*):ab
20. (CABG):ti or (CABG):ab
21. (PTCA):ti or (PTCA):ab
22. (stent* and (heart or cardiac*)):ti or (stent* and (heart or cardiac*)):ab
23. MeSH descriptor: [Heart Bypass, Left] explode all trees
24. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”):ti or (HFNEF or HFPEF or HFREF or “HF NEF” or
“HF PEF” or “HF REF”):ab
25. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #
20 or #21 or #22 or #23 or #24)
26. MeSH descriptor: [Rehabilitation Centers] this term only
27. MeSH descriptor: [Exercise Therapy] explode all trees
28. MeSH descriptor: [Sports] this term only
29. MeSH descriptor: [Physical Exertion] explode all trees
30. (rehabilitat*):ti or (rehabilitat*):ab
31. (physical* near (fit* or train* or therap* or activit*)):ti or (physical* near (fit* or train* or therap* or activit*)):ab
32. MeSH descriptor: [Exercise] explode all trees
33. (train*) near (strength* or aerobic or exercise*):ti or (train*) near (strength* or aerobic or exercise*):ab
34. ((exercise* or fitness) near/3 (treatment or intervent* or program*)):ti or ((exercise* or fitness) near/3 (treatment or intervent* or
program*)):ab
35. MeSH descriptor: [Rehabilitation] explode all trees
36. MeSH descriptor: [Patient Education as Topic] this term only
37. (patient* near/3 educat*):ti or (patient* near/3 educat*):ab
38. ((lifestyle or life-style) near/3 (intervent* or program* or treatment*)):ti or ((lifestyle or life-style) near/3 (intervent* or program*
or treatment*)):ab
39. MeSH descriptor: [Self Care] explode all trees
40. MeSH descriptor: [Ambulatory Care] explode all trees
41. MeSH descriptor: [Psychotherapy] explode all trees
42. (psychotherap*):ti or (psychotherap*):ab
43. (psycholog* near intervent*):ti or (psycholog* near intervent*):ab
44. (relax*):ti or (relax*):ab
45. MeSH descriptor: [Mind-Body Therapies] explode all trees
46. ((Mind or Body) and (Relaxation Techniques)):ti or ((Mind or Body) and (Relaxation Techniques)):ab
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47. MeSH descriptor: [Counseling] explode all trees
48. (counseling or counselling):ti or (counseling or counselling):ab
49. MeSH descriptor: [Cognitive Therapy] explode all trees
50. MeSH descriptor: [Behavior Therapy] explode all trees
51. ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):ti or ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):
ab
52. MeSH descriptor: [Stress, Psychological] explode all trees
53. (stress near manage*):ti or (stress near manage*):ab
54. (cognitive* near therap*):ti or (cognitive* near therap*):ab
55. MeSH descriptor: [Meditation] explode all trees
56. (meditat*):ti or (meditat*):ab
57. MeSH descriptor: [Anxiety] this term only
58. ((manage*) near (anxiety or depres*)):ti or ((manage*) near (anxiety or depres*)):ab
59. (CBT):ti or (CBT):ab
60. (hypnotherap*):ti or (hypnotherap*):ab
61. (goal near/3 (setting)):ti or (goal near/3 (setting)):ab
62. ((psycho-educat*) or (psychoeducat*)):ti ((psycho-educat*) or (psychoeducat*)):ab
63. (motivat* near (interv*)):ti or (motivat* near (interv*)):ab
64. MeSH descriptor: [Psychopathology] explode all trees
65. (psychopathol*):ti or (psychopathol*):ab
66. MeSH descriptor: [Autogenic Training] explode all trees
67. (autogenic*):ti or (autogenic*):ab
68. (self near (manage* or care or motivat*)):ti or (self near (manage* or care or motivat*)):ab
69. (distress*):ti or (distress*):ab
70. (psychosocial* or psycho-social):ti or (psychosocial* or psycho-social):ab
71. MeSH descriptor: [Health Education] explode all trees
72. (nutrition or diet or health near (education)):ti or (nutrition or diet or health near (education)):ab
73. (heart manual):ti or (heart manual):ab
74. (#26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37)
75. (#38 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56
or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73)
76. (#74 or #75)
77. (#76 and #25)
78. #77 from 2008, in Trials
MEDLINE(R) Ovid 1946 to January week 4 2013
1. exp Myocardial Ischemia/
2. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
3. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4. exp Coronary Artery Bypass/
5. coronary.ti,ab.
6. exp Coronary Disease/
7. exp Myocardial Revascularization/
8. Myocardial Infarction/
9. (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 infarct$5).ti,ab.
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp Heart Failure/
14. (heart adj5 failure).ti,ab.
15. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
16. or/1-15
17. exp Heart Diseases/
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18. (heart adj5 disease$2).ti,ab.
19. myocard$5.ti,ab.
20. cardiac$2.ti,ab.
21. CABG.ti,ab.
22. PTCA.ti,ab.
23. (stent$4 and (heart or cardiac$4)).ti,ab.
24. Heart Bypass, Left/ or exp Heart Bypass, Right/
25. or/17-24
26. *Rehabilitation Centers/
27. exp Exercise Therapy/
28. *Rehabilitation/
29. exp Sports/
30. Physical Exertion/ or exertion.ti,ab.
31. exp Exercise/
32. rehabilitat$5.ti,ab.
33. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
34. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
35. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
36. Patient Education as Topic/
37. (patient$2 adj5 educat$4).ti,ab.
38. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
39. *Self Care/
40. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
41. *Ambulatory Care/
42. exp Psychotherapy/
43. psychotherap$2.ti,ab.
44. (psycholog$5 adj5 intervent$5).ti,ab.
45. relax$6.ti,ab.
46. exp Relaxation Therapy/ or exp Mind-Body Therapies/
47. exp Counseling/
48. (counselling or counseling).ti,ab.
49. exp Cognitive Therapy/
50. exp Behavior Therapy/
51. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
52. *Stress, Psychological/
53. (stress adj5 management).ti,ab.
54. (cognitive adj5 therap$2).ti,ab.
55. meditat$4.ti,ab.
56. *Meditation/
57. exp Anxiety/
58. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
59. CBT.ti,ab.
60. hypnotherap$5.ti,ab.
61. (goal adj5 setting).ti,ab.
62. (goal$2 adj5 setting).ti,ab.
63. (psycho-educat$5 or psychoeducat$5).ti,ab.
64. (motivat$5 adj5 (intervention or interv$3)).ti,ab.
65. Psychopathology/
66. psychopathol$4.ti,ab.
67. psychosocial$4.ti,ab.
68. distress$4.ti,ab.
69. exp Health Education/
70. (health adj5 education).ti,ab.
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71. (heart adj5 manual).ti,ab.
72. Autogenic Training/
73. autogenic$5.ti,ab.
74. or/26-39
75. or/40-73
76. 16 or 25
77. 74 or 75
78. 76 and 77
79. randomized controlled trial/
80. randomized controlled trial.pt.
81. controlled clinical trial.pt.
82. controlled clinical trial/
83. Random Allocation/
84. Double-Blind Method/
85. single-blind method/
86. (random$ or placebo$).ti,ab.
87. ((singl$3 or doubl$3 or tripl$3 or trebl$3) adj5 (blind$3 or mask$3)).ti,ab.
88. exp Research Design/
89. Clinical Trial.pt.
90. exp clinical trial/
91. (clinic$3 adj trial$2).ti,ab.
92. or/79-91
93. 78 and 92
94. (Animals not Humans).sh.
95. 93 not 94
96. limit 95 to yr=“2008 -Current”
MEDLINE In-Process and Other Non-Indexed Citations Ovid 5 February 2013
1. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
2. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
3. coronary.ti,ab.
4. (myocard$5 adj5 infarct$5).ti,ab.
5. (heart adj5 infarct$5).ti,ab.
6. angina.ti,ab.
7. (heart adj5 failure).ti,ab.
8. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
9. or/1-8
10. (heart adj5 disease$2).ti,ab.
11. myocard$5.ti,ab.
12. cardiac$2.ti,ab.
13. CABG.ti,ab.
14. PTCA.ti,ab.
15. (stent$4 and (heart or cardiac$4)).ti,ab.
16. or/10-15
17. Physical Exertion/ or exertion.ti,ab.
18. rehabilitat$5.ti,ab.
19. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
20. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
21. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
22. (patient$2 adj5 educat$4).ti,ab.
23. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
24. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
25. psychotherap$2.ti,ab.
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26. (psycholog$5 adj5 intervent$5).ti,ab.
27. relax$6.ti,ab.
28. (counselling or counseling).ti,ab.
29. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
30. (stress adj5 management).ti,ab.
31. (cognitive adj5 therap$2).ti,ab.
32. meditat$4.ti,ab.
33. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
34. CBT.ti,ab.
35. hypnotherap$5.ti,ab.
36. (goal adj5 setting).ti,ab.
37. (goal$2 adj5 setting).ti,ab.
38. (psycho-educat$5 or psychoeducat$5).ti,ab.
39. (motivat$5 adj5 (intervention or interv$3)).ti,ab.
40. psychopathol$4.ti,ab.
41. psychosocial$4.ti,ab.
42. distress$4.ti,ab.
43. (health adj5 education).ti,ab.
44. (heart adj5 manual).ti,ab.
45. autogenic$5.ti,ab.
46. or/17-45
47. 9 or 16
48. 46 and 47
49. (random$ or placebo$).ti,ab.
50. ((singl$3 or doubl$3 or tripl$3 or trebl$3) adj5 (blind$3 or mask$3)).ti,ab.
51. (clinic$3 adj trial$2).ti,ab.
52. 49 or 50 or 51
53. 48 and 52
54. limit 53 to yr=“2008 -Current”
EMBASE Ovid 1980 to 2013 week 5
1. exp heart disease/
2. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
3. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4. exp coronary artery disease/
5. transluminal coronary angioplasty/
6. (coronary adj5 (disease$2 or bypass$2 or thrombo$5 or angioplasty$2)).ti,ab.
7. exp heart infarction/
8. (myocard$5 adj5 infarct$5).ti,ab.
9. (heart adj5 infarct$5).ti,ab.
10. heart muscle revascularization/
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp congestive heart failure/
14. (heart adj5 failure).ti,ab.
15. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
16. or/1-15
17. (heart adj5 disease$2).ti,ab.
18. cardiac$2.ti,ab.
19. CABG.ti,ab.
20. PTCA.ti,ab.
21. (stent$4 and heart).ti,ab.
22. exp extracorporeal circulation/
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23. or/17-22
24. 16 or 23
25. *Psychotherapy/
26. psychotherapy$2.ti,ab.
27. (psycholog$5 adj5 intervent$5).ti,ab.
28. relax$6.ti,ab.
29. relaxation training/
30. *counselling/
31. (counselling or counseling).ti,ab.
32. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
33. stress management/
34. (stress adj5 management).ti,ab.
35. *Mediation/
36. meditat$5.ti,ab.
37. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
38. CBT.ti,ab.
39. hypnotherap$2.ti,ab.
40. (goal$2 adj5 setting).ti,ab.
41. (psycho-educat$5 or psychoeducat$5).ti,ab.
42. (motivat$5 adj5 intervent$6).ti,ab.
43. exp psychosocial care/ or exp psychosocial rehabilitation/
44. psychosocial.ti,ab.
45. exp health education/
46. (health adj5 education).ti,ab.
47. (heart adj5 manual).ti,ab.
48. autogenic training/
49. autogenic.ti,ab.
50. *Rehabilitation/
51. rehabilitation center/
52. rehabil$.ti,ab.
53. exp Sport/
54. exp Kinesiotherapy/
55. exp Exercise/
56. exp Physiotherapy/
57. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
58. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
59. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
60. (aerobic$4 adj5 exercise$4).ti,ab.
61. (kinesiotherapy or physiotherapy).ti,ab.
62. patient education/
63. (patient$2 adj5 educat$4).ti,ab.
64. ((((lifestyle or life) adj1 style) or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
65. exp self care/
66. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
67. exp ambulatory care/
68. (psycho-educat$5 or psychoeducat$5).ti,ab.
69. (motivat$5 adj5 intervent$6).ti,ab.
70. psychosocial care/ or psychosocial rehabilitation/
71. psychosocial.ti,ab.
72. exp health education/
73. (health adj5 education).ti,ab.
74. (heart adj5 manual).ti,ab.
75. autogenic training/
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76. autogenic$5.ti,ab.
77. (psycho-educat$5 or psychoeducat$5).ti,ab.
78. (motivat$5 adj5 intervent$6).ti,ab.
79. psychosocial care/ or psychosocial rehabilitation/
80. psychosocial.ti,ab.
81. exp health education/
82. (health adj5 education).ti,ab.
83. (heart adj5 manual).ti,ab.
84. or/25-50
85. or/51-83
86. 84 or 85
87. (random$ or placebo$).ti,ab.
88. ((singl$4 or doubl$4 or tripl$4 or trebl$4) adj5 (blind$4 or mask$4)).ti,ab.
89. (controlled adj1 clinical adj1 trial).ti,ab.
90. randomized controlled trial/
91. or/87-90
92. 24 and 86
93. 91 and 92
94. (animal$ not human$).sh,hw.
95. 93 not 94
96. limit 95 to yr=“2008 -Current”
PsycINFO Ovid 1806 to January week 5 2013
1. exp heart disorders/
2. *Myocardial Infarctions/
3. exp Ischemia/
4. *Heart Surgery/
5. angioplasty.ti,ab.
6. (heart adj1 bypass).ti,ab.
7. coronary.ti,ab.
8. (ischemi$3 or ischaemi$3).ti,ab.
9. (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 (infarct$5 or failure or attack)).ti,ab.
11. angina.ti,ab.
12. (heart adj5 disease$2).ti,ab.
13. myocard$5.ti,ab.
14. cardiac$4.ti,ab.
15. CABG.ti,ab.
16. PTCA.ti,ab.
17. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
18. or/1-17
19. exp Physical Activity/
20. exp Sports/
21. *Physical Education/
22. exp Health Behavior/
23. *Physical Fitness/
24. (physical adj1 education).ti,ab.
25. exertion$6.ti,ab.
26. rehabilitat$6.ti,ab.
27. (physical adj5 (fit$5 or train$5 or therap$5 or activit$4)).ti,ab.
28. (train$4 adj5 (strength$4 or aerobic or exercise$2)).ti,ab.
29. ((exercise$3 or fitness) adj5 (treatment or intervent$4 or program$4 or therap$2)).ti,ab.
30. patient with education.ti,ab.
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31. exp Client Education/
32. exp Health Promotion/
33. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
34. exp Outpatient Treatment/
35. or/19-34
36. exp Psychotherapy/
37. psychotherapy$2.ti,ab.
38. exp Treatment/
39. (psycholog$4 adj5 intervent$5).ti,ab.
40. exp Counseling/
41. exp Coping Behavior/
42. *Meditation/
43. *Autogenic Training/
44. exp Health Education/
45. relax$6.ti,ab.
46. (counselling or counseling).ti,ab.
47. ((behavior or behaviour) adj5 (modif$5 or therap$5 or rehabilit5 or change)).ti,ab.
48. (stress adj5 management).ti,ab.
49. meditat$5.ti,ab.
50. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
51. ((cbt or cognitive$2) adj5 therap$3).ti,ab.
52. hypnotherap$3.ti,ab.
53. (psycho-educat$6 or psychoeducat$6).ti,ab.
54. (motivat$5 adj5 intervent$5).ti,ab.
55. (self adj5 manag$6).ti,ab.
56. autogenic$3.ti,ab.
57. (goal adj5 setting).ti,ab.
58. (health adj5 education).ti,ab.
59. (heart adj1 manual).ti,ab.
60. or/36-59
61. 18 and (35 or 60)
62. (random$5 or placebo$5).ti,ab.
63. ((single$4 or double$4 or triple$4) and (blind$4 or mask or sham$4 or dummy)).ti,ab.
64. RCT.ti,ab.
65. or/62-64
66. 61 and 65
67. limit 66 to yr=“2008 -Current”
CINAHL EBSCOhost, search date 5 February 2013
1. TI((myocard* N5 ischaemi*) or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*)) OR AB((myocard* N5
ischaemi*) or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*))
2. TI(coronary) or AB(coronary)
3. TI((myocard* N5 infarc*) or (heart N5 infarc*)) or AB((myocard* N5 infarc*) or (heart N5 infarc*))
4. TI(angina) OR AB(angina)
5. TI(heart N5 failure) or AB(heart N5 failure)
6. TI(heart N5 diseas*) or AB(heart N5 diseas*)
7. TI(cardiac) or AB(cardiac)
8. TI(CABG) or AB(CABG)
9. TI(PTCA) or AB(PTCA)
10. TI(Stent* and (heart or cardiac*)) or AB(Stent* and (heart or cardiac*))
11. (MH “Myocardial Ischemia+”)
12. (MH “Myocardial Infarction+”)
13. (MH “Coronary Artery Bypass+”)
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14. (MH “Coronary Disease+”)
15. TI(cardiac N5 patient*) or AB(cardiac N5 patient*)
16. TI(Cardiomyopathies) or AB(Cardiomyopathies)
17. (MH “Myocardial Revascularization+”)
18. (MH “Heart Diseases+”)
19. (MH “Cardiovascular Diseases+”)
20. (MH “Heart Failure+”)
21. (MH “Angina Pectoris+”)
22. TI(HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”) or AB(HFNEF or HFPEF or HFREF or “HF NEF”
or “HF PEF” or “HF REF”)
23. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR
S17 OR S18 OR S19 OR S20 OR S21 OR S22
24. (MM “Rehabilitation”)
25. (MM “Sports”)
26. (MM “Physical Activity”)
27. (MH “Muscle Strengthening+”)
28. (MH “Aerobic Exercises+”)
29. (MH “Physical Fitness+”)
30. (MH “Patient Education+”)
31. (MH “Therapeutic Exercise+”)
32. TI(rehabilitat*) or AB(rehabilitat*)
33. TI((physical* N5 fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*)) or
AB((physical* N5 fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*))
34. TI((train N5 strength) or (train N5 aerobic) or (train N5 exercis*)) or AB((train N5 strength) or (train N5 aerobic) or (train N5
exercis*))
35. TI((exercise N5 treatment) or (fitness N5 treatment) or (exercise N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*)
or (fitness N5 program) or (exercise N5 therapy) or (fitness N5 therapy)) or AB((exercise N5 treatment) or (fitness N5 treatment)
or (exercise N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*) or (fitness N5 program) or (exercise N5 therapy) or
(fitness N5 therapy))
36. TI(patient* N5 educat*) or AB(patient* N5 educat*)
37. TI ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or (life-style N5 program*) or (lifestyle N5
treatment) or (life-style N5 treatment)) OR AB ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or
(life-style N5 program*) or (lifestyle N5 treatment) or (life-style N5 treatment))
38. (MH “Self Care+”)
39. TI((self N5 manage*) or (self N5 care) or (self N5 motivat*)) or AB((self N5 manage*) or (self N5 care) or (self N5 motivat*))
40. (MM “Ambulatory Care”)
41. TI(aerobic) or AB(aerobic)
42. TI(resistance W1 train*) or AB(resistance W1 train*)
43. TI(muscle W1 strength*) or AB(muscle W1 strength*)
44. TI(resistance W1 train*) or AB(resistance W1 train*)
45. TI(muscle W1 strength*) or AB(muscle W1 strength*)
46. (MH “Psychotherapy+”)
47. TI(psychotherap*) or AB(psychotherap*)
48. TI(psycholog* N5 intervent*) or AB(psycholog* N5 intervent*)
49. TI(relax) or AB(relax)
50. (MH “Relaxation Techniques+”)
51. TI(counselling or counseling) or AB(counselling or counseling)
52. (MH “Counseling+”)
53. TI((behavio?r* N5 modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change)) or AB((behavio?
r* N5 modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change))
54. (MM “Stress Management”)
55. TI(stress N5 manag*) or AB(stress N5 manag*)
56. TI(cognitive N5 therap*) or AB(cognitive N5 therap*)
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57. (MM “Meditation”)
58. TI(meditat*) or AB(meditat*)
59. (MH “Anxiety+”)
60. TI((manage* N5 anxiety) or (manage* N5 depress*)) or AB((manage* N5 anxiety) or (manage* N5 depress*))
61. TI(CBT) or AB(CBT)
62. TI(hypnotherap*) or AB(hypnotherap*)
63. TI(goal* N5 setting) or AB(goal* N5 setting)
64. TI(psycho-educat* or psychoeducat*) or AB(psycho-educat* or psychoeducat*)
65. TI((motivat* N5 interv*) or (motivate* N5 intervent*)) or AB((motivat* N5 interv*) or (motivate* N5 intervent*))
66. TI(psychosocial*) or AB(psychosocial*)
67. (MH “Health Education+”)
68. TI(health N5 educat*) or AB(health N5 educat*)
69. TI(heart W1 manual) or AB(heart W1 manual)
70. TI(autogenic*) or AB(autogenic*)
71. S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38
OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45
72. S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60
OR S61 OR S62 OR S63 OR S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70
73. S71 OR S72
74. S23 AND S73
75. PT CLINICAL TRIAL
76. (MH “Clinical Trials+”)
77. TI (random* or placebo*) or AB (random* or placebo*)
78. TI(singl* or double* or triple* or treble* and (blind* or mask*)) or AB(singl* or double* or triple* or treble* and (blind* or mask*))
79. TI(controlled w1 clinical w1 trials) or AB(controlled w1 clinical w1 trials)
80. S75 OR S76 OR S77 OR S78 OR S79
81. S74 AND S80 date limit=2008-current
Web of Science, search date 6 February 2013
1. TS=((myocard*) SAME (isch?emia or infarct* or revasculari?*))
2. TS=((coronary* or heart*) SAME (by?pass or disease*))
3. TS=((heart) SAME (infarct* or isch?emia or failure or attack))
4. TS=(angina or cardiac* or PTCA or CABG)
5. TS=(HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”)
6. #1 OR #2 OR #3 OR #4 OR #5
7. TS=(rehab* or educat*)
8. #6 AND #7
9. TS=(random* or placebo*)
10. TS=((singl* or doubl* or tripl* or trebl*) SAME (blind* or mask*))
11. TS=(“clinic* trial*”)
12. #9 OR #10 OR #11
13. #8 AND #12
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2008-2013
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WH A T ’ S N E W
Last assessed as up-to-date: 30 June 2013.
Date Event Description
1 November 2013 New citation required but conclusions have not
changed
This update review identified a further 14 trials.Whilst
conclusions of the review do not change, this update
provides broader body of evidence of the benefit of
exercise-based interventions that includes HFPEF pa-
tients and delivery in a home-based setting
14 February 2013 New search has been performed Searches updated
H I S T O R Y
Protocol first published: Issue 4, 2001
Review first published: Issue 3, 2004
Date Event Description
18 May 2004 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
Rod Taylor and Viral Sagar led the design of the update review.
Simon Briscoe developed the updated the searches.
Viral Sagar and Rod Taylor undertook study selection, data extraction, assessment of risk of bias and data analysis.
Viral Sagar and Rod Taylor wrote the first draft of the update review, and all co-authors commented on a draft of the report.
D E C L A R A T I O N S O F I N T E R E S T
Rod Taylor and Hayes Dalal are co-lead investigators on an ongoing National Institute for Health Research (NIHR) Programme Grants
for Applied Research funded study - Rehabilitation Enablement in Chronic Heart Failure (REACH-HF) - to develop and evaluate the
costs and outcomes of a home-based self help heart failure exercise rehabilitation manual (RP-PG-1210-12004).
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S O U R C E S O F S U P P O R T
Internal sources
• None, Not specified.
External sources
• None, Not specified.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Compared with previous version of this review, the inclusion criteria extended to include HFPEF.
N O T E S
None.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Exercise Therapy; Chronic Disease; Exercise Tolerance; Health Status; Heart Failure [mortality; ∗rehabilitation]; Quality of Life;
Randomized Controlled Trials as Topic
MeSH check words
Adult; Aged; Humans; Middle Aged; Young Adult
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